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Chapter 1
1 GENERAL INTRODUCTION
1 .1  U rete r  a n d  Re co n s tr u c ti o n  Te c h n i q u e s
The ureter is a tubular organ responsible for the safe transport of urine from the 
kidney to the urinary bladder. The ureter consists of three compartments: i) The 
inner multi-layered lining of urothelial cells (UCs) has a barrier function preventing 
urine from leaking to adjacent tissue and preventing diffusion of toxic products 
and subsequent tissue damage. ii) A muscle layer composed of longitudinally- and 
circumferentially arranged smooth muscle cells (SMCs) organize urine transport by 
active contraction (peristalsis). iii) Connective tissue determines the overall tissue 
architecture and elasticity [1].
Ureter damage is mainly the consequence of trauma such as motor accidents, 
gun shots, or iatrogenic injuries incurred during surgical procedures [2]. Although 
ureteral injury is relatively uncommon, the failure to recognize the injury can lead 
to severe side effects, including sepsis or loss of renal function. Specific anatomical 
characteristics of the ureter, such as the segmental vascular supply, the site of 
ureteral injury (e.g. upper ureter, mid ureter, lower ureter or complete ureter) and 
the lack of native tissue for repair limits surgical ureteral reconstruction possibilities. 
Several surgical techniques are recommended to repair ureteral defects [3,4]: A 
uretero-ureterostomy is the most common repair performed albeit only preferred 
in small size defects of the upper and mid-ureter. Distal ureteral injuries are best 
managed by ureteral reimplantation which can be combined with a psoas hitch 
between the bladder and the ipsilateral psoas tendon. In extensive mid-lower 
ureteral injury, the large gap between ureter and bladder can be bridged with a 
tubularized L-shaped bladder flap (boari flap). Renal auto-transplantation and ileal 
interposition are options in reconstruction of the entire ureter. Especially, creation 
of neotissue using autologous harvested bowel tissue is associated with severe 
side effects and multiple unfavorable outcomes. For example, reconstructive 
surgery using tissue replacements created from tubularized intestine segments 
for ureter reconstruction often result in urinary tract infections, partial small bowel 
obstruction and metabolic imbalances [5,6]. In many cases multiple procedures are 
needed over time, mostly due to (re-)stenosis and (re-)strictures, and ultimately 
nephrectomy may be needed [7,8].
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1 . 2  U rin a r y  B la d d e r  a n d  U rin a r y  D i ve r s i o n
The urinary bladder is a flexible hollow organ which acts a temporary urine reservoir 
until the urine is actively evacuated by means of muscle contraction via the urethra 
to the exterior. The anatomy of the bladder wall is similar to that of the ureter 
and is composed of an multi-layered urothelium, a detrusor muscle composed of 
organized SMCs, and connective tissue [9].
Dysfunction of the urinary bladder are related to congenital defects (e.g. spina 
bifida), nerve damage (e.g. neuropathic bladder), inflammatory conditions (e.g. 
bladder pain syndrome) or tumors arising from bladder cancer. In all cases, surgical 
interventions are restricted to the use of bowel tissue for bladder reconstruction 
or radical cystectomy followed by urinary diversion may often be required. Here, 
the ileal conduit remains the gold standard procedure: Urine is drained from the 
ureters by a piece of small bowel tissue which is anastomosed to the abdominal 
skin surface [10]. However, the ileal conduit is associated with many post-operative 
complications: bowel obstruction, urinary flow obstruction, fistulas, stone formation, 
metabolic- or nutritional disorders are consequences of the bowel surgery and/or 
the urostomy transplantation [11–13].
1 . 3  T i s s u e  En g in e e rin g  ( T E ),  B i o m ate ria l s  a n d  S c af f o l d  D e s i g n
Taken together, alternative graft materials for ureter reconstruction and urinary 
diversion are highly desirable. The field of Tissue Engineering (TE) holds great 
potential to restore functionality of diseased organs and tissue and may circumvent 
gold standard related complications and graft shortage. In the “classical” TE paradigm 
autologous neotissue is created by using a so-called scaffold (aka template or matrix) 
[14]. The scaffold is the backbone of tissue-engineered grafts. The ideal scaffold 
should mimic the tissue of interest as much as possible as it needs to be able to keep 
its form to fill the defect and it needs to adapt to dynamic (bio)mechanical loads 
until its replaced by host tissue [15]. Hence, the scaffold design and its remodeling 
characteristics are pivotal to ensure functionality. Different biomaterials can be used 
to create tubular scaffolds for ureter reconstruction and urinary diversion, which 
can be of synthetic- or natural origin and each class of biomaterials have its specific 
advantages and disadvantages. Scaffolds designed from synthetic biomaterials are 
highly tunable and reproducible in overall architecture and strength but have a 
low bioactivity and biocompatibility. In contrary, scaffolds composed of natural 
biomaterials promote excellent cell adhesion and growth, but show limited design 
tunability and/or strength [16].
1
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Chapter 1
The main structural protein of most hard and soft tissues in mammals, collagen 
may be a promising naturally-derived biomaterial due to its biocompatibility, 
biodegradability, bioactivity and low antigenicity [16,17]. Due to the fact that collagen-
based scaffolds can be tuned to highly porous tubular sponges of various diameter, 
length and pore architecture, they remain ideal candidates for customized tubular 
organ manufacture [18]. Unfortunately, highly porous collagen-based scaffolds have 
poor (bio)mechanical properties and they cannot comply with demands of native 
tissue. Chemical crosslinking by N-ethyl-3-(3-dimethylaminopropyl)-carbodiimide 
(EDC) / N-hydroxysuccinimide (NHS) is mostly performed to enhance overall 
strength and resistance against enzymatic degradation [19–22]. Furthermore, 
EDC/NHS -crosslinking can be used to actively bound growth factors to collagen to 
enhance graft remodeling and vascularization [23,24]. Although, crosslinking can 
enhance overall strength of collagen scaffolds, they remain fragile and their patency 
is strongly diminished during surgery as they can rupture easily [25,26]. Another 
strategy to induce overall strength to collagen-based scaffolds, reinforcement 
with e.g. (tubularized) meshes or electrospun synthetic biomaterials have been 
performed [27–29]. Such hybrid scaffolds may be proper templates for tubular organ 
reconstruction such as the ureter or urinary diversion. The supportive synthetic 
polymer acts as the backbone of the tubular graft providing sufficient strength 
and flexibility, while the collagen acts as the cellular stratum, guiding formation of 
neotissue.
1 .4  M o n ito rin g  o f  T E  Co n s tr u c t s
Traditionally, (immuno)histochemical techniques have been used to evaluate tissue-
engineered constructs at pre-determined time points after implantation. However, 
these methods are destructive, and they do not allow for insights in graft integrity, 
remodeling up to resorption in real-time. Thus, the ability to monitor the fate of 
tissue-engineered constructs upon implantation is a critical need. Several imaging 
modalities are available for monitoring in a noninvasive, highly-sensitive manner 
including X-ray computed tomography (CT), optical coherence tomography (OCT), 
ultrasound (USI), positron emission tomography (PET), single-photon emission 
computed tomography (SPECT), and magnetic resonance imaging (MRI) [30]. 
Especially, MRI is an attractive multi-functional and non-invasive imaging modality 
which does not use ionizing radiation. However, tissue-engineered constructs such 
as collagen-based scaffolds usually give poor contrast as the selected materials 
have similar composition as that of the surrounding host tissue, and thus are 
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difficult to distinguish. In this context, collagen scaffolds have been labeled with 
contrast agents (CAs) such as superparamagnetic iron oxide nanoparticles (USPIOs) 
to enhance their MR visibility [31,32]. USPIOs generate a negative contrast, which 
however may be misinterpreted as other tissue components such as air inclusion 
may also cause negative contrast. Furthermore, the effect of USPIOs on the water 
signal may extend beyond its local presence (´ blooming´ effect) and thus hamper 
their precise localization [31–33]. Since supportive polymers (e.g. electrospun 
material) give also a negative contrast in MR imaging [34–36], alternative CAs are 
desirable for MR imaging of hybrid collagen-based scaffolds.
1 . 5  A n im a l  M o d e l s  a n d  Clin i c a l  Tra n s lati o n  o f  T E  Co n s tr u c t s
To allow translation to clinical settings, preclinical testing of new designed scaffolds 
upon in vitro characterization is required. Preclinical evaluation often starts with 
subcutaneous implantation of novel scaffolds in small animal models, to test 
their overall biocompatibility and tissue remodeling characteristics [37–40]. 
Subsequently, large animal models were used to reconstruct functional defects 
with tissue-engineered constructs as they may mimic more the human situation at 
clinically relevant sites with scaffolds of comparable size and surgical techniques 
[41]. Since different large animal models vary in their (cell) growth and regeneration 
kinetics (e.g. German Landrace and Göttingen Minipig) [42], different models for 
patients groups (e.g. young- and older patients) can be established.
Regardless, of the chosen animal model or type of scaffold, implementation of 
scaffolds to (pre)-clinical applications requires terminal sterilization. Therefore, it is 
a critically important task to choose an appropriate FDA/EMA- approved sterilization 
technique (e.g. gamma-irradiation, EtO-degassing) in order to effectively sterilize 
biodegradable scaffolds but at the same time to maintain their structural and 
biochemical integrity [43].
1
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2 THESIS OBJECTIVE
The aim of this thesis was to develop innovative tools which can be used for ureteral 
reconstruction or creation of an artificial urostomy. Upon development of hybrid 
scaffolds, insights were given in scaffold design, (bio)mechanical properties, 
noninvasive MR imaging and tissue remodeling.
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3 OUTLINE OF THIS THESIS
To indicate the “state-of-the-art” of ureter reconstruction and urinary diversion 
using TE approaches, a literature review was performed in chapter 2 with emphasis 
on biomaterials, scaffold designs and reconstruction strategies.
Chapter 3 focuses on the development of new supportive structures composed 
of synthetic polymers. So-called coupled helical coils (CHCs) were manufactured 
to mimic collagen fiber orientation as found in tubular organs such as the ureter. 
Therefore, CHCs may be promising tools in tubular scaffold manufacture. CHCs of 
different polymer composition were tested to determine their mechanical properties 
and degradation profiles. In a final set of experiments, seamless and stable hybrid 
constructs consisting of CHCs and porous collagen type I were produced.
Subsequently, MR imaging was established as a noninvasive tool to monitor 
tissue-engineered hybrid constructs. In chapter 4, we used a naturally-derived 
hemin-L-lysine complex (HL) as a potential CA to label hybrid templates. In chapter 
5, a fully synthetic injectable hydrogel was used in combination with a CA and cell 
binding motifs. This imageable ‘artificial ECM’ was monitored over time to access its 
properties as a template for tissue repair as well as a cell- and drug delivery vehicle.
Since the choice of sterilization may affect the overall performance of natural- 
and synthetic biomaterials, we studied the influence of γ-irradiation and EtO 
degassing on hybrid tubular scaffolds in chapter 6. The in vitro characteristics were 
extensively studied, including tensile strength analysis and degradation studies. 
For in vivo evaluation, constructs were subcutaneously implanted in a goat model 
to access tissue remodeling of biohybrid constructs.
Finally, chapter 7 summarize the findings of this thesis and potential future 
directions are discussed.
1
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ABSTRACT
The standard for long-segment reconstruction of the ureter and urinary diversion 
is the creation of neo-tissue using autologous bowel tissue, albeit associated 
with multiple complications. Tissue-engineered (TE) constructs may provide 
alternative solutions. Here, we review ureter reconstruction and urinary diversion 
using Tissue Engineering approaches. A literature search strategy was applied 
in PubMed to identify available preclinical studies published up until September 
2018. Subsequently, studies were screened for scaffolds used and relevance (e.g. 
reconstruction of full circumferential defects in preclinical settings) and further 
categorized based on whether grafts were directly implanted, seeded with cells 
prior to implantation, or preimplanted (with or without cells) before functional 
implantation. Future prospects are discussed with emphasis on scaffold design 
and functional tissue maturation of tissue engineered constructs to foster clinical 
translation.
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1 INTRODUCTION
The main cause of ureter damage is trauma caused by e.g. motor accidents, gun 
shots, or iatrogenic injuries incurred during surgery [1]. While ureteral injury is 
relatively uncommon, the failure to recognize it can lead to severe side effects, 
including sepsis or loss of renal function. Surgical ureteral reconstruction possibilities 
are limited due to specific anatomical characteristics of the ureter (e.g. segmental 
vascular supply), site of ureteral injury, and the lack of native tissue for repair. 
Several surgical techniques are recommended to repair ureteral defects [2]. For 
long-segment reconstruction, the creation of neotissue using autologous harvested 
bowel tissue remains the gold standard. However, the use of this unrelated tissue 
source is associated with severe side effects and multiple unfavorable outcomes 
[3]. In many cases multiple procedures are needed over time, mostly due to (re-)
stenosis and (re-)strictures, and ultimately nephrectomy may be needed [4].
For muscle-invasive bladder cancer (MIBC) and non-muscle invasive bladder 
cancer (NMIBC) with high risk of progression, the European guidelines recommend 
radical cystectomy followed by urinary diversion [5]. The most used form of urinary 
diversion is the ileal conduit using autologous intestine segments [6]. However -and 
very similar to ureteral reconstruction-, this is associated with many post-operative 
complications [7].
Thus, there is a clear need for alternative graft material and reconstruction 
techniques. The field of Tissue Engineering (TE) holds great potential to restore 
functionality of diseased organs and tissue and may circumvent gold standard-
related complications and graft shortage [8]. Implementation of tissue-engineered 
grafts may prevent invasive bowel surgery, life-threatening complications and 
ultimately may improve quality of life (QoL) and reduce health costs significantly.
2
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2 SEARCH STRATEGY AND AIM OF THIS REVIEW
Here, we review state-of-the art biomaterials, scaffold designs and reconstruction strategies 
in preclinical studies using TE approaches which may be used for ureter regeneration and 
urinary diversion. A predefined search strategy was applied in PubMed using customized 
search filters for ureter reconstruction, urinary diversion, scaffolds and tissue engineering 
synonyms [9]. These search filters were combined with the animal study filter developed by 
Hooijmanns, et al. [10] (see Appendix) resulting in 1290 studies (see Figure 1). After removal 
of studies which did not contain TE approaches (studies were considered to be about TE 
when processed tubular scaffolds composed of natural- and/or synthetic biomaterials 
were used) of full circumferential defects in original pre-clinical studies, studies were sub-
divided according to their application (ureter reconstruction and urinary diversion) and 
reconstruction strategy (Figure 2): a) scaffolds directly implanted, b) scaffolds seeded 
with cells prior to implantation, or c) preimplanted (with or without cells) before functional 
implantation. Subsequently, basic information regarding animal model, scaffold (bio)
material and defect length were extracted (see Table 1 and Table 2). Furthermore, studies 
were analyzed in terms of functional outcomes such as urothelium formation, muscle 
ingrowth, vascularization and side-effects (e.g. graft shrinkage, strictures, obstruction/
occlusion, hydronephrosis). Additionally, we discuss a selection of recently published in 
vitro studies that describe novel scaffold designs and functional tissue maturation strategies 
which may ultimately foster clinical translation.
Figure 1: Flowchart of search- and screening process of preclinical studies including ureter 
reconstruction and urinary diversion using Tissue Engineering (TE) approaches.
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Figure 2: Implantation strategies of preclinical studies for full circumferential ureter recon-
struction (I) and urinary diversion (II, black line marks the skin outlet) using Tissue Engineering 
(TE) approaches. A) Scaffolds directly implanted for reconstruction. B) (Stem) cells isolated 
from biopsies, expanded under cell culture conditions and seeded to a scaffold prior to func-
tional implantation. C) Scaffolds or cells-seeded scaffolds are preimplanted before functional 
implantation.
Table 1: Preclinical studies of ureter reconstruction using Tissue Engineering (TE) approaches.
Authors / Year Animal 
Model
Scaffold Type / Cell Source 
/ Preimplantation Site 
(time in weeks)
Defect
Length
Functional Outcome
Positive / Negative
A: Direct Implantation of Scaffolds to Full Circumferential Ureteral Defects
1 Shalhav, et al.; 1999 [13] (Mini)
Pig
SIS (T*) and DU (T) 1.5-2.8 cm U, M H, F, I, Shr, Str, Ob
2 Xie, et al.; 2000 [14] Pig SIS (T*) 8 cm U Ur, F, H, Str
3 Jaffe, et al.; 2001 [15] Rabbit SIS (T*) 11 cm U, M, V D
4 Sofer, et al.; 2002 [16] Pig SIS (T*) 2 cm U, M F, I-2, H, Occ
5 Duchene, et al. 2004 [17] Pig SIS (T*)-halofuginone 2 cm U, M, F RA, H, I-2
6 El-Assmy, et al.; 2004 [19] Dog SIS (T*) 4 cm U, M F, I-2, H, Occ, Shr, D
7 Salehipour, et al.; 2013 [21] Dog AM (T*) 3.0 cm - L, H, F, I-2, D, Ob
8 Osman, et al.; 2004 [22] Dog DU (T) 3 cm U, M F, H, Obs, Shr
9 Dahms, et al.; 1997 [23] Rat DU (T) 0.3-0.8 cm U, M, N, V H
10 Tachibana, et al.;1985 [37] Dog COL (T) 5.0 cm U, M F, D, Str
2
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Authors / Year Animal 
Model
Scaffold Type / Cell Source 
/ Preimplantation Site 
(time in weeks)
Defect
Length
Functional Outcome
Positive / Negative
11 De Jonge, et al.; 2016 [51] Pig Collagen-Vicryl®-VEGF-bFGF (T) 5 cm U, M H, Ur, Str, Shr
12 Varady, et al.; 1982 [43] Dog PTFE (T) 5 cm U F, Obs
13 Sabanegh, et al.; 1996 [44] Dog PTFE (T) 10 cm U, M H, I-2, Obs
14 Peters, et al.; 1996 [45] Dog PTFE (T) 5 cm V F, Occ
15 Baltaci, et al.; 1998 [46] Dog PTFE (T) 5-8 cm - H, D, F, Str
16 Kloskowski, et. al.; 2015 [24] Rat AAM (T) and PLCL (T) 1.0 cm U, M H, I-1, Ob
B: Cell-Seeding of Scaffolds before Functional Implantation
1 El-Hakim, et al.; 2005 [18] Pig SIS (T*) / UC+SMC 5.0 cm - F, H, Ob, Shr
2 Zhao, et al.; 2012 [25] Rabbit VECM (T*) / ADSCs -> SMCs 3.0 cm U, M -
C: Preimplantation of Scaffolds before Functional Implantation
1 de Jonge et al.; 2017 [52] Goat COL-Vicryl® (T) / - / Subcutis (4) 5 cm U, V F
2 El-Hakim, et al.; 2005 [18] Dog DU (T) / UCs + SMCs / 
Omentum (ND)
3 cm U, M, V F, Ob, Shr
3 Zhao, et al.; 2016 [26] Rabbit VECM / ADSCs -> UCs + 
SMCs / Omentum (3)
ND U, M, V -
4 Liao, et al.; 2013 [27] Rabbit BAM (T*) / SMCs + MSCs / 
Omentum (2)
4 cm U, M, V -
5 Meng, et al.; 2015 [28] Rabbit BSM (T*) / SMCs + ADSCs / 
Omentum (2)
4 cm U, M, V -
Scaffold Abbreviations: COL, collagen; PTFE, polytetrafluorethylene (Dacron); SIS, small intestine 
submucosa; DU, decellularized ureter; AM, amniotic membrane; AAM, acellular aortic arch; PLCL, 
poly(L-lactide-co-caprolactone); VECM, vascular extracellular matrix; BAM, bladder acellular 
matrix; BSM, bladder submucosa matrix; VEGF, vascular endothelial growth factor; bFGF, basic 
fibroblast growth factor; T: Seamless tubular form; T*: Tubularized form; 
Cell Source abbreviations: UCs, urothelial cells; SMCs, smooth muscle cells; MSCs, mesenchymal 
stem cells; ADSCs, adipose derived stem cells; ->, stem cell differentiation. 
Functional outcome abbreviations: U, urothelial formation; M, muscle formation; N, nerve 
fibers; V, vascularization; F, fibrosis; Ur, urinoma; H, hydronephrosis; I, inflammation; I-1, mild 
inflammation; I-2, severe inflammation; RA, renal atrophy; Ob, obstruction; Str, stricture; D, 
dilatation; occlusion; Shr, (graft) shrinkage.
ND: not defined.
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Table 2: Preclinical studies of creation of an artificial urostomy for urinary diversion using TE 
approaches.
Authors / Year Animal 
Model
Scaffold / Cell Source
/ Preimplantation Site 
(time in weeks)
Urostoma
Length
Functional 
Outcome
Positive / Negative
A: Creation of an Urostoma by using “off-the-shelf” Scaffolds
1 Kloskowski, 
et. al.; 2015 [24]
Rat
Rat
AAM (T)
PLCL (T)
1.0 cm
1.0 cm
U, M
U, M
H, Obs, Shr
H, Obs, Shr
B: Cell-Seeding of Scaffolds before Creation of an Urostoma
1 Drewa, et al.; 
2007 [20] 
Rat SIS (T*) / 3T3 3.0 cm F, H, I-2, Occ
2 Geutjes, et 
al.; 2012 [53]
Pig COL-Vypro®II (T) / UCs 12 cm U F, H, Occ
3 Basu, et al.; 
2012 [50]
(Mini) 
Pig
PGA-PLGA (T*) /
bladder SMCs
adipose-derived SMCs
peripheral blood-derived SMCs
ND
U, M, V
U, M, V
U, M, V
-
-
-
C: Preimplantation of (cell-seeded) Scaffolds before Creation of an Urostoma
1 Sloff, et al.; 
2016 [55]
Pig COL-Vicryl® (T) / - / Subcutis (4) 12 cm U, M, V H, Shr
2 Liao, et al.; 
2013 [29] 
Rabbit BAM (T*) / UCs / Omentum (2) 4 cm U, V -
3 Meng, et al.; 
2016 [30]
Rabbit BAM (T*) / SMCs + ADSCs / 
Omentum (2)
4 cm U, M, V -
Scaffold abbreviations: COL, collagen; SIS, small intestine submucosa; AAM, acellular aortic 
arch; PLCL, poly(L-lactide-co-caprolactone); BAM, bladder acellular matrix; PGA, polyglycolic 
acid; PLGA, poly-dl-lactide-coglycolide; T, seamless tubular form; T*, tubularized form. 
Cell source abbreviations: UCs, urothelial cells; SMCs, smooth muscle cells; ADSCs, adipose 
derived stem cells. 
Functional outcome abbreviations: U, urothelial formation; M, muscle formation; V, 
vascularization; F, fibrosis; H, hydronephrosis; Ob, obstruction; Occ, occlusion; Shr, shrinkage; 
I-2, severe infammation.
ND: not defined.
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3 BIOMATERIALS AND SCAFFOLD DESIGN IN 
PRECLINICAL SETTINGS
3 .1  N atu ra l  G raf t s
In TE applications, so-called scaffolds are the building blocks to create graft 
materials. The ideal scaffold should mimic the tissue of interest as much as 
possible, which guides material choice and mechanical design: it should be able 
to (i) keep its form to fill the defect, (ii) should be readily implantable, (iii) enhance 
tissue regeneration, and (iv) should be able to support tissue-specific functional 
demands, including (bio)mechanical loads until complete remodeling by the host 
tissue [11,12]. In most preclinical TE studies tubular scaffolds were produced from 
decellularized native tissue specimens such as small intestine submucosa [13–20], 
amniotic membrane [21], ureter [13,18,22,23], blood vessels [24–26] or bladder 
tissue [27–30]. Decellularized tissue resembles the native tissue the closest: it 
combines unique micro- and macro-architectural characteristics such as a regular, 
yet anisotropic network of extracellular matrix fibers, albeit that this architecture 
differs between organs and species [31,32]. Importantly, cell binding molecules and 
specific growth factors can be retained despite the decellularization process [33].
When designing a ureteral substitute, the (bio)mechanical properties should 
be considered. The ureter displays a “J”-shaped stress-strain behavior with a high 
elasticity zone giving rise to a stiffer zone at higher strain [34]. In general, the ureter 
is stiffer in longitudinal than in circumferential direction due to the collagen fiber 
density and its arrangement within the ECM of the ureter [35] and decellularized 
material such as a decellularized ureter can mimic this situation [36].
Alternatively, scaffolds have been produced from naturally-derived biomaterials 
such as collagen type I [37,38]. Besides being the main structural protein of most 
hard and soft tissues in mammals, collagen may a promising naturally-derived 
biomaterial due to its biocompatibility, biodegradability, bioactivity and low 
antigenicity [12,39]. However, this yields scaffolds of randomly oriented collagen 
fibers and collagen scaffolds need to be crosslinked to enhance strength and to slow 
down enzymatic degradation and thus the natural characteristics are chemically 
altered [40–42].
3 . 2  Sy nth eti c  G raf t s
Besides natural derived biomaterials, fully synthetic scaffolds have been used for 
ureter reconstruction and urinary diversion. These can be categorized in degradable 
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or non-degradable scaffolds. Non-degradable polytetrafluoroethylene (PTFE) grafts 
were used for ureteral reconstruction in 4/16 studies [43–46]. This type of graft 
material has been used as an “off-the-shelf” graft for blood vessel reconstruction 
[47], and may also be applicable to genitourinary applications. Alternatively, (melt)
electrospinning offers many opportunities in scaffold manufacture because 
scaffolds of different shape, porosity and fiber arrangement can be easily created 
[48] and electrospun scaffolds can be used as stents for treatment of ureteral 
strictures [49]. Despite of this flexibility, preclinical studies with electrospun material 
have been limited [24,50].
3 . 3  H y b ri d  G raf t s
Alternatively, hybrid scaffolds have been produced combining natural and synthetic 
biomaterials aimed at improving handling ease and mechanical characteristics. 
Although chemical crosslinking provides increased strength to collagen scaffolds, 
these are still too weak to withstand the (bio)mechanical demands of native (ureteral) 
tissue. Hence collagen scaffolds have been reinforced with synthetic polymers to 
create stronger hybrid scaffolds [51–55]. Indeed, reinforcement with a mesh of 
synthetic polymers resulted in stronger hybrid scaffolds with a “J” shaped stress-
strain behavior similar to the native ureter [52]. Furthermore, inclusion of these 
materials greatly improved the surgical handling which was much better compared 
to collagen-alone scaffolds examined in an earlier study [38,54]. Subsequently, full 
biodegradable collagen-based hybrid scaffolds showed superior tissue regeneration 
with respect to urothelium coverage, muscle pedicles and elastin formation when 
compared to semi-biodegradable hybrids [54]. Therefore such (biodegradable) 
collagen-based hybrid scaffolds appear to be promising candidates in genitourinary 
TE applications in view of the versatility of purified collagen type I to create tubular 
scaffolds of different diameter and pore size [56] that can easily be combined with 
enforcing materials.
2
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4 RECONSTRUCTION STRATEGIES IN PRECLINICAL 
STUDIES USING TISSUE-ENGINEERED CONSTRUCTS
4 .1  D ire c t  Im p la nt ati o n  o f  G raf t s
4.1.1 Ureter
Because ureteral damage is usually acute it requires immediate reconstruction, 
emphasizing the need for a readily available ‘off-the-shelf’ product. Indeed, this 
approach was used in most preclinical studies (Table 1A). Direct implantation 
of decellularized tissue to fill a full ureteral defect (Figure 2A) showed limited 
tissue regeneration: urothelial cells covered the graft lumen, but smooth muscle 
cell (SMC) ingrowth remained mainly limited to the anastomosis side of the graft 
[13–17,19,21,22] regardless of the animal model used. As a result, most animals 
presented with (intense) fibrosis of the ureteral graft and graft shrinkage, strictures, 
obstruction as well as hydronephrosis occurred in almost all studies, an undesired 
outcome.
In other studies, scaffolds created from collagen-rich decellularized rat 
ureter showed enhanced epithelial lining and muscle formation throughout the 
transplanted scaffold in small defects < 0.8 cm in a rat model [23]. However, muscle 
ingrowth remained limited when larger defects were repaired in a large animal 
model (dog) using seamless tubular scaffolds composed of purified natural collagen. 
Fibrosis and dilatation of the ureter above the anastomosis side occurred, indicating 
progressive obstruction [37].
To enhance graft acceptance and graft remodeling growth factors (GFs) have 
been added to enhance tissue regeneration. In pig studies scaffolds were loaded with 
vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) 
through heparin binding meant to boost vascularization and tissue remodeling [51]. 
In all animals, graft shrinkage (approx. 24%) and constriction at the anastomosis 
site was observed as well as hydronephrosis. Post implantation the lumen of the 
neo-ureter was covered with a single layer of urothelium, regardless of whether GFs 
were added. Muscle ingrowth was limited and mainly occurred at the anastomosis 
site and in general, addition of GFs did not improve the outcome. Loading of SIS 
with the type I collagen inhibitor halofuginone meant to prevent stricture formation 
after grafting which was possibly caused by fast collagen degradation and tissue 
remodeling also did not improve outcome in porcine models [17].
Direct implantation of fully synthetic non-degradable grafts which would be easy 
to produce and kept as off-the-shelf grafts has met little success. Grafting resulted 
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in substantial complications such as fibrosis, acute and chronic inflammation around 
the implant, as well as obstruction/occlusion and stricture at the anastomosis site 
in a dog model [43–46].
Implantation of biodegradable electrospun PLCL scaffolds in wistar rats with a 
full ureteral defect resulted in a substantial size reduction of the graft (30%) and 
implantation of the PLCL template resulted in patent uretero-scaffold anastomosis 
in 4/6 animals studied, but ureter outcome and kidney function and its integration 
with native ureter was generally worse compared to decellularized scaffold [24].
Regardless of the graft (bio)material and animal model used, direct implantation 
of bare scaffolds to bridge full circumferential ureteral defects has been consistently 
associated with severe side effects such as fibrosis, graft shrinkage, strictures, 
dilatation and/or hydronephrosis. Albeit that urothelium regeneration was 
possible in most cases, formation of functional muscle tissue has remained limited. 
Therefore, direct implantation of current cell-free grafts may not advisable.
4.1.2 Urinary Diversion
When an urostoma is created, graft material is anastomosed to the ureter and as 
such, a urinary conduit used for urinary diversion can be viewed as an extended 
ureter (Figure 2, II). Thus, the requirements for scaffolds used for urinary diversion 
are similar to the requirements of ureteral scaffolds. Unlike ureteral reconstruction 
where immediate repair is mostly imperative, clinical management of muscle-
invasive bladder cancer provides a time-window for TE approaches: cystectomy, 
requiring the formation of an urinary diversion, should be performed within 3 
months of diagnosis to have a significant survival benefit [5].
Studies examining whether direct implantation of scaffolds could be used to 
form a urinary diversion have been very limited (Table 2A). Implantation of synthetic 
and biodegradable conduits showed poor integration with the ureter, and a patent 
conduit-to-skin anastomosis with good functional results was only formed in 1 out 
of 5 cases [24] in a rat model. Grafting of decellularized material led to occlusion at 
the conduit-to-skin anastomosis and graft shrinkage, hydronephrosis and ureter 
dilatation [24] in the same model.
4 . 2  Ce ll -S e e din g  o f  S c af f o l d s  b e f o re  Fu n c ti o n a l  Im p la nt ati o n
4.2.1 Ureter
Despite the difficulties encountered with current cell-free scaffolds and in view 
of the possibility that cell seeding might enhance tissue regeneration, very few 
2
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preclinical studies have been performed examining the effect of cell seeding before 
implantation (Table 1B and Figure 2B). It is important to realize that grafts for ureter 
repair and urinary diversion will be exposed to and saturated with urine, and that 
this will probably hamper tissue regeneration. A cellular lining might mitigate the 
detrimental effects of urine exposure on tissue regeneration. An early strategy was 
to seed a SIS scaffold with autologous porcine bladder UCs and SMCs, followed by 
conditioning under static cell culture conditions to bridge a 5 cm full circumferential 
ureteral defect in a pig model [18]. The cell-seeding and conditioning did not improve 
the functional outcome when compared to the implanted non-seeded SIS: In all 
grafts contraction and stenosis occurred, with complete obstruction of the ipsilateral 
renal unit. Severe hydroureteronephrosis was evident proximal to the graft as well as 
total renal obstruction. In one study autologous adipose derived stem cells (ADSCs) 
were seeded [25]. This cell type could be differentiated into SMCs and seeding 
of these cells to scaffolds upon implantation improved the outcome in a rabbit 
model: post implantation, a stratified urothelium and organized muscle bundles 
were observed in the implants and ureteral strictures or hydroureteronephrosis 
were absent. Thus, whether the addition of autologous cells to scaffolds is beneficial 
remains unclear.
4.2.2 Urinary Diversion
In one of the first TERM studies for urinary diversion an artificial urinary conduit was 
formed by seeding 3T3 fibroblasts to SIS scaffolds and transplanted in a rat model. 
Based on the inflammatory reaction within the peritoneal cavity and the occurrence 
of hydronephrosis in all transplanted animals it was concluded that 3T3 fibroblasts 
are not useful as a “feeder layer” for ureteral augmentation [20].
Implantation of tubular semi-biodegradable hybrid collagen-Vypro® scaffolds 
seeded with primary UCs as an incontinent urostomy revealed the formation of a 
retroperitoneal tunnel functioning as a urostomy in 50% of cases in pigs. However, 
complications still occurred and included a hydroureter and hydronephrosis in all 
animals without major differences between cellular and acellular constructs [53].
In another study, synthetic scaffolds were combined with cells followed by 
bioreactor conditioning demonstrating that the addition of SMCs was essential: 
after grafting of tissue engineered tubular constructs seeded with autologous SMCs 
in a mini pig model, a patent urinary diversion for post cystectomy management of 
urine elimination was created [50].
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4 . 3  Pre im p la nt ati o n  o f  S c af f o l d s  b e f o re  Fu n c ti o n a l 
Im p la nt ati o n
4.3.1 Ureter
Preimplantation of scaffolds at non-functional implantation sites (Figure 2C) 
aims at scaffold remodeling and the development of a vascularized scaffold 
outside of the functional defect. Transposition, preferably with the vascular trunk 
intact might enhance tissue regeneration because an adequate blood supply is 
important for the viability of the graft. Tubular scaffolds have been preimplanted 
at the omentum or subcutis to induce angiogenesis and to form neotissue in large 
animal models within 2-4 weeks (Table 1C). Subcutaneous implantation of cell-
free collagen-based scaffolds in adult goats, mimicking the elderly human target 
population, produced a remodeled and well-vascularized scaffold which showed 
(bio)mechanical characteristics comparable to the native goat ureter [52]. After 
functional implantation these preimplants showed significantly better outcomes 
compared to directly implanted collagen-Vicryl® hybrid scaffolds. However, muscle 
ingrowth was not improved, and functional muscle tissue was only formed at the 
anastomosis site.
Preimplantation has also been used in combination with cell seeding: autologous 
bladder cells were seeded on decellularized ureters of porcine origin and these 
constructs were preimplanted in the omentum and subsequently used to replace 
a 3 cm segment of the ureter in a dog model. Despite better vascularity caused by 
the omental implantation, similar clinical results were observed when compared 
to non-seeded or cell-seeded scaffolds in a pig model [18].
The combination of preimplantation and cell seeding with stem cells has shown 
promising results: Co-culture of ADSC-differentiated UCs and SMCs [26], primary 
SMCs with MSCs [27] and primary SMCs with ADSCs [28] on scaffolds followed by 
pre-implantation in the omentum resulted in urothelium and muscle formation and 
vascularization over the entire scaffold in a rabbit model. The functional outcome 
was very promising as strictures and hydronephrosis were absent.
Thus far, preimplantation of cell-seeded scaffolds appears to be the most 
promising strategy as it is associated with good functional outcomes when 
compared to other implantation strategies. However, this approach remains very 
time consuming (approximately 4-7 weeks), complex and clinical translation is not 
readily foreseen.
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4.3.2 Urinary Diversion
In several studies scaffolds were pre-implanted before functional implantation for 
urinary diversion (Figure 2C and Table 2C). When different strategies were compared 
in landrace pigs, transplantation of a pre-implanted hybrid tubular collagen-
Vicryl® scaffold showed a favorable outcome compared to non-preimplantation 
strategies (better urinary drainage, limited hydroureteronephrosis, improved tissue 
regeneration) albeit that severe construct shrinkage and skin contraction occurred 
[55].
Better functional outcomes were also observed when cells were added before 
preimplantation: in rabbits functional urostoma were created with multilayered 
urothelium on the luminal side and organized smooth muscle tissue on the other 
side, without leakage, stricture, or obstructions when a urostoma was engineered 
from pre-implanted decellularized tissue seeded with bladder epithelial cells [29] or 
co-culture of ADSCs and SMCs [30]. Similar to ureter reconstruction, the complexity 
of this procedure may limit clinical translation.
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5 FUTURE DIRECTIONS
5.1  Re g ulato r y  Af f a ir s
In Europe, tissue engineering products fall under the European regulation on 
Advanced therapy medicinal products (ATMPs). In the US tissue engineered products 
(TEMPs) are regulated as drugs, biologics, devices, or combination products by the 
US Food and Drug Administration (FDA). Whether the product can be viewed as a 
regenerative medicine advances therapy (RMAT) in the US is governed by Section 
3033 of the 21st Centuries Cures Act of the FDA regulations [57]. Other regulations 
may apply, depending on homologous use of cells [58]. Regulations for ATMPs/
RMAT are complex and this has lead to the establishment of the Committee for 
Advanced Therapies (CAT) in Europe [59]. The (hybrid) scaffolds without/with 
cells that have been studied thus far are clear examples of ATMPs/RMAT products 
that fall under the CAT directory. CAT and FDA accept that rigorous control of the 
manufacturing process has limitations inherent to the complex character of ATMPs. 
Nevertheless, in view of the regulations it is certainly advisable to think about 
regulatory requirements before initiating studies. For instance, can the production 
of the chosen components be controlled, what is the influence of sterilization on 
the final product. Thus far, this issue was not addressed in the reviewed studies, 
but is of utmost importance when clinical translation is desired. It is undesirable 
to study scaffolds that will never pass regulatory hurdles. Future studies should 
take regulatory issues into account, particularly with respect to material choice, 
sterilization and complexity. This “bedside to bench and back” approach for 
developing TEMPs for clinical applications was recently reviewed [60].
5. 2  S c af f o l d  D e s i g n
Although engraftment of tubularized intestine segments remains the standard 
procedure for long-segment ureter reconstruction and urinary diversion in the 
clinic, their complication rates are relatively high. For TE approaches to be a viable 
alternative the functional outcome must at least be similar: safe and active transport 
of urine must be ensured. At the same time complications must be minimal. In 
particular stricture formation, occlusion, dilatation and hydronephrosis must be 
circumvented. The collective evidence of the animal studies showed that cell-free 
functional implantation of scaffolds –regardless of the biomaterial of choice- 
appears to be problematic: it leads to fibrosis, graft-shrinkage, stricture formation, 
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occlusion and ultimately hydronephrosis despite the generation of a urothelial 
lining. Thus, there is a need of novel smart graft (bio)materials.
Natural biomaterials such as decellularized tissue have been hypotized as ideal 
candidates for grafting as they are biocompatible and may closely resemble the 
tissue of interest. However, despite the similarity of decellularized tissues to native 
tissue, the functional outcome of ureter reconstruction and urinary diversion has 
been disappointing. It is possible that the decellularization processes can alter its (bio)
mechanical functionality [33,36,61,62], potentially impairing its use as ureteral graft and 
ultimately graft failure may relate to these alterations. Reinforcement of decellularized 
tissue has been performed to improve their biomechanical performance [63,64].
Other graft materials such as PTFE scaffolds showed a structural stiffness and 
low radial compliance which are known to cause poor long-term patency [47]. 
Therefore, this type of graft material may not suitable for ureteral reconstruction. 
To mimic the general (bio)mechanical behavior of soft tubular tissues such as the 
ureter, Rapoport et al. engineered a hybrid synthetic scaffold of electrospun elastic 
polyurethane reinforced with a poly-glycolic acid (PGA) woven mesh [65]. The in vivo 
functionality as a tubular genitourinary scaffold remains to be established.
Similar, biodegradable collagen-based hybrid scaffolds have been prepared 
to improve their overall strength and tissue regeneration [54], but despite these 
improvements the functional outcome was poor in preclinical studies [51,52,55]. 
Thus, other design parameters such as fiber arrangement, thickness and degradation 
profile of the reinforcement may be of importance. Coupled helical coils (CHCs) may 
be a promising reinforcement design. Through incorporation of “stent-like” CHCs 
within collagen type I sponges, hybrid scaffolds can be prepared with a ”J”-shaped 
stress-strain behavior similar to the ureter [66]. Additionally, the hybrid scaffold 
can resist compressive loads to maintain its tubular form. This may ultimately be 
beneficial to prevent graft shrinkage, stricture formation and occlusion.
Equally important is the cellular stratum that guides tissue regeneration. 
The collagen component of hybrid scaffolds can be further tuned with radial 
oriented pores [67] or an alternating multilayered arrangement of condensed- and 
porous layers [68]. Both strategies may guide cell alignment and ECM deposition. 
Alternatively, collagen can also be used in electrospinning to produce smart mixtures: 
Electrospun spiral poly-L-lactic acid (PLLA) in combination with electrospun collagen 
was used in vivo, showing improved cell attachment and regeneration [69,70].
Regardless of the biomaterial of choice, clinical implementation of grafts requires 
sterilization with EMA- and FDA- approved techniques. A recent study showed that 
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the effect of final sterilization of hybrid scaffolds is considerable: Sterilization affects 
tissue remodeling upon implantation [71]. Thus, the method of sterilization should 
be carefully considered when designing novel scaffolds.
In summary, combinations of natural- and synthetic biomaterials to form smart 
hybrid scaffolds combing defined (bio)mechanical properties and a biocompatibility 
may improve graft patency. However, it is important to realize that grafts will 
be heavily exposed to urine leading to saturation of scaffolds with urine which 
contains waste material and its composition is non-physiologic and detrimental to 
cells. This may explain the poor outcome that has been observed when scaffolds 
were implanted without cell seeding or bioreactor conditioning. Possibly, luminal 
coating with biocompatible but urine impenetrable materials may solve part of the 
complications that are observed leading to satisfactory functional outcome, but 
this remains to be established. Such luminal coating should still provide a proper 
surface area to permit urothelium formation acting as a “starter” submucosa guiding 
urothelial formation preferably at the luminal side.
5. 3  G e n e rati o n  o f  Fu n c ti o n a lize d  T i s s u e
Seeding of e.g. collagen-based scaffolds with SMCs cells and culturing in a conventional 
incubator at 37 °C and 5% CO2 exposure (static conditions) lead to an unorganized 
SMC alignment within the scaffold architecture which is atypical for native tissue [72]. 
Improved seeding techniques and culture conditions may be needed to overcome 
limited SMC ingrowth which is generally observed but is necessary to generate 
functional neotissue. Culturing of cell-seeded tubular constructs in bioreactor systems 
may overcome these problems as they provide mechanical cues by means of continuous 
flow and/or axial stretching (dynamic culturing). In several bioreactor studies implants 
were created that resembled complex tubular structures consisting of multiple cell 
types (Table 3): bioreactor culture of tubularized cell sheets of dermal fibroblasts 
seeded with urothelial cells in the lumen resulted in a tubular graft with urothelium 
lining the luminal surface. The burst pressure of this construct was three times as 
high as that of porcine urethras and suturing was accomplished without difficulty [73]. 
Furthermore, a mature stratified- and multilayered urothelium could be generated 
which ultimately improved barrier function [74]. When primary porcine SMC were 
embedded in a fibrin gel with a stabilizing PVDF (poly(vinylidene fluoride)) mesh and 
cultured under dynamic conditions, histological evaluation revealed a native-like cellular 
alignment in the fibrin gel: smooth muscle cells were circumferentially aligned inside 
the matrix and longitudinally aligned on the outer surface of the tubular structure 
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[75]. When cell-laden (primary human SMCs and UCs) compressed tubular collagen 
scaffolds were stimulated in a flow bioreactor mimicking the physiological pressure, 
peristalsis, and flow conditions of the human ureter [72] the differentiation of both 
cell types into their mature forms was observed. Furthermore, smooth muscle cells 
aligned predominantly perpendicular to the flow direction, comparable to the cell 
orientation in native ureteral tissue [72]. Wang et al. used ADSCs seeded tubularized 
PGA scaffolds and differentiated these into SMCs and further conditioned the construct 
by mechanical extension in a bioreactor [76]. The investigators were able to form neo-
muscular tubes and after the addition of primary oral mucosal epithelial and additional 
stimulation in a bioreactor an epithelial lining similar to native tissue was observed [77]. 
When these mechanically stimulated constructs were tested in a dog model to treat a 
full circumferential urethral defect, development into relatively normal architectures 
resembling nearby autologous urethral tissue was observed.
Additionally, alternative cell sources and bacterial cellulose (BC) as scaffold 
material has been studied to tissue-engineer a urinary diversion [78]. These scaffolds 
were seeded with human urine-derived stem cells (UDSC) that were differentiated 
into UCs and SMCs. After culturing under dynamic conditions (rotary orbital shaker 
at 10 or 40 rpm) for 1 week, the scaffold surface was covered with multiple layers 
of SMCs and UCs, and some cells infiltrated into the scaffold. After subcutaneous 
implantation of the cell-seeded scaffolds in mice, the cells appeared to differentiate 
and expressed urothelial and SMC markers. Based on these initial promising results, 
cell-seeded BC scaffolds may hold promise for use as urinary conduits for urinary 
diversion. Moreover, cell coverage of scaffolds will prevent saturation with passing 
urine which may alleviate complications.
Buccal mucosa may be another potential source of tissue for reconstruction 
purposes. Buccal mucosa graft ureteroplasty has been used successfully and this 
has become a gold standard for urethral reconstruction when feasible, owing to 
its excellent tissue characteristics for grafting into the urinary tract [79]. However, 
harvesting of oral mucosa may lead to donor-site morbidity [80]. To overcome 
this, tissue-engineered oral mucosa grafts have been produced from small buccal 
mucosa biopsies and found to be safe and efficient in urethroplasty [81]. Thus, 
tissue-engineered oral mucosa grafts may have a high potential for future long-
defect ureter reconstruction and urinary diversion purposes.
It is clear that addition of cells, mechanical stimulation and/or preimplantation of 
cell-seeded scaffolds are promising strategies for genitourinary TE, but such procedures 
are very challenging and time-consuming: time that is not available when acute ureteral 
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defects need to be repaired. However, a percutaneous nephrostomy catheter may be 
used to drain urine [82] and may allow for a time window until (functional) neotissue is 
generated. Nevertheless, generation of neotissue should be as fast as possible.
Table 3: Studies using dynamic culturing (mechanical stimulation) in a bioreactor system to 
generate functional tissue for tubular genitourinary tissue reconstruction.
Authors / 
Year
Scaffold
Type
Cell
Source
Dynamic Culturing Procedure
(Mechanical Stimulation Protocol) 
/ Culturing Time
Cell 
Orientation
Functional 
Outcome1
1 Magnan, et 
al.; 2008 [73]
gelatine coating
(cell sheet) (T*)
DF + UCs intraluminal perfusion (continuous 
flow) / 1 week
ND BP →,
UC-GE ↑
2 Cattan, et 
al.; 2011 [74]
cell sheets (T*) DF + UCs intraluminal perfusion (flow rate: 15 
mL/min; shear stress: 0.1 dynes/cm2 
+ hydrostatic pressure: 15 cmH2O) / 
2 weeks
stratified-, 
multilayered U
ECM ↑, 
BF ↑*,
UC-GE ↑*
3 Seifarth, et 
al.; 2015 [75]
fibrin gel +
PVDF mesh (T)
SMCs mimicking urine bolus via 
kyphoplasty catheter (1st: inflation 
of catheter tip, 2nd: pulling through 
scaffold lumen at a constant 
unidirectional speed of 2.5 mm/s; 3rd: 
deflation of catheter tip; 4th: repetition 
at a frequency of 0.015 Hz) / 2 weeks
scaffold lumen:
circumferential
+
outer scaffold 
layer: axial
BP ↑, 
BF →,
4 Vardar, et 
al.; 2015 [72]
compressed
collagen (T)
UCs + 
SMCs
intraluminal flow mimicking 
ureter peristalsis (5±1 peristaltic 
contractions/minute; luminal 
pressure: ∼ 22 cmH2O; shear stress: ∼ 
4 dynes/cm2; R: < 2000) / 2 weeks
SMCs 
perpendicular 
to the flow +
U lining similar 
to native
P →, 
ECM ↑,
UC-GE ↑*, 
SMC-GE ↑*
5 Fu, et al.; 
2014 [77]
PGA (T*) ADSCs
-> SMCs
+
#OMEC/ECs
intraluminal flow (mechanical 
extension stimulation by peristaltic 
pump; 75 times/minute; luminal 
pressure: 0.02 MPa) / 7 weeks
scaffold lumen: 
ECs
scaffold center:
SMCs
ECM ↑*, 
PGA ↓*,
SMC-GE ↑*
Scaffold abbreviations: T, seamless tubular form; T*, tubularized form; PVDF, poly vinylidene 
fluoride; PGA, poly-glycolic acid. 
Cell source abbreviations: UCs, urothelial cells; SMCs, smooth muscle cells; DF, dermal 
fibroblasts; # OMECs, oral mucosa epithelial cells were sorted by flow cytometry to yield ECs, 
epithelial cells; ->, stem cell differentiation. 
Functional outcome (1compared to static culturing in a conventional incubator without any 
mechanical stimulation): ↑ , enhancement/increase;  ↑*, significant enhancement/increase;  ↓*, 
significant decrease; →, no difference; U, urothelium formation; M, muscle formation; ECM, 
production/formation of extracellular matrix de novo; BP, burst pressure; P, proliferation; 
BF, barrier function, UC-GE, gene expression of urothelial cells; SMC-GE, gene expression of 
smooth muscle cells.
ND, not defined; R, Reynolds number; rpm, rounds per minute.
5.4  3 D  B i o p rintin g
3D Bioprinting has emerged as a new key technology in TE approaches and may be 
valuable for ureter reconstruction and urinary diversion. This technology enables the 
simultaneous printing of cells and biomaterials in precise locations within defined 
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patient specific dimensions [83,84]. In a recent in vitro study, primary UCs and SMCs 
isolated from a bladder biopsy were printed with fibrin-based hydrogels and with 
synthetic PCL/PLCL blends as scaffolding (bio)material to form a 3D bioprinted 
urethra [85]. This study provides a basis to produce tubular constructs with proper 
mechanical properties and bioactivity within a reasonable time frame. In future 
studies, 3D bioprinting may be used to create patient (animal model) specific grafts 
which can be subsequently used for dynamic stimulation, preimplantation and/or 
direct implantation for genitourinary reconstruction purposes.
5. 5  Stu d y  D e s i g n
In most studies, cell-seeded and/or preimplanted constructs were compared 
with non-seeded constructs. Remarkably, except in one animal [18], none of 
the preclinical studies included repair of a defect with the clinical standard - 
reconstruction with bowel tissue - as control. Thus, it is difficult to assess the value 
of the tissue-engineered constructs. It would be advisable to implement such 
controls in preclinical studies to justify the scaffold biomaterial and reconstruction 
strategy. Moreover, different animal models have been used hampering a solid 
conclusion. Importantly, the composition of urine differs between species and this 
may influence the outcome between different animal models as well. In view of the 
former, the study design of future studies needs to improve to be able to adequately 
judge the value of a particular TE approach.
In the majority of preclinical studies large animal were studied. A recent 
systematic review suggested that this appears to allow a better translation to the 
human situation, within respect to surgical techniques, scaffold dimensions and 
anatomy [9]. Nevertheless, remodeling kinetics of tissue-engineered constructs 
may vary: for example, Göttingen minipigs and juvenile German Landrace pigs 
differ in (cell) growth, and show different regeneration kinetics [86]. Moreover, 
further research should focus on larger numbers of patients / animals and study 
endpoints of > 12 months need to be included to confirm the long-term safety of 
TE approaches. 
Finally, in future studies a special focus is needed on the stoma region and 
skin interaction in relation with the external urinary collecting bag and adhesive 
materials, an aspect that has received little attention. This may ultimately aid the 
translation of TE approaches to the clinic as alternative reconstruction procedures.
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APPENDIX
S e a rc h  Strate g y  Pu b M e d
Search Component 1: Urology (Ureter and Urinary Diversion)
(ureter[MeSH] OR urinary diversion[MeSH] OR ureterostomy[Mesh] OR 
genitourinary[tiab] OR ureter[tiab] OR ureters[tiab] OR (urinary[tiab] AND 
diversions[tiab]) OR (urinary[tiab] AND diversion[tiab]) OR (ileal[tiab] AND 
conduit[tiab]) OR ureterostomy[tiab] OR ureterostomies[tiab] OR ureteral[tiab] OR 
ureteral reconstruction[tiab] OR ureterotomy[tiab] OR ureterotomies[tiab])
Search Component 2: Scaffold and Tissue Engineering
(tissue scaffolds [MeSH] OR biocompatible materials [MeSH] OR decellularized 
[tiab] OR acellular [tiab] OR autograft [tiab] OR autografts [tiab] OR graft [tiab] OR 
grafts [tiab] OR matrix [tiab] OR matrices [tiab] OR biomatrix [tiab] OR biomatrices 
[tiab] or biomaterial [tiab] OR biomaterials [tiab] OR scaffold [tiab] OR scaffolds 
[tiab] OR scaffolding [tiab] OR bioengineered substitutes [tiab] OR cell-free [tiab] 
OR extracellular matrix [tiab] OR conduit [tiab] OR cell constructs [tiab] OR tissue 
engineering [MeSH] OR tissue culture techniques [MeSH] OR organ culture 
techniques [MeSH] OR organoids [MeSH] OR guided tissue regeneration [MeSH] 
OR regenerative medicine [MeSH] OR artificial organs [MeSH] OR biocompatible 
materials [MeSH] OR (regenerative [tiab] AND (medicine [tiab] OR medicines 
[tiab])) OR regeneration [tiab] OR regenerated [tiab] OR regenerating [tiab] OR 
reconstruction [tiab] OR reconstructed [tiab] OR reconstructing [tiab] OR tissue-
engineered [tiab] OR (tissue [tiab] AND (engineered [tiab] OR engineering [tiab])) 
OR bio-engineering [tiab] OR bioengineering [tiab] OR bioengineered [tiab] OR bio-
engineered [tiab] OR organoids [tiab] OR organoid [tiab] OR bioartificial [tiab] OR 
bio-artificial [tiab] OR artificial [tiab])
Search Component 3 (‘Animal Filter’): 
(adapted from: C.R. Hooijmans, A. Tillema, M. Leenaars, M. Ritskes-Hoitinga, 
Enhancing search efficiency by means of a search filter for finding all studies on 
animal experimentation in PubMed, Lab. Anim. 44 (2010) 170–175. DOI:10.1258/
la.2010.009117)
(“animal experimentation”[MeSH Terms] OR “models, animal”[MeSH Terms] 
OR “invertebrates”[MeSH Terms] OR “Animals”[Mesh:noexp] OR “animal 
population groups”[MeSH Terms] OR “chordata”[MeSH Terms:noexp] OR 
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“chordata, nonvertebrate”[MeSH Terms] OR “vertebrates”[MeSH Terms:noexp] OR 
“amphibians”[MeSH Terms] OR “birds”[MeSH Terms] OR “fishes”[MeSH Terms] OR 
“reptiles”[MeSH Terms] OR “mammals”[MeSH Terms:noexp] OR “primates”[MeSH 
Terms:noexp] OR “artiodactyla”[MeSH Terms] OR “carnivora”[MeSH Terms] OR 
“cetacea”[MeSH Terms] OR “chiroptera”[MeSH Terms] OR “elephants”[MeSH Terms] 
OR “hyraxes”[MeSH Terms] OR “insectivora”[MeSH Terms] OR “lagomorpha”[MeSH 
Terms] OR “marsupialia”[MeSH Terms] OR “monotremata”[MeSH Terms] OR 
“perissodactyla”[MeSH Terms] OR “rodentia”[MeSH Terms] OR “scandentia”[MeSH 
Terms] OR “sirenia”[MeSH Terms] OR “xenarthra”[MeSH Terms] OR “haplorhini”[MeSH 
Terms:noexp] OR “strepsirhini”[MeSH Terms] OR “platyrrhini”[MeSH Terms] OR 
“tarsii”[MeSH Terms] OR “catarrhini”[MeSH Terms:noexp] OR “cercopithecidae”[MeSH 
Terms] OR “hylobatidae”[MeSH Terms] OR “hominidae”[MeSH Terms:noexp] 
OR “gorilla gorilla”[MeSH Terms] OR “pan paniscus”[MeSH Terms] OR “pan 
troglodytes”[MeSH Terms] OR “pongo pygmaeus”[MeSH Terms]) OR ((animals[tiab] 
OR animal[tiab] OR mice[Tiab] OR mus[Tiab] OR mouse[Tiab] OR murine[Tiab] OR 
woodmouse[tiab] OR rats[Tiab] OR rat[Tiab] OR murinae[Tiab] OR muridae[Tiab] 
OR cottonrat[tiab] OR cottonrats[tiab] OR hamster[tiab] OR hamsters[tiab] OR 
cricetinae[tiab] OR rodentia[Tiab] OR rodent[Tiab] OR rodents[Tiab] OR pigs[Tiab] 
OR pig[Tiab] OR swine[tiab] OR swines[tiab] OR piglets[tiab] OR piglet[tiab] OR 
boar[tiab] OR boars[tiab] OR “sus scrofa”[tiab] OR
ferrets[tiab] OR ferret[tiab] OR polecat[tiab] OR polecats[tiab] OR “mustela 
putorius”[tiab] OR “guinea pigs”[Tiab] OR “guinea pig”[Tiab] OR cavia[Tiab] 
OR callithrix[Tiab] OR marmoset[Tiab] OR marmosets[Tiab] OR cebuella[Tiab] 
OR hapale[Tiab] OR octodon[Tiab] OR chinchilla[Tiab] OR chinchillas[Tiab] OR 
gerbillinae[Tiab] OR gerbil[Tiab] OR gerbils[Tiab] OR jird[Tiab] OR jirds[Tiab] OR 
merione[Tiab] OR meriones[Tiab] OR rabbits[Tiab] OR rabbit[Tiab] OR hares[Tiab] 
OR hare[Tiab] OR diptera[Tiab] OR flies[Tiab] OR fly[Tiab] OR dipteral[Tiab] OR 
drosophila[Tiab] OR drosophilidae[Tiab] OR cats[Tiab] OR cat[Tiab] OR carus[Tiab] 
OR felis[Tiab] OR nematoda[Tiab] OR nematode[Tiab] OR nematodes[Tiab] OR 
sipunculida[Tiab] OR dogs[Tiab] OR dog[Tiab] OR canine[Tiab] OR canines[Tiab] OR 
canis[Tiab] OR sheep[Tiab] OR sheeps[Tiab] OR mouflon[Tiab] OR mouflons[Tiab] 
OR ovis[Tiab] OR goats[Tiab] OR goat[Tiab] OR capra[Tiab] OR capras[Tiab] OR 
rupicapra[Tiab] OR rupicapras[Tiab] OR chamois[Tiab] OR haplorhini[Tiab] OR 
monkey[Tiab] OR monkeys[Tiab] OR anthropoidea[Tiab] OR anthropoids[Tiab] 
OR saguinus[Tiab] OR tamarin[Tiab] OR tamarins[Tiab] OR leontopithecus[Tiab] 
OR hominidae[Tiab] OR ape[Tiab] OR apes[Tiab] OR “pan paniscus”[Tiab] OR 
2
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bonobo[Tiab] OR bonobos[Tiab] OR “pan troglodytes”[Tiab] OR gibbon[Tiab] 
OR gibbons[Tiab] OR siamang[Tiab] OR siamangs[Tiab] OR nomascus[Tiab] 
OR symphalangus[Tiab] OR chimpanzee[Tiab] OR chimpanzees[Tiab] OR 
prosimian[Tiab] OR prosimians[Tiab] OR “bush baby”[Tiab] OR bush babies[Tiab] OR 
galagos[Tiab] OR galago[Tiab] OR pongidae[Tiab] OR gorilla[Tiab] OR gorillas[Tiab] 
OR “pongo pygmaeus”[Tiab] OR orangutan[Tiab] OR orangutans[Tiab] OR 
lemur[Tiab] OR lemurs[Tiab] OR lemuridae[Tiab] OR horse[Tiab] OR horses[Tiab] 
OR equus[Tiab] OR cow[Tiab] OR calf[Tiab] OR bull[Tiab] OR chicken[Tiab] OR 
chickens[Tiab] OR gallus[Tiab] OR quail[Tiab] OR bird[Tiab] OR birds[Tiab] OR 
quails[Tiab] OR poultry[Tiab] OR poultries[Tiab] OR fowl[Tiab] OR fowls[Tiab] OR 
reptile[Tiab] OR reptilia[Tiab] OR reptiles[Tiab] OR snakes[Tiab] OR snake[Tiab] OR 
lizard[Tiab] OR lizards[Tiab] OR alligator[Tiab] OR alligators[Tiab] OR crocodile[Tiab] 
OR crocodiles[Tiab] OR turtle[Tiab] OR turtles[Tiab] OR amphibian[Tiab] OR 
amphibians[Tiab] OR amphibia[Tiab] OR frog[Tiab] OR frogs[Tiab] OR bombina[Tiab] 
OR salientia[Tiab] OR toad[Tiab] OR toads[Tiab] OR “epidalea calamita”[Tiab] 
OR salamander[Tiab] OR salamanders[Tiab] OR eel[Tiab] OR eels[Tiab] OR 
fish[Tiab] OR fishes[Tiab] OR pisces[Tiab] OR catfish[Tiab] OR catfishes[Tiab] OR 
siluriformes[Tiab] OR arius[Tiab] OR heteropneustes[Tiab] OR sheatfish[Tiab] OR 
perch[Tiab] OR perches[Tiab] OR percidae[Tiab] OR perca[Tiab] OR trout[Tiab] OR 
trouts[Tiab] OR char[Tiab] OR chars[Tiab] OR salvelinus[Tiab] OR minnow[Tiab] 
OR cyprinidae[Tiab] OR carps[Tiab] OR carp[Tiab] OR zebrafish[Tiab] OR 
zebrafishes[Tiab] OR goldfish[Tiab] OR goldfishes[Tiab] OR guppy[Tiab] OR 
guppies[Tiab] OR chub[Tiab] OR chubs[Tiab] OR tinca[Tiab] OR barbels[Tiab] OR 
barbus[Tiab] OR pimephales[Tiab] OR promelas[Tiab] OR “poecilia reticulata”[Tiab] 
OR mullet[Tiab] OR mullets[Tiab] OR eel[Tiab] OR eels[Tiab] OR seahorse[Tiab] 
OR seahorses[Tiab] OR mugil curema[Tiab] OR atlantic cod[Tiab] OR shark[Tiab] 
OR sharks[Tiab] OR catshark[Tiab] OR anguilla[Tiab] OR salmonid[Tiab] OR 
salmonids[Tiab] OR whitefish[Tiab] OR whitefishes[Tiab] OR salmon[Tiab] OR 
salmons[Tiab] OR sole[Tiab] OR solea[Tiab] OR lamprey[Tiab] OR lampreys[Tiab] 
OR pumpkinseed[Tiab] OR sunfish[Tiab] OR sunfishes[Tiab] OR tilapia[Tiab] OR 
tilapias[Tiab] OR turbot[Tiab] OR turbots[Tiab] OR flatfish[Tiab] OR flatfishes[Tiab] 
OR sciuridae[Tiab] OR squirrel[Tiab] OR squirrels[Tiab] OR chipmunk[Tiab] OR 
chipmunks[Tiab] OR suslik[Tiab] OR susliks[Tiab] OR vole[Tiab] OR voles[Tiab] 
OR lemming[Tiab] OR lemmings[Tiab] OR muskrat[Tiab] OR muskrats[Tiab] OR 
lemmus[Tiab] OR otter[Tiab] OR otters[Tiab] OR
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marten[Tiab] OR martens[Tiab] OR martes[Tiab] OR weasel[Tiab] OR badger[Tiab] 
OR badgers[Tiab] OR ermine[Tiab] OR mink[Tiab] OR minks[Tiab] OR sable[Tiab] OR 
sables[Tiab] OR gulo[Tiab] OR gulos[Tiab] OR wolverine[Tiab] OR wolverines[Tiab] 
OR mustela[Tiab] OR llama[Tiab] OR llamas[Tiab] OR alpaca[Tiab] OR alpacas[Tiab] 
OR camelid[Tiab] OR camelids[Tiab] OR guanaco[Tiab] OR guanacos[Tiab] OR 
chiroptera[Tiab] OR chiropteras[Tiab] OR bat[Tiab] OR bats[Tiab] OR fox[Tiab] 
OR foxes[Tiab] OR iguana[Tiab] OR iguanas[Tiab] OR xenopus laevis[Tiab] OR 
parakeet[Tiab] OR parakeets[Tiab] OR parrot[Tiab] OR parrots[Tiab] OR donkey[Tiab] 
OR donkeys[Tiab] OR mule[Tiab] OR mules[Tiab] OR zebra[Tiab] OR zebras[Tiab] 
OR shrew[Tiab] OR shrews[Tiab] OR bison[Tiab] OR bisons[Tiab] OR buffalo[Tiab] 
OR buffaloes[Tiab] OR deer[Tiab] OR deers[Tiab] OR bear[Tiab] OR bears[Tiab] 
OR panda[Tiab] OR pandas[Tiab] OR “wild hog”[Tiab] OR “wild boar”[Tiab] OR 
fitchew[Tiab] OR fitch[Tiab] OR beaver[Tiab] OR beavers[Tiab] OR jerboa[Tiab] OR 
jerboas[Tiab] OR capybara[Tiab] OR capybaras[Tiab] OR canine [tiab] OR bovine 
[tiab] OR porcine [tiab] OR hog [tiab] OR hogs [tiab]) NOT medline[sb])
SC1 + SC2 + SC3= 1290 hits (12th of September 2018)
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ABSTRACT
The design of constructs for tubular tissue engineering is challenging. Most 
biomaterials need to be reinforced with supporting structures such as knittings, 
meshes or electrospun material to comply with the mechanical demands of 
native tissues. In this study, coupled helical coils (CHCs) were manufactured to 
mimic collagen fiber orientation as found in nature. Monofilaments of different 
commercially available biodegradable polymers were wound and subsequently 
fused, resulting in right-handed and left-handed polymer helices fused together 
in joints where the filaments cross. CHCs of different polymer composition were 
tested to determine the tensile strength, strain recovery, hysteresis, compressive 
strength and degradation of CHCs of different composition. Subsequently, seamless 
and stable hybrid constructs consisting of PDSII® USP 2-0 CHCs embedded in porous 
collagen type I were produced. Compared to collagen alone, this hybrid showed 
superior strain recovery (93.5 ± 0.9% vs 71.1 ± 12.6% in longitudinal direction; 87.1 
± 6.6% vs 57.2 ± 4.6% in circumferential direction) and hysteresis (18.9 ± 2.7% vs 
51.1 ± 12.0% in longitudinal direction; 11.5 ± 4.6% vs 46.3 ± 6.3% in circumferential 
direction). Furthermore, this hybrid construct showed an improved Young’s Modulus 
in both longitudinal 0.5 ± 0.1 MPa vs 0.2 ± 0.1 MPa; 2.5-fold) and circumferential 1.65 
± 0.07 MPa vs (2.9 ± 0.3) x 10-2 MPa; 57-fold) direction, respectively, compared to 
templates created from collagen alone. Moreover, hybrid template characteristics 
could be modified by changing the CHC composition and CHCs were produced 
showing a mechanical behavior similar to the native ureter. CHC-enforced templates, 
which are easily tunable to meet different demands may be promising for tubular 
tissue engineering.
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1 INTRODUCTION
The design of an ideal template in Tissue Engineering and Regenerative Medicine 
(TERM) is defined to be able to keep its form to fill the defect, should be readily 
implantable, enhance tissue regeneration, and should be able to support tissue-
specific functional demands including (bio)mechanical loads [1]. Especially in 
tubular Tissue Engineering (TE), construct strength as well as elasticity are pivotal 
parameters to guarantee functionality of a construct to avoid compliance mismatch, 
which can result in failure of the graft [2,3]. Additionally, the template should 
be able to withstand external mechanical loads initially as well as degrade and 
resorb progressively as it is being replaced by new tissue [4,5]. Tubular templates 
have been produced by (melt) electrospinning [6], casting of extracellular matrix-
based biomaterials [7], cell sheets [8] or decellularized tissues [9]. In general, the 
mechanical strength of these templates may be limited and reinforcement with 
e.g. tubularized woven or non-woven meshes, knittings or electrospun material is 
needed to provide sufficient strength and, ideally, comply with the (bio)mechanical 
requirements of native tissue [10–14].
The stress-strain behavior of native soft tubular tissue is reported as a “J-shaped” 
curve beginning with an initial high elasticity followed by sharp strain-induced 
stiffening prior rupture [15]. The amount and orientation of structural extracellular 
matrix proteins such as elastin and collagen significantly impact the mechanical 
behavior [16]. Thus, an engineered template with a fiber arrangement like native 
tissue may be a valuable approach as previously suggested [17].
Within the intimal- and adventitial layer of the aorta and healthy arteries, 
collagen fibers are helically arranged to coupled helical coils (CHCs) -also known 
as a cross-ply structure-. Such collagen fiber arrangement is also observed within 
the submucosa of tubular organs like the ureter, the esophagus and small intestine 
[18–21]. To comply with (bio)mechanical demands of various tubular organs, 
incorporation of tunable synthetic CHCs may be a beneficial design for tubular 
template engineering [22].
In this research report, we created bioinspired CHCs prepared of different 
commercially available, resorbable surgical suture monofilaments and studied their 
mechanical properties. Porcine ureteral tissue was used as an example of native 
tubular tissue for comparison, to evaluate their potential for tubular TE purposes. 
The most promising CHC was incorporated in a tubular collagen type I sponge to test 
the mechanical performance of this biocompatible, but structurally weak, template.
3
534676-L-bw-Janke
Processed on: 27-8-2019 PDF page: 58
58
Chapter 3
2 MATERIALS AND METHODS
2 .1  M ate ria l s
Resorbable surgical suture monofilaments used were: Monocryl® (poly(glycolide-
co-ɛ-caprolactone) (PGCL), Ethicon, LLC, Sommerville, NJ, USA), PDSII® (poly(p-
dioxanone) (PDS), Ethicon, LLC, Sommerville, NJ, USA) and Caprolon® (poly(L-
lactide-co-ɛ-caprolactone) (PLCL), Resorba Medical GmbH, Nuremberg, Germany). 
Filament size was USP 2-0 (0.255 – 0.299 mm) and USP 1 (0.400 – 0.499 mm). Unless 
otherwise indicated, reagents were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). Ureteral tissue from Landrace pigs (100 kg; 6 months old) was obtained from 
the local slaughterhouse < 4 h after slaughter.
2 . 2  Pre p a rati o n  o f  Co u p l e d  H e li c a l  Co il s
Figure 1A-B shows the manufacturing procedure of coupled helical coils (CHCs). 
Monofilaments were wound on a custom-made steel mandrel with a diameter of 
8 mm connected to a rotator (Labinco, Breda, The Netherlands). Filaments were 
wrapped around the mandrel in a clockwise- and anticlockwise helix (approximately 
11 rpm), resulting in tubular structures with a defined rhombus pattern (Figure 1C; 
distance between filaments = 5 mm). Filament intersection points were fused in a 
laboratory oven (UT6, Thermo, Langenselbold, Germany) at defined temperature 
for 5 min. Temperatures used were 120 °C for PDSII® CHCs, 175 °C for Caprolon® 
CHCs and 200 °C for Monocryl CHCs, respectively. The filament thickness and the 
thickness at the filament intersection points in longitudinal (LONG) and circular 
(CIRC) direction were measured with a digital caliper (Kraftfixx, Stuhr, Germany). 
Mesh pore size, mesh angle in LONG and CIRC direction, as well as the surface 
area at the filament intersection points, were examined using ImageJ (U.S. National 
Institutes of Health, Bethesda, Maryland, USA).
2 . 3  Pre p a rati o n  o f  a  Co lla ge n  Te m p late  Rein f o rce d  w ith  a 
Co u p l e d  H e li c a l  Co il
Tubular collagen type I templates were prepared as previous described with slight 
modifications [11,23]. Highly purified collagen type I from bovine Achilles tendon 
(Collagen Solutions, Glasgow, Scotland, United Kingdom) was swollen in 0.25 M acetic 
acid overnight followed by homogenization using a Silverson L5M-A laboratory mixer 
(Silverson, Chesham, United Kingdom) and de-airing by centrifugation (800 rpm for 30 
min) to obtain a 0.7% (w/v) solution. The collagen solution was poured in a polystyrene 
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mold and a steel mandrel (6 mm in diameter) was placed in the middle of the mold 
to form a tubular template made of a collagen alone (COL). To form a hybrid tubular 
template (hybrid), a CHC of PDSII® USP 2-0 was placed between the steel mandrel and 
polystyrene wall (Figure 1E). Samples were frozen down at -20 °C for at least 24 h. 
After the freezing procedure, samples were lyophilized (Zirbus Sublimator 500II, Bad 
Grund, Germany) and subsequently chemically crosslinked with 33 mM N-ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDC) and 6 mM N-hydroxysuccinimide (NHS) 
to enhance strength and resistance against degradation of collagen [24–26]. In brief, 
templates were transferred to 50 mM 2-morpholineoethane sulphonic acid (MES 
buffer; pH 5.0) containing 40% (v/v) ethanol. Templates were incubated for a total of 
4 h to EDC/NHS dissolved in MES buffer. Crosslinking reaction was stopped by 2 times 
washing with 0.1 M Na2HPO4 for 1 h. Subsequently, templates were washed using 1M 
NaCl, 2M NaCl and demineralized water. Finally, templates were stored in 70% (v/v) 
ethanol at -20 °C until further use.
2 .4  S c a n n in g  El e c tro n  M i c ro s co py  (S E M)
SEM was used to analyze filament structure, filament intersection points after 
production and during degradation and integration of CHC in tubular collagen type 
I sponges. Examination was performed with a JEOL SEM 6310 apparatus ( JEOL Ltd., 
Japan) operating at an accelerating voltage of 15 kV. Prior SEM analyses, samples 
were fixed on a stub with double-sided carbon tape and sputtered with gold for 
60 seconds (1.5 kV; 20 mA) by a Scancoat Six SEM Sputter Coater (Temescal/Edwards, 
Crawley, United Kingdom) to achieve an ultrathin gold layer (approximately 20.4 nm) 
before being analyzed.
2 . 5  M e c h a n i c a l  Pro p e r ti e s
2.5.1 Tensile Tests
To investigate the mechanical properties of suture monofilaments and various 
tubular templates, test specimen of l = 25 mm of suture monofilaments (n = 3), 
CHCs alone (n = 5), COL (n = 3), hybrid (n = 5) and porcine ureter (n = 5) were mounted 
to a tensile tester (Z2.5 TN, Zwick/Roell, Ulm, Germany) via plastic hose clamps. 
Load cells used were 20 N (CHCs; COL; hybrid) and 2.5 kN (suture monofilaments; 
porcine ureter), respectively. All ring specimen were hydrated in phosphate buffered 
saline (PBS; 0.01 M; pH 7.4) prior mounting. With a crosshead speed of 50 mm/
min, a uniaxial load was applied in a longitudinal direction until rupture of the 
construct (gauge length constructs = 10 mm). Construct testing were valid when the 
3
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sample broke in the middle. Force-displacement data were normalized to the test 
specimen dimensions to compute a stress-strain curve. The stress was expressed 
as the recorded force F [N] which reacted on the cross-sectional area A [mm2] of 
the test specimen, while the strain was expressed as the change in length delta 
L [mm] divided by its original length L0 [mm]. Material parameters were derived 
as previously described [12,27]: (1) Initial modulus (E1) was calculated from the 
first slope (toe region) of the computed stress-strain curve. (2) Upswing (Young s´) 
modulus (E2) was calculated from the slope (upswing region) of the computed 
stress-strain curve. (3) Ultimate tensile strength (UTS) and (4) failure strain were 
defined as the maximum stress and maximum strain, respectively in the stress-
strain curve before failure of the construct. 
Subsequently, ring specimen (l = 10 mm; n = 3) of COL and hybrid templates 
were also stretched in the circumferential direction. Therefore, test specimen 
were mounted between custom-made hooks (hook-to-hook distance = 6 mm) and 
stretched until total failure of the construct. Test machine and material parameter 
were derived and used as described above.
2.5.2 Cyclic Stretching
To investigate strain recovery and energy loss, CHCs (l = 65 mm; diameter = 8 mm; n 
= 5) were loaded in the tensile tester as described above (load cell = 20 N; cross head 
speed = 50 mm/min) and stretched longitudinally to identify the most appropriate 
CHC. Constructs were stretched ten times up to 15% of their original length. Strain 
recovery was calculated as previously described [28,29]. In brief, Strain recovery was 
defined as the difference in applied strain and the resulting strain after 10 cycles 
divided by the applied strain. Materials´ loss in energy uptake during unloading 
(hysteresis) was expressed as the percentage area under the loaded- and unloaded 
curve divided by the area under the loading curve using ImageJ. 
Subsequently, measurements were also performed on COL and hybrid 
in longitudinal (stretching 10 times up to 15% of their original length) and 
circumferential (stretching ten times up to 50% of their original length) direction, 
respectively. Measurements were performed in triplicate.
2.5.3 Compression Test
To study the behavior of CHCs under compressive loads, 20 mm long specimens 
(n = 5) were placed between 2 plates. A strain rate of 50 mm/min was applied until 
the test specimen was compressed to 50% of the constructs’ original diameter. 
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A compressive load was retained for 15 sec and released until the construct had 
regained the original diameter. Recorded compressive loads (load cell = 2.5 kN) 
were normalized and expressed in megapascal [MPa]. Compressive stress over 
time and compressive stress-strain curves were recorded and the compressive 
modulus was determined from the slope of the compressive stress-strain curve. 
The percentage remaining compressive strength was calculated as the difference in 
peak compressive stress at 50% strain and stress after retention for 15 sec. 
Subsequently, the hybrid (l = 10 mm; n = 4) were compressed to 50% of the 
constructs’ original diameter. Compressive modulus for the hybrid template was 
derived from the slope between 25% and 45% strain to neglect initial compressive 
strength caused by collagen (Appendix A4).
2 . 6  D e g ra dati o n  Te s t
To test long-term stability of all produced CHCs, ring specimen (l = 20 mm; n= 5) of 
CHCs were incubated in an enzymatic degradation solution as previous described 
with modifications [30]. In brief, to phosphate buffered saline (PBS; 0.01 M; pH 7.4), 
244 U/L α-amylase from Bacillus sp., 24 ng/mL collagenase, 13 mg/L lysozyme, 190 U/
mL lipase, 2.6 U/mL hyaluronidase, 10.8 mg/L phospholipase A2 and 0.2 g/L sodium 
azide were added. Samples were immersed in this solution (10 mL per CHC) and kept 
in a cell culture incubator under standard cell culture conditions (37 °C; 5% CO2). 
Samples were collected at day 0, 3, 6, 10 and 18 for weight measurement (dry weight) 
and compression test as described above. Calculated strength degradation curve 
was expressed as the peak compressive stress over time. Calculated mass loss of 
CHCs was expressed as relative loss of samples initial dry weight over time (weight 
loss % = (initial dry weight before degradation – dry weight after degradation) / initial 
dry weight before degradation x 100%).
2 .7  St ati s ti c s
All values are expressed as means ± standard deviation. Minimum requirement for 
independent assays was n = 3. One-way ANOVA with Bonferroni post-hoc test was 
performed for statistical analysis of differences between different CHCs and CHCs 
compared with native porcine ureteral tissue. If COL templates were compared with 
hybrid templates, unpaired two-tailed Student’s t-tests were performed. P < 0.05 
was considered statistically significant. All statistical calculations were performed 
using GraphPad Prism software (version 5.03 and 7.04 respectively, GraphPad 
Software Inc, La Jolla, CA, USA).
3
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3 RESULTS
3 .1  Co u p l e d  H e li c a l  Co il -  a n d  H y b ri d  D im e n s i o n s
The diameters of the resorbable surgical suture monofilaments were 0.29 ± 0.01 
mm and 0.47 ± 0.01 mm for USP 2-0 and USP 1 filaments, respectively. The distance 
from one intersection point to the next in longitudinal (LONG) direction after 
fusing was approximately 5 mm, while the distance in circular (CIRC) direction was 
approximately 8 mm. The mesh pore sizes of CHC were as follows: PDSII® USP 2-0: 
19.2 ± 2.2 mm2; PDSII® USP 1: 19.3 ± 1.2 mm2, Monocryl® USP 2-0: 18.6 ± 2.4 mm2; 
Monocryl® USP 1: 18.6 ± 1.3 mm2; Caprolon® USP 2-0: 18.3 ± 3.4 mm2 and Caprolon® 
USP 1: 20.8 ± 1.8 mm2 respectively. The difference in the pore size between CHC was 
not significant (p > 0.999). The LONG angle and CIRC angle of different constructs 
were similar (p > 0.999) underscoring the control of CHC manufacture. 
Figure 1: Preparation of coupled helical coils (CHCs) and production of a hybrid tubular template. 
(A) Schematic illustration of the production procedure. CHCs are manufactured by winding suture 
monofilaments around a steel mandrel in a clockwise- and anticlockwise helix and fusing in a 
laboratory oven. (B) CHCs with a crosswise/rhombus pattern. Left coil: Monocryl® USP 2-0 CHC. 
Right coil: Monocryl® USP 1 CHC. (C) Macroscopic image of the crosswise/rhombus pattern (scale 
bar = 5 mm. (D) Scanning electron microscopy (SEM) image of the filament intersection points 
fused together in joints (scale bar = 100 micron). (E) Production of a hybrid tubular template. Cast-
ing of collagen type I suspension in a polystyrene mold containing a steel mandrel (diameter = 6 
mm) and CHC. After freezing and subsequent lyophilization, a hybrid tubular template is formed. 
(F) Tubular collagen type I template (COL, left) and hybrid tubular template (hybrid, right). The 
hybrid maintained its tubular structure with an open lumen, while COL collapsed when wetted. 
(G) SEM image of the hybrid. The CHC was well integrated in the collagen template (see white 
arrow) without influencing the luminal site (indicated by the asterisks; scale bar = 100 micron).
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Fusing of CHCs resulted in a decrease of the filament’s original diameter (Appendix 
A1). The filaments were flattened, and the filament thickness decreased to 
approximately 50% of the original diameter. Filament thickness outside the 
intersection points differed substantially from the thickness at the intersection 
points in all constructs. Intersections of USP 2-0 CHCs and Monocryl® USP 1 
CHC (Figure 1D) showed joint-like structures with a smaller surface area, and 
consequently showed a more flexible behavior (more compliant) in the axial direction 
as compared to PDSII® USP 1- and Caprolon® USP 1 CHC. Overall, CHC production 
process resulted in seamless tubular structured with structural anisotropy.
Collagen type I (0.7%(w/v)) reinforced with a PDSII® USP 2-0 CHC (hybrid) resulted 
in a stable tubular template (Figure 1F). The CHC was well integrated in the typical 
porous honeycomb-like collagen scaffold structure (Figure 1G).
3 . 2  M e c h a n i c a l  Pro p e r ti e s
3.2.1 Tensile Tests
For suture monofilaments, a linear stress-strain curve was obtained until the 
filaments ruptured. Young’s modulus of suture monofilaments was as follows: PDSII® 
USP 2-0: (1.26 ± 0.08) x 103 MPa; PDSII® USP 1: (1.4 ± 0.4) x 103 MPa; Monocryl® USP 
2-0: (1.1 ± 0.6) x 103 MPa; Monocryl® USP 1: (0.9 ± 0.4) x 103 MPa; Caprolon® USP 
2-0: (1.4 ± 0.6) x 103 MPa and Caprolon® USP 1: (1.2 ± 0.3) x 103 MPa, respectively. 
Differences in Young’s modulus between all suture monofilaments were not 
significant (p > 0.05).
The results of the tensile tests of coupled helical coils (CHCs) and porcine ureter 
along the longitudinal axis are shown in Figure 2. Porcine ureter and CHCs made 
of USP 2-0 fibers showed a typical ‘ ’J’ ’ shaped stress-strain curve with an initial 
high elasticity (toe region) followed by an uprising slope indicative of a significant 
(p < 0.05) stiffness before total failure, while Monocryl® USP 2-0 underwent plastic 
deformation prior rupture (see plateau phase of Monocryl® CHCs in Figure 2A). 
In all Caprolon® constructs, also plastic deformation beyond the initial toe region 
was observed indicating strain hardening of the material. Consequently, Caprolon® 
constructs showed a limited strain range in reversible elasticity compared to all other 
constructs. For PDSII® USP 1- and Monocryl® USP 1 CHC, a linear curve was obtained 
until the construct ruptured. Regardless of CHC composition, all constructs ruptured 
at their filament intersection points. Furthermore, the upswing (Young` s) modulus 
E2 in both constructs differed from native tissue. Ultimate tensile strength (UTS), 
failure strain was highest for Monocryl® USP 2-0 CHCs. No significant differences (p 
3
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= 0.1810 for E1; p = 0.1230 for E2; p = 0.0568 for UTS; p > 0.9999 for failure strain) of 
PDSII® USP 2-0 CHCs were found when compared with porcine ureter.
Figure 2: Mechanical analysis of CHCs and porcine ureter in longitudinal direction. (A) Rep-
resentative stress-strain curves of CHCs prepared from USP 2-0 suture monofilaments. (B) 
Representative stress-strain curves of CHCs prepared from USP 1 suture monofilaments. (C) 
Representative stress-strain curves of porcine ureteral tissue. (D) Mechanical properties derived 
from stress-strain curves in longitudinal direction of CHCs and native porcine ureteral tissue. 
Data represent mean ± standard deviation. One-way ANOVA with Bonferroni post-hoc test, *= 
p < 0.05 compared to ureteral tissue, **= p < 0.01 compared to ureteral tissue, ***= p < 0.0001 
compared to ureteral tissue.
The results of the tensile tests of COL- and hybrid template along both, longitudinal 
and circumferential axis are shown in Figure 3. Like native tissue, stress-strain 
behavior of COL templates and hybrids were “J”-shaped in longitudinal- and 
circumferential direction, respectively (Appendix A2A and Appendix A2B). In 
the longitudinal direction, the collagen reinforced with a CHC made of PDSII® USP 
2-0 showed a significant improvement (p < 0.05) in strength compared to the COL 
template. Initial modulus E1 were (1.8 ± 0.6) x 10-2 MPa and 0.12 ± 0.06 MPa for 
the COL template and the hybrid template, respectively. The upswing (Young` s) 
modulus E2 were 0.2 ± 0.1 MPa and 0.5 ± 0.1 MPa for the COL template and the 
hybrid template, respectively. Ultimate tensile strength and corresponding failure 
strain of the hybrid were dictated by the collagen component of the hybrid; the CHC 
remained intact. No significant differences of failure in ultimate tensile strength (p 
= 0.4947) and failure strain (p = 0.1049) of the hybrid were observed compared to 
COL (Figure 3B).
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Figure 3: Mechanical properties and subsequent analysis under cyclic loads of collagen type 
I templates (COL) and collagen type I templates reinforced with a PDSII® 2-0 CHC (hybrid). (A) 
Analysis of initial elastic modulus (E1) and upswing (Young’s) modulus (E2) of COL and hybrid in 
longitudinal direction. (B) Analysis of ultimate tensile strength (UTS) and failure strain of COL and 
hybrid in longitudinal direction. (C) Relative strain recovery of COL and hybrid after 10 loading 
cycles in longitudinal direction. (D) Relative energy loss after unloading of COL and hybrid after 
10 loading cycles in longitudinal direction. (E) Initial modulus (E1) and upswing (Young’s) modulus 
(E2) of COL and hybrid in circumferential direction. (F) Analysis of ultimate tensile strength (UTS) 
and failure strain of COL and hybrid in circumferential direction. (G) Relative strain recovery of 
COL and hybrid after 10 loading cycles in circumferential direction. (H) Relative energy loss after 
unloading of COL and hybrid after 10 loading cycles in circumferential direction. Data represent 
mean ± standard deviation. Two-tailed Student’s t-test, *= p < 0.05, **= p < 0.01, ***= p < 0.0001.
Furthermore, the formed hybrid showed a significantly (p < 0.0001) superior 
strength in the circumferential direction as compared to the COL template. In the 
circumferential direction, Initial modulus E1 were (1.8 ± 0.8) x 10-3 MPa and 0.16 ± 
0.02 MPa for the COL template and the hybrid template, respectively. The upswing 
(Young` s) modulus E2 were (2.9 ± 0.3) x 10-2 MPa and 1.65 ± 0.07 MPa for the collagen 
template and the hybrid template, respectively. The ultimate tensile strength (UTS) 
and corresponding failure strain of the hybrid were dictated by the CHC. The hybrid 
ruptured at the CHC component of the construct. No distortion of the collagen 
before rupture of CHC was observed. Additionally, the UTS of hybrid templates was 
significantly higher (p < 0.0001) than COL. No significant differences (p = 0.6103) in 
failure strain of the hybrid were observed compared to COL (Figure 3F).
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3.2.2 Cyclic Stretching
Strain recovery of Monocryl®- and PDSII® CHCs from longitudinal cyclic loading 
was significantly (p < 0.0001) better than the recovery of CHCs produced from 
Caprolon® (Appendix A3A). Subsequently, analysis of construct energy loss during 
unloading/relaxation showed the smallest hysteresis loop for PDSII® USP 2-0 CHC, 
and thus lowest loss of energy during relaxation compared to other constructs 
(8.3 ± 1.0% loss of energy; Appendix A3B). As can be seen in Figure 3C and Figure 
3G, strain recovery (93.5 ± 0.9% in the longitudinal direction; 87.1 ± 6.6% in the 
circumferential direction) of the hybrid were significantly (p < 0.01) improved as 
compared to COL (71.1 ± 12.6% in the longitudinal direction; 57.2 ± 4.6% in the 
circumferential direction). Additionally, reinforcement of collagen with PDSII® USP 
2-0 CHC resulted in a significantly (p < 0.01) smaller hysteresis (18.9 ± 2.7% and 11.5 
± 4.6%) as compared with COL (51.1 ± 12.0% and 46.3 ± 6.3%) in longitudinal- and 
circumferential direction, respectively (Figure 3D and Figure 3H).
3.2.3 Compression Tests
Figure 4: Analysis of the behavior of coupled helical coils (CHCs) under compressive loads. (A) 
Representative graph of resulting compressive strength over time of different CHCs. (B) Quan-
titative evaluation of the compressive modulus of different CHCs. (C) Quantitative evaluation 
of the remaining compressive strength after holding the compressive load for 15 seconds. Data 
represent mean ± standard deviation. One-way ANOVA with Bonferroni post-hoc test, **= p < 
0.01, ***= p < 0.0001.
Compression tests demonstrated that all prepared CHCs resisted compressive loads 
(Figure 4A). Individual compressive moduli are shown in Figure 4B. The compressive 
modulus increased with increased filament dimensions. PDSII® and Caprolon® in 
the dimension USP 1 showed the highest compressive strength compared to other 
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constructs. When the applied pressure was maintained for 15 seconds, a decrease 
of the peak compressive stress was observed for all constructs (see plateau phase 
or drop of strength, respectively in Figure 4A). The remaining compressive load 
normalized to the initial compressive load for PDSII® was 89.7 ± 1.8% and 87.5 ± 2.0% 
for USP 2-0 and USP 1 constructs, respectively. The loss of compressive strength 
of PDSII®- and Monocryl® CHCs were lower expressed compared with Caprolon® 
CHCs (Figure 4C).
The hybrid template of collagen type I and CHC resulted in a seamless tubular 
structure in which an open lumen was maintained, while tubular structures made 
from collagen type I only collapsed when wetted (Figure 1F). Hybrid templates kept 
an open lumen when compressed up to 50% of the original diameter (Appendix 
A4A). The hybrid structure remained intact when compressed. When unloaded, the 
hybrid structure resumed its original dimensions (Appendix A4B). Compressive 
stress-strain behavior was also “J”-shaped indicating that the initial compressive 
load was carried by the collagen type I only. After approximately 10% strain, the 
compressive load was carried by the CHC. The compressive modulus of the hybrid 
was (3.8 ± 0.7) x 10-2 MPa.
3
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3.2.4 Degradation
Figure 5: Degradation study of prepared coupled helical coils (CHCs). (A) Peak compressive 
strength of CHCs over time. (B) Relative mass loss of CHCs over time. Representative scan-
ning electron microscopy (SEM) images at the intersection points of (B) PDSII® USP 1 CHC, (C) 
Monocryl® USP 1 CHC and (D) Caprolon® USP 1 CHC at day 12. Scale bar = 100 micron.
The degradation of CHCs was investigated concerning the loss of peak compressive 
strength (Figure 5A) and relative mass loss (Figure 5B) at different time points. 
Monocryl® constructs lost their original strength and became fragile at day 10 
(residual compressive strength of 55.0 ± 20.6% and 52.9 ± 16.4% for USP 2-0 CHCs 
and USP 1 CHCs, respectively) while other constructs remained their original 
strength and structural integrity much longer (Figure 5A). Beyond day 10, any 
mechanical load that could be born (e.g. compression, tensile or cyclic) was very low 
on Monocryl® CHCs. These CHCs almost immediately collapsed once any mechanical 
load was applied. Additionally, Monocryl® constructs showed a mass loss of 5.9 ± 
2.0% and 3.6 ± 0.4% for USP 2-0 CHCs and USP 1 CHCs respectively at day 10 (Figure 
5B). At Day 18, mass loss was determined as 19.5 ± 4.8% and 8.5 ± 0.9% for USP 2-0 
CHCs and USP 1 CHCs respectively. Other constructs remained their original mass. 
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Furthermore, incubation of PDSII®- and Caprolon® CHCs showed no impact 
on the microstructure as determined by SEM analysis (Figure 5C, Figure 5E). In 
contrast, the initially smooth surface of Monocryl® CHCs was fractured along 
the circumferential axis (Figure 5D), resulting in a total collapse of the CHC when 
compressed after degradation.
3
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4 DISCUSSION
Development of bioinspired materials and constructs as tubular templates for soft 
tissue engineering has been hampered by their poor (bio)mechanical performance 
once implanted. We hypothesized that tubular templates with a CHC would be 
superior to other designs such as tubularized meshes or electrospun materials. 
Through the incorporation of CHCs produced from polymers that have received FDA 
approvals as suture threads, seamless and stable, yet compliant, tubular structures 
that showed similar mechanical behavior to native tissue were produced. 
In the current study, we specifically focused on the development of a template 
useful for a urological indication, i.e. the ureter, where there is need for new 
templates which guide ureteral regeneration [31]. In tubular organs, such as the 
ureter, collagen fibers are arranged as coupled helical coils (CHCs) combining 
strength and flexibility needed to pass urine [18].
CHC were manually produced from PDSII®, Monocryl® and Caprolon® of different 
filament diameter. Because fusing changed the original dimensions and the original 
mechanical properties of the suture filaments was altered. Thus, comparison between 
the cured CHC and the filament was deemed less relevant. More important, overall 
mechanical properties of produced CHCs are based on 3 parameter: (i) Winding of 
CHCs (pitches and pitch size): We have produced multiple CHC with different pitches 
in pilot experiments (data not shown). At a higher density, the coils became like 
meshes, at higher pitch sizes the coils became extraordinary flexible and showed 
little mechanical resistance. The pitch size (mesh pores) also influenced the outcome 
of the final hybrid template as collagen were less integrated at higher pitch sizes. (ii) 
Surface area at the fiber intersection points: CHCs produced from Monocryl® USP 1 
and PDSII® USP 1 showed a linear stress-strain behavior until failure, very dissimilar 
from native tissue elasticity. While the rigidity of the PDSII® USP 1 might be caused by 
the large surface area at the intersection points, resulting in a limited elasticity and 
hence increased strength, the weakness of Monocryl® USP 1 CHC, might be caused by 
the limited intersection surface area. (iii) filament diameter: By changing the filament 
diameter to 0.29 mm (PDSII® USP 2-0 and Monocryl® USP 2-0) the longitudinal stress-
strain behavior of CHCs were very similar to native tubular tissue such as the ureter, 
which was used as reference tissue. In these CHCs designs, the intersections act as 
a joint, providing high initial elasticity associated with a lower tensile strength to 
increased tensile strength at higher strain, a mechanical characteristic similar to the 
extracellular matrix of native tissue [16]. Because the surface area of an intersection 
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point can be tailored by adapting the fusion time and temperature, upswing strength, 
UTS and failure strain can be modified. Additionally, diameter of CHCs can be easily 
adjusted by changing the steel mandrel. This provides the opportunity to customize 
the mechanical properties of CHC to match the requirements of different tissues. 
While overall elasticity/strength is important, strain recovery and hysteresis (energy 
transmission) of templates are equally important for templates that undergo continuous 
or repetitive movements due to peristalsis or lateral extensions: strain recovery should 
be high with minimal energy loss. CHCs from PDSII® USP 2-0 showed a high strain 
recovery and the lowest energy loss during cyclic tensile loads. Collectively these results 
demonstrate that CHCs from PDSII® USP 2-0 may be superior to CHC from other tested 
materials to reinforce relatively weak biomaterials for tubular tissue engineering. 
It is clear that CHCs alone cannot function as a template and that they have 
to be incorporated in other biomaterials to provide a cellular stratum. Collagen 
type I-based sponges are used abundantly in soft tissue engineering. Despite their 
excellent biocompatibility, these templates are relatively weak and reinforcement 
with supporting materials are needed to enhance its (bio)mechanical performance 
[3,11,23]. Incorporation of CHCs into 0.7% (w/v) collagen type I templates resulted 
in seamless hybrid tubular templates with adequate mechanical performance and 
native-like anisotropy. Many tissues, including those with a tubular architecture 
(ureter, blood vessels, trachea, esophagus), are characterized by anisotropy, that 
is an asymmetric mechanical performance when the load is applied in different 
directions. Therefore, collagen type I templates (COL) and hybrid templates were 
also exposed to various loads. In agreement with earlier work [32], pressure build-
up in porous structures such as the hybrid and COL described here, was minimal 
in burst pressure measurements as fluids extravasated before a pressure build-
up could occur (data not shown). In tubular tissues such as the ureter, build-up of 
high pressures are unlikely [31,33]. Nevertheless, to prevent potential e.g. urine 
leakage of the hybrid after transplantation, fibrin glue may be used as a sealant 
[23]. However, in vivo experiments are needed to investigate this issue. 
COL templates are very weak in both longitudinal- and circumferential direction 
respectively if compared with the hybrid. At biologically relevant physiological 
stress-strain of native tubular tissues such as the ureter [31,33], the CHCs remained 
fully incorporated within the template, without any visible exfoliation or rupture/
displacement of the collagen from the CHC. Based on the longitudinal- and 
circumferential tensile tests, the produced hybrid template has superior suture 
retention strength compared to the COL template.
3
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Next to longitudinal- and circumferential tensile loads, CHC were exposed to 
compressive loads. All produced CHCs and the hybrid counterpart were dimensionally 
stable and resisted repetitive compressive loads, while templates made of collagen 
alone collapsed. We hypothesized that constructs serving as substitutes for tubular 
tissues should to be able to resist compressive loads caused from the surrounding 
tissue (e.g. due to wound healing) to prevent collapse, which will result in obstruction 
and formation of strictures [34,35]. Indeed, strictures still remain the biggest problem 
in tubular organ TERM. Our manufactured CHCs and the formed hybrid may be a useful 
approach to avoid strictures and guarantee the maintenance of an open lumen once 
implanted [4]. However, the CHCs described here are manufactured from biodegradable 
polymers, i.e. structural and mechanical support will be temporary only. Since the 
template degrades and is resorbed progressively as it is being replaced by new tissue 
[36], the degradation rate of CHCs should be tuned carefully to match the regenerative 
behavior of the intended organ and species of interest. A moderate degradation rate is 
suggested to be optimal [4], Therefore, fast degrading materials such as Monocryl® with 
CHC physically collapsing after 10 days may not be adequate. Slowly degrading materials 
such as PDSII® that retained their strength and mass over 48 days (data not shown) 
may be more beneficial. Nevertheless, the rate of degradation and remodeling will be 
highly dependent on the area of implantation: ureter, esophagus, vascular, or urethra 
replacement are likely to show very different outcomes. We have previously shown that 
implantation at different tissues results in very different remodeling [37], Moreover, 
the in vivo outcome will be highly dependent on retained mechanical properties, which 
differ between different organs. Indeed, in vivo experiments are going to be crucial to 
show the ultimate value of CHC/collagen hybrid templates. In previous studies, we have 
analyzed constructs similar to the ones described here [23], These were prepared from 
collagen type I and either (a) a semi-biodegradable Vypro® II polymer (COL-Vypro®), (b) 
a rapidly biodegradable Vicryl® polymer (COL-Vicryl®) or (c) an additional collagenous 
layer (COL-DUAL). After implantation as a bladder appendix COL-DUAL and COL-Vicryl® 
showed better biocompatibility and only small remnants of these constructs were 
found 1 month post-implantation. Based on this information we assume that the hybrid 
CHC that we describe here will have very similar characteristics, although this must be 
shown in vivo.
Various approaches have been described for the production of tubular 
templates, albeit almost exclusively for vascular grafts. Textile fabrics (e.g. knitted- 
and woven meshes), and polymer windings/springs have been used to provide 
mechanical support to tubular structures, and tubular structures were created 
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by electrospinning [17,38], However, these approaches have shown functional 
limitations such as isotropy, low kinking resistance and compliance mismatch [17], 
For instance, the implantation of a vascular construct (diameter approximately 6 
mm) with mismatched (bio)mechanical behavior created local tissue stiffening. 
The compliance of the tubular wall was dissimilar, while the disturbed flow might 
cause thrombus formation and hyperplasia [2,3,12,39], It is likely that mechanical 
compatibility and compliance mismatch also play a role for tubular templates of 
larger diameter. To the best of our knowledge, the importance of mechanical match 
on tissue remodeling of implanted tubular scaffolds of large diameter it is currently 
unclear. However, native-like compliance of flat structures such as heart valves 
is of utmost importance to guarantee pliability of tissue-engineered leaflets [40], 
It is likely that the same holds true for tubular templates. While the mechanical 
characteristics of textile fabrics and electrospun materials do not match native 
tissues, reinforcement with macro fibers, arranged in a native-like manner, were 
shown to improve graft patency [40], Similarly, the reinforcement of tubular scaffolds 
with CHCs is expected to lead to a better functional outcome with less fibrosis, less 
construct shrinkage, and maintenance of desired structural dimensions.
Other approaches to engineering various tubular templates have been based 
on the use of decellularized tubular tissues e.g. arteries and trachea. However, 
decellularization processes can result in reduced mechanical functionality and, 
therefore, the reinforcement with other tubular materials may be advantageous 
to ensure compliance like native (cellularized) tissue as well as structural integrity 
[13,41], Besides collagen and decellularized tissue, tubular templates were also 
prepared from tubularized cell sheets. Highly organized cell sheets have been 
investigated as an excellent template [8,42], Some cell-sheet fabrics displayed 
adequate physiological compliance and strength [43,44], However, very similar to 
collagen templates, these templates are structurally weak and reinforcement with 
the e.g. electrospun material may be required [14]. Albeit that cell-sheet fabrics have 
been used to engineer small diameter vascular grafts, large engineered constructs 
combining cell sheet techniques remains to be demonstrated. 
Finally, the hybrid architecture described here shows also a similar physiological 
stress-strain behavior of larger native tissues such as the trachea [45,46]. 
Furthermore, paired with the versatility of the production process, mainly by simply 
changing molding- and casting tools [7], hybrid collagen type I templates of various 
tube diameter, wall thickness and tube length can be prepared for a wide variety 
of purposes.
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5 CONCLUSION
CHCs are promising bioinspired materials and constructs as support structures 
to produce tubular templates. The production procedure is relatively easy, 
reproducible and mechanical features can be controlled. We created a hybrid 
tubular template composed of collagen type I reinforced with a CHC showing similar 
mechanical behavior as native tubular soft tissue. These CHC-enforced templates 
which are easily tunable to meet different demands are promising for tubular tissue 
engineering.
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APPENDIX
A1: Dimensions of coupled helical coils (CHCs) produced from different commercially available, 
resorbable surgical suture monofilaments.
A2: Mechanical properties of collagen type I templates (COL) and collagen type I templates 
reinforced with a PDSII® USP 2-0 coupled helical coil (hybrid). (A) Representative stress-strain 
curves of COL and hybrid in longitudinal direction. (B) Representative stress-strain curves of 
COL and hybrid in circumferential direction.
534676-L-bw-Janke
Processed on: 27-8-2019 PDF page: 81
81
Bioinspired Coupled Helical Coils for Tissue Engineering
A3: Analysis of coupled helical coil (CHCs) under cyclic mechanical loads. (A) Relative strain 
recovery of CHCs after 10 loading cycles. (B) relative energy loss after unloading of CHCs after 
10 loading cycles. Data represent mean ± standard deviation. One-way ANOVA with Bonferroni 
post-hoc test, *= p < 0.05, ***= p < 0.0001.
A4: Analysis of collagen type I template reinforced with a PDSII® USP 2-0 coupled helical coil 
(hybrid) under compressive loads. (A) Compression of the hybrid. No distortion of the hybrid 
was observed during compression and after release of the load (B). (C) Corresponding stress-
strain curve of the hybrid under compressive loads.
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ABSTRACT
In vivo monitoring of tissue-engineered constructs is important to assess their 
integrity, remodeling, and degradation. However, this is challenging when the 
contrast with neighboring tissues is low, necessitating labeling with contrast 
agents (CAs), but current CAs have limitations (i.e., toxicity, negative contrast, label 
instability, and/or inappropriate size). Therefore, a naturally derived hemin-L-lysine 
(HL) complex is used as a potential CA to label collagen-based templates for magnetic 
resonance imaging (MRI). Labeling does not change the basic characteristics of the 
collagen templates. When hybrid templates composed of collagen type I reinforced 
with degradable polymers are subcutaneously implanted in mice, longitudinal 
visualization by MRI is possible with good contrast and in correlation with template 
remodeling. In contrast, unlabeled collagen templates are hardly detectable, and the 
fate of these templates cannot be monitored by MRI. Interestingly, tissue remodeling 
and vascularization are enhanced within HL-labeled templates. Thus, HL labeling 
is presented as a promising universal imaging marker to label tissue-engineered 
implants for MRI, which additionally seems to accelerate tissue regeneration.
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1 INTRODUCTION
Tissue engineering (TE) aims at the development of templates that repair, regenerate, 
or replace damaged tissues and/or organs [1]. The ideal TE template should keep 
its form to fill the defect, be readily implantable, enhance tissue regeneration, 
and be able to support tissue-specific functional demands until the template is 
remodeled completely and replaced by native host tissue [2,3]. Transplantation of 
tissue-engineered templates often leads to shrinkage or graft failure (e.g., stricture 
formation and obstruction) and graft failure is often recognized too late or, in 
experimental settings, when templates are harvested [4–6]. Therefore, monitoring 
the fate of templates upon implantation is of utmost importance. Several imaging 
modalities are available to provide information of template integrity, remodeling, 
and resorption in a noninvasive, highly sensitive manner [7], albeit imaging of 
implanted grafts has been limited. 
Magnetic resonance imaging (MRI) is an attractive multifunctional and noninvasive 
imaging modality that does not use ionizing radiation. Various templates used in TE 
have been monitored using MRI. For example, good image contrast was achieved in 
vivo for bone TE, particularly after modifications of the filling material (e.g., calcium 
phosphate cement) with contrast agents (CAs) [8–10]. Indeed, templates used for 
TE usually give poor contrast as the selected materials have similar composition to 
that of the surrounding host tissue, and thus difficult to distinguish. For instance, 
porous collagen type I templates show excellent biocompatibility and have been used 
for various applications extensively [11], but the imaging contrast to surrounding 
tissues is poor, and the evaluation of its remodeling after transplantation in vivo 
commonly relies on histological examinations. Incorporation of CAs such as ultrasmall 
superparamagnetic iron oxide nanoparticles (USPIOs) in collagen templates can 
enhance MR visibility [12,13]. USPIOs decrease the signal of water by T2 or T2* relaxation 
and thus generate a negative contrast, which however may be misinterpreted as 
other tissue components such as air inclusion may also cause negative contrast. 
Furthermore, the effect of USPIOs on the water signal may extend beyond its local 
presence (“blooming” effect) and thus hamper their precise localization. Finally, 
USPIOs may be washed out of the collagen independent of its remodeling and thus 
images may not accurately represent the engineered template [12–14].
Another limitation associated with collagen type I templates is their poor 
mechanical strength. Incorporation of polymers or surgical meshes can enhance 
overall strength and ensure the stability of collagen templates [15–17]. An additional 
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advantage is that these supportive polymers give a negative contrast in MR images, 
which can assist as an anatomical guide within the hybrid structure [18–20]. 
However, USPIO-labeled collagen templates cannot be distinguished from these 
polymers via MR anymore since both generate a negative contrast. 
Low molecular weight gadolinium (Gd) complexes are widely used for MRI, 
generating a positive MR signal. Gd labeling of collagen templates might enhance 
MRI visibility and allow longitudinal follow-up. However, Gd has been linked to 
adverse effects such as local or systemic fibrosis, especially in patients with renal 
insufficiency as well as brain accumulation in patients with normal renal function 
[21]. Additionally, areas of long-term deposition of Gd-based CAs appeared to be 
the bone and spleen in healthy subjects [22]. Alternatively, (metallo)porphyrins 
may be considered as an alternative class of MR CAs, because they form stable 
chelate complexes with paramagnetic metal ions [23,24]. Hemin, one of the (metallo)
porphyrins, is a natural Fe3+-containing constituent of oxygen-carrying hemoglobin 
[25] and may be suited as an MR CA since it is a high spin complex. However, hemin 
is virtually insoluble under physiological conditions. Here, we synthesized a water-
soluble hemin-L-lysine (HL) complex to label various collagen type I based templates 
via covalent conjugation and physical adsorption. The MRI properties of the labeled 
templates, their labeling efficiency, and their biocompatibility were examined in 
vitro. Furthermore, HL-labeled templates were implanted subcutaneously in vivo to 
assess their visibility by MRI and to longitudinally study their remodeling.
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2 MATERIALS AND METHODS
2 .1  M ate ria l s
Hemin, L-lysine, N-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC), 
N-hydroxysuccinimide (NHS) and 2-morpholineoethane sulphonic acid (MES) were 
purchased from Sigma-Aldrich (St. Louis MO, USA). Acetone, NaCl and Na2HPO4 
and phosphate buffered saline (PBS) were purchased from Merck (Darmstadt, 
Germany). Trinitrobenzene sulfonic acid (TNBS) was purchased from Fluka Chemie 
AG (Buchs, Switzerland). Dry and highly purified collagen type I derived from bovine 
achilles tendon was purchased from Collagen Solutions (Glasgow, Scotland, United 
Kingdom). USP2-0 Maxon® resorbable suture monofilaments were purchased from 
Covidien / Medtronic (Neustadt/Donau, Germany).
2 . 2  H e m in - L- Ly s in e  Co m p l ex  (H L)  Co n j u g ati o n
Hemin-L-lysine conjugation was performed as described by Ingberg et al. [26]. In 
brief, Hemin and L-lysine (molar ratio 1:3) were suspended in a solvent mixture of 
demineralized water and acetone (1:15 (v/v)). The sample was rotated overnight and 
the solid formed was filtered, washed with acetone and lyophilized resulting as a 
water-soluble dark powder (hemin-L-lysine complex (HL)).
2 . 3  Co lla ge n  Ty p e  I  Te m p late  Pro d u c ti o n 
Templates made of collagen type I were prepared as previously described [17,27] 
with slight modifications. A 0.5 % (w/v) collagen solution was prepared by swelling 
highly purified collagen type I from bovine achilles tendon in 0.25 M acetic acid 
overnight followed by homogenization using a Silverson L5M-A laboratory mixer 
(Silverson, Chesham, United Kingdom) and de-airing by centrifugation (800 rpm 
for 30 min). To create a standard collagen type I template (COL), homogenized and 
de-aired collagen suspensions of 2 mL were poured into 24-well plates. To create 
a hybrid tubular template (COL-CHC), homogenized and de-aired collagen type I 
suspensions (7 mL) were poured into a polystyrene mold. A steel mandrel (d = 6 mm) 
was fixed to the middle of the polystyrene mold. To reinforce the collagen and to 
strengthen the construct, a coupled helical coil made of Maxon® USP2-0 was placed 
between the steel mandrel and polystyrene wall. Afterwards, the mold was stored 
in a metal block. Filled molds were frozen at -20 °C for at least 24 hours. Samples 
were subsequently lyophilized (Zirbus Sublimator 500II, Bad Grund, Germany). After 
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lyophilization, 10 mm disc-shaped hybrid patches (COL-CHC patches) were prepared 
from hybrid tubular templates by using a tissue punch (Punchy, Erlangen, Germany).
2 .4  L a b e lin g  o f  H L  to  Co lla ge n  Ty p e  I  Te m p late s
HL of different concentration was dissolved in 0.1 M phosphate buffered saline (PBS; 
7.4 pH; range 0 - 1.25 mM). Dry collagen type I templates were pre-wetted in 70% (v/v) 
ethanol to preserve the porous structure [28]. For covalent conjugation: collagen 
type I templates were soaked in 25 mL HL solution at different concentrations, 
de-gassed under vacuum and incubated until a homogenous distribution of 
HL within the collagen template was achieved (approx. 4 h) as judged by visual 
inspection. Afterwards, crosslinking / covalent conjugation of HL-soaked templates 
was performed with 33 mM EDC and 6 mM NHS [28–30]. In detail, templates were 
transferred to 50 mM MES buffer (pH 5.0) containing 40% (v/v) ethanol. Next, the 
templates were incubated for 4 h in EDC / NHS / MES buffer solution. Crosslinking 
/ labeling reaction was stopped by 2 times washing with 0.1 M Na2HPO4 for 1 h. 
Subsequently, templates were washed twice with 1.0 M NaCl, 2.0 M NaCl (3x) and 
demineralized water (6x). Alternatively, collagen templates were labeled with HL 
by physical adsorption. Here, collagen templates were crosslinked as described 
above, incubated in 70% (v/v) ethanol, de-gassed and soaked in 25 mL of various 
HL solutions (approx. 4h until the appearance of the template was homogeneous) 
followed by washing with PBS (11x) (similar to washings for actively-labeled 
templates). For in vitro studies, all templates were washed in 70% (v/v) ethanol (4 x 
for 1 h and 1 x overnight) and sterile NaCl (4x for 1 h and 1x overnight) followed by 
an overnight incubation in culture medium if cell seeding studies were performed. 
For in vivo evaluation, all templates were frozen again at -20 °C and lyophilized. Dry 
scaffolds were sterilized by 25 kGray of gamma (γ)-irradiation (Staris, Etten-Leur, 
The Netherlands).
2 . 5  Te m p late  Ch a ra c te riz ati o n
Produced templates were subsequently analyzed in terms of pore architecture via 
scaning electron microscopy (SEM). SEM was performed with a Zeiss Sigma 300 (Carl 
Zeiss, Jena, Germany) operating at an accelerating voltage of 15 kV. Samples were 
sputtered with gold for 60 seconds by a Scancoat Six SEM Sputter Coater (Temescal/
Ferrotec, Unterensingen, Germany) before being analyzed. Degree of Crosslinking 
was performed via 2,4,6-trinitrobenzenesulfonic acid (TNBS) assay [29] and the iron 
content of each template was determined by inductively coupled plasma optical 
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emission spectrometry (ICP-OES). In brief, samples were dissolved in 65% nitric 
acid (HNO2) and diluted to 4% HNO2 with milliQ water. The obtained values were 
expressed in micro grams of iron per mg collagen template material.
2 . 6  M e c h a n i c a l  Pro p e r ti e s
To investigate the mechanical properties of the hybrid templates, compression and 
tensile ring tests were performed. For compression tests, COL- and COL-HL cylinders 
with different HL amounts (n = 9; diameter = 13 mm; height = 8 mm) were placed 
in a petri dish filled with PBS (0.1 M; pH 7.4). A compressive load was applied via a 
tensile tester (Z2.5 TN, Zwick/Roell, Ulm, Germany) equipped with a load cell of 20 
N. With a test speed of 50 mm/min, test specimen were compressed up to 80% of 
its original length and the resulting load in Newton [N] were subsequently recorded 
to indicate compressive strength. To indicate the mechanical behavior of COL-CHC 
and COL-HL-CHC, a tensile ring test was performed on ring specimen (l = 5 mm; 
n = 5) mounted between customized hooks (hook-to-hook distance = 6 mm). With 
a crosshead speed of 50 mm/min, all test specimens were pre-conditioned radially 
by stretching 10 times up to 50% of constructs’ strain. Afterwards, the uniaxial load 
was applied in radial direction until rupture of the construct. Mechanical properties 
of the templates were derived as previously described [17].
2 .7  Cy to co m p atib il it y
NIH 3T3 fibroblasts were cultured in standard culture medium composed of 
DMEM (Gibco, Invitrogen, Germany) supplemented with 10% fetal calf serum (FCS; 
Invitrogen, Germany) including 1% Pen/Strep (10,000 U/mL penicillin; 10,000 U/
mL streptomycin, Invitrogen, Germany). For cytotoxicity studies, equal amounts 
(length: 10 mm; weight: 30 mg) of the COL-CHC and COL-HL-CHC templates and 
latex material (positive control) were incubated in standard culture medium for 72 
h. Subsequently, the conditioned culture media were added to NIH 3T3 cells (cell 
density: 4,000 cells / 96-well) and incubated for 24 h. Cell viability was measured 
using the WST-1 assay (Roche) according to manufacturer’s protocol.
In a subsequent set of experiments, NIH 3T3 cells (2 x 106 cells/mL) were seeded 
on COL and COL-HL (diameter = 13 mm; height = 8 mm) as follows: 1 mL of cell 
suspension was added to each pre-wetted template and incubated for 6 h on 
a rollerbank in a humidified incubator (5% CO2) at 37 °C to allow cell adhesion. 
Subsequently, specimen were placed in tissue culture dishes and harvested after 
cell adhesion (day 0; n = 6) and day 7 (n = 6) post-seeding to determine double 
4
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stranded DNA (dsDNA) content. In brief, a biopsy of the cell-seeded template was 
minced, transferred to milliQ water and frozen down to -20 °C. Subsequently, the 
supernatant was collected and diluted in Tris-EDTA (TE) buffer (10 mM Tris-HCl, 1 mM 
EDTA, pH 8). dsDNA content was measured in an opaque white, 96-wells plate using 
a Quant-iTTM PicoGreen® kit (Invitrogen, Carlsbad, USA) according to manufactures 
protocol. Fluorescence was measured with a Victor3 multilabel plate reader (Perkin 
Elmer, Waltham, USA) at an excitation of 485 nm and emission of 528 nm. A DNA 
quantification curve was made using a Lambda DNA standard (Promega, Madison, 
USA).
2 . 8  I n  vit ro  M a g n eti c  Re s o n a n ce  Im a g in g
MRI experiments were performed on an 11.7 Tesla preclinical MR system (BioSpec, 
Bruker, Germany) equipped with a 1H volume coil with an inner diameter of 40 mm. 
Templates were embedded in 10% (w/v) agarose phantoms prior to scanning. A 
rapid acquisition with relaxation enhancement (RARE) sequence was employed for 
acquiring T1- weighted MR imaging, with the following parameters: echo time (TE) = 6 
ms, repetition time (TR) = 600ms, excitation angle = 90°, refocusing angle = 180°, 
number of slices = 20, slice thickness = 0.5 mm, RARE factor = 4, field of view 
(FOV) = 50 × 50 mm, matrix size = 256 × 256 and 8 averages. The scan time was 3 
mins 5 secs. The T1- and T2 relaxation properties of hemin–L-lysine and the hemin 
conjugate incorporated in collagen templates were estimated with a multi-TR and 
multi-TE RARE sequence. For T1 estimation, images were recorded at 8 TRs (i.e., 200, 
500, 1000, 2000, 3000, 5000, 7000, 10000 ms) and T1 values were estimated by fitting 
the signal intensity (Mz) as a function of TR to the model:
The scan time was 7 minutes and 39 seconds. For T2 estimation, the image signal 
intensity at 30 TEs from 10 to 300 ms with an increment of 10 ms were recorded with 
a total scan time of 3 mins 12 seconds. The image signal intensity (M) at different TEs 
were fitted with a mono-exponential model to determine T2 values:
The reciprocals of T1- and T2 relaxation times, defined as R1- and R2 relaxation 
rates, were calculated, respectively. Subsequently, R1- and R2 relaxation rate were 
plotted as a function of the HL concentration to determine the overall relaxivity 
(slope of the curve; see Appendix A1).
Image contrast between the applied template and the background were assessed 
using the contrast to noise ratio (CNR), which was defined as the difference in the 
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two contrast giving tissues divided by the standard deviation of the background 
noise. A region of interest (ROI) of 0.15 cm² was drawn within the area of contrast 
giving tissues (template and tissue phantom, respectively) and background. Mean 
image intensities as well as the standard deviations were obtained using imageJ 
(U.S. National Institutes of Health, Bethesda, Maryland, USA).
2 .9  I n  vivo  Eva l uati o n
HL-modified and plain COL-CHC patches were grafted subcutaneously in 18 immune-
competent female BALB/cByJ mice (age: 7-8 weeks; weight: ± 20 g) to follow the fate 
of the implant in vivo. The animal experiment was conducted in accordance with 
standards and protocols of the Radboudumc, Nijmegen, The Netherlands. National 
guidelines for care and use of laboratory animals were obeyed and the experiment 
was approved by the Ethical Committee on Animal Research of the Radboud 
University Medical Center, Nijmegen, The Netherlands (DEC 2017-0013-005). Mice 
were randomly divided into 3 groups. Prior to surgery, the mice were pre-medicated 
by intraperitoneal injection of Rimadyl (Pfizer, USA; 5 mg carprofen/kg). Anesthesia 
was induced by inhalation of 5% Isoflurane FiO2/N2O 1:2 (maintenance dose of 2-3% 
Isoflurane FiO2/N2O 1:2) and the skin of the graft area was disinfected with Iodine 
(Eurovet animal health, the Netherlands). An incision of ± 1.5 cm was made on the 
back of the mice in line with the spine and two subcutaneous pockets were created 
on the left and right side of the back of the mouse (viewed from the prone position). 
HL-labeled hybrid patches were placed in the right pocket and unlabeled (control) 
hybrid patches were placed in the left pocket. The incision was closed with metal 
clips that were removed after wound closure (± 3 days). For day 0 evaluation, the 
incision of each randomly chosen mouse (n = 6) was closed with an absorbable 6-0 
coated Vicryl Plus suture (Ethicon, USA). For MRI, animals were anesthetized with 
2-3% Isoflurane FiO2/N2O 1:2, and heartbeat and body temperature were monitored 
during scanning.
In vivo MRI experiments were also performed at 11.7T using the same 1H volume 
coil as used for the in vitro studies. High resolution T1 weighted MR images were 
acquired with a RARE sequence to visualize the implanted template in mice at weeks 
2, 4 and 12. The following sequence parameters values were used: TE = 10ms, TR = 560 
ms, RARE factor = 2, number of slices = 20, slice thickness = 0.5 mm, FOV = 50 × 50 
mm, matrix size = 512 × 512 and 16 averages. The scan time was 28 minutes and 40 
seconds. In addition, the same protocol as used for the in vitro study was applied 
to determine T1 relaxation times of the implanted templates at each time point. In 
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addition, image contrast of implanted templates in mice was estimated using the 
CNR. For both, T1 and CNR calculations, a 0.6 mm2 ROI was set within the collagen-
labeled structure of the scaffold. Volumes of implanted COL-HL-CHC templates were 
determined as previously described by using ImageJ. [12] In brief, the template 
volume was measured by manually outlining the template area in each MR image 
slice and multiplication by slice thickness (0.5 mm). At pre-determined endpoints 
(2, 4, and 12 weeks post transplantation), animals were sacrificed by carbon dioxide 
asphyxiation, imaged and tissues harvested for analysis.
2 .10  (Im m u n o) h i s to c h e m i c a l  A n a l y s i s
Harvested implants were split and fixed in 4% paraformaldehyde (PFA) followed by 
paraffin embedding, or immediately embedded in Tissue Tek (Sakura, Torrance, USA) 
and snap-frozen in a dry ice cooled isopentane and stored at -85°C. Morphology, 
cellular content of implanted materials and extracellular matrix deposition were 
analyzed by Hematoxyline and Eosin (HE), Masson Trichrome / Verhoeff stain and 
immuno(fluorescence) staining.
2.10.1 Vessel formation
To visualize vessel formation, excised implants were stained for collagen type I, 
alfa-smooth muscle actin (α-SMA) and Cluster of Differentiation 31 (CD31). Cryostat 
sections were fixed in ice-cold aceton, washed with PBS and incubated with rabbit 
anti-mouse collagen I (NB600-408, Novus Biologicals, Cambridge, United Kingdom, 
1:100), rat anti-mouse CD31 (553370, BD Biosciences, Heidelberg, Germany, 1:100) or 
Biotin anti-mouse smooth muscle actin (BK61501.0.5, Progen, Heidelberg, Germany, 
1:500) in 12% BSA/PBS at 4°C overnight. After washing sections were incubated 
with Goat anti-rabbit IgG (111-155-003, Dianova, Hamburg, Germany, 1:50), Donkey-
anti-Rat IgG (712-546-153, Dianova, Hamburg Germany, 1:350) or Streptavidin anti-
biotin (ab134348, Abcam, Cambridge, United Kingdom, 1:100) in 12% BSA/PBS for 
45 min at room temperature. After washing sections were embedded in Mowiol® 
and analyzed.
To quantify blood vessel formation, sections were stained for alfa-smooth 
muscle actin with Bright-3,3’Diaminobenzidine (Bright-DAB). Paraffin sections (5 
micron) were deparaffinized using xylene, followed by graded series of ethanol 
and re-hydrated in PBS. Subsequently, sections were immersed in 1% (v/v) H2O2/
PBS for 10 minutes at room temperature to block endogenous peroxidase followed 
by mouse-on-mouse blocking with MOM kit (Sigma Aldrich, St. Louis MO, USA). 
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Afterwards, sections were incubated with anti-alfa-smooth muscle actin (Sigma 
Aldrich, St. Louis MO, USA), washed and incubated with biotinylated anti-mouse 
IgG (Immunologic, Duiven, The Netherlands) for 10 minutes at room temperature. 
Next, the sections were washed in PBS and incubated for 45 minutes with ABC-PO 
(Avidin 1:100 and Biotin 1:100 in PBS; 30’ pre-incubation at room temperature (Sigma 
Aldrich, St. Louis MO, USA). All sections were stained with Bright-DAB (Immunologic) 
for 5 minutes and counterstained with hematoxylin. For blood vessel quantification, 
the number of blood vessels were counted and normalized to the cross-sectional 
area of the region of interest using ImageJ.
2.10.2 Immune Response
The excised implants were stained for F4/80 and Dihydrochloride (DAPI) for 
immune response evaluation. Sections were first stained with rat anti-mouse F4/80 
(MCA497GA, AbD Serotec (Bio-Rad), Düsseldorf, Germany, 1:50) in 12% BSA/PBS 
and were incubated at 4 °C overnight. Following to washing step, sections were 
incubated with donkey anti-rabbit IgG (711-546-152, Dianova, Hamburg, Germany, 
1:500) and donkey anti-rat IgG (712-166-153, Dianova, Hamburg, Germany, 1:500) 
in 12% BSA/PBS for 45 min at room temperature. As a final step, sections were 
counterstained with 4’,6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI, Life 
Technologies, Carlsbad, USA, 1:500) in 12% BSA/PBS for 45 min at room temperature 
and mounted. To quantify F4/80 positive cells, the ratio of F4/80 positive cells (nuclei) 
over total nuclei content was calculated using 3 micrographs (magnification: 200x) 
from n = 3 mice per time point and template with ImageJ micrographs. Furthermore, 
brightfield images were scored to indicate cellular content (lymphocytes, polynuclear 
morphocytes, giant cells and (myo)fibroblasts), extracellular matrix and vascularity. 
Scoring was performed by 2 independent observers (HPJ, AYS). If the observers were 
discordant, samples were re-analyzed until concordance was reached. Infiltrating 
cells were scored as – = not present, +/- = sporadically present, + = moderately 
present or ++ = abundantly present.
2 .11  St ati s ti c a l  A n a l y s i s
Data regarding the pore perimeter of COL and COL-HL were obtained directly from 
each measurement, without any pre-processing. Results are presented as mean ± 
standard deviation. Per template type, 10 randomly chosen pores were measured 
and each template type was measured n = 3 independently. A Student’s t-test (two-
tailed) was applied to determine statistical differences between COL and COL-HL.
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DNA content of cell seeded templates were obtained from raw absorbance data 
and normalized to the weight of individual templates. Data are expressed as mean 
± standard deviation. Sample size was n = 6 for each group. A two-tailed Student’s 
t-test was performed to determine statistical differences between COL and COL-HL.
Load-displacement data from tensile ring tests were normalized to dimensions 
and gauge lengths of COL-CHC and COL-HL-CHC to obtain initial modulus (E1), 
upswing (Young’s) modulus (E2), ultimate tensile strength (UTS and failure strain 
from a computed stress-strain curve. Data are expressed as mean ± standard 
deviation with a sample size of n = 5 for each group. A Student’s t-test (two-tailed) 
was applied to indicate statistical differences between COL-CHC and COL-HL-CHC.
Iron content data (ppm) were normalized to µg iron per mg of template material. 
Results are expressed as mean ± standard deviation. Sample size was n = 9 for each 
condition.
Data regarding compressive strength were directly obtained from measurements 
without any pre-processing. Data are expressed as mean ± standard deviation. 
Sample size was n = 9 for each group from independent measurements. Regression, 
Pearson correlation coefficient r and p value (two-tailed) were determined to 
describe the correlation between iron concentration and strength of different 
templates.
Data from the TNBS assay (free NH2-groups) were obtained from raw absorbance 
data and normalized to the weight of individual templates. To obtain the degree of 
crosslinking, crosslinked templates were normalized to non-crosslinked templates. 
Results correspond to mean ± standard deviation of a sample size of n = 3. A two-
tailed Student’s t-test was performed to determine statistical differences between 
crosslinked and non-crosslinked templates. In addition, regression, Pearson 
correlation coefficient r and p value (two-tailed) were determined to describe the 
correlation between iron concentration and NH2-groups.
Relaxation rate (R1) data were calculated from relaxation time (T1) measurements 
and data on contrast-to-noise ratio (CNR) data were calculated from raw imaging 
data (image intensities). All data sets are expressed as mean ± standard deviation. 
Sample size for each group was n = 6 for each group. When COL-CHC templates were 
compared with COL-HL-CHC templates, a two-tailed Student’s t-test was performed 
to determine statistical differences. Regression, Pearson correlation coefficient r 
and p value (two-tailed) were determined to describe the correlation between iron 
concentration and strength of different templates.
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To determine the number of blood vessels, blood vessels were counted and 
normalized to the cross-sectional area of the ROI. Data represent mean ± standard 
deviation with a sample size of n = 6 for each group. COL-CHC were compared with 
COL-HL-CHC. A two-tailed Student’s t-test was performed to determine statistical 
differences.
For all analysis, p < 0.05 was considered statistically significant. GraphPad Prism 
(version 5.03, GraphPad Software Inc, La Jolla, CA, USA) was used for all statistical 
analysis.
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3 RESULTS AND DISCUSSION
3 .1  Te m p late  Pro d u c ti o n  a n d  H L  In co r p o rati o n
Prior to labeling with the hemin-L-lysine complex (HL, Figure 1A), various collagen 
type I-based templates were produced as prototypic template materials: i) simple 
disc-shaped collagen type I templates (COL; Figure 1B-i), ii) hybrid tubular templates 
composed of collagen type I reinforced with a coupled helical coil (COL-CHC; Figure 
1B-ii) and iii) COL-CHC patches derived from hybrid tubular templates (Figure 1B-
iii). All produced templates showed a typical honeycomb-like porous structure as 
evaluated by scanning electron microscopy (SEM) (see Figure 1B-iv for COL and 
Figure 1B-v for COL-CHC).
To increase the solubility of hemin in aqueous media, three mole of L-lysine / 
mole hemin was needed to dissolve the hemin [26]. This yielded in a soluble hemin-
L-lysine (HL) complex: no precipitate was observed after 20 min of centrifugation 
at 10000g. HL solutions of different concentrations ranging from 0.0 mM to 1.25 
mM were prepared in phosphate buffered saline (PBS; 0.1 M; pH 7.4) in glass vials.
Subsequently, collagen type I templates were incubated in these HL 
concentrations. To achieve a homogeneous distribution of HL throughout the 
templates pre-incubation of dry collagen type I templates in 70% (v/v) ethanol 
and subsequent de-airing / degassing under vacuum was essential to preserve 
the honeycomb-like porous structure: dry COL soaked directly in HL collapsed 
immediately resulting in an inhomogeneous distribution of HL mainly at the 
outer margin of the templates. Subsequently, HL was covalently conjugated to 
amine- (NH2) and / or carboxylic (COOH) groups of collagen type I via N-ethyl-
3-(3-dimethylaminopropyl)-carbodiimide (EDC) / N-hydroxysuccinimide (NHS) 
during crosslinking to form stable amide bonds (Figure 1C). In addition to collagen 
crosslinking, this method has been well established to covalently conjugate 
molecules to collagen templates (e.g., chondroitin-sulfate and heparan sulfate) 
[31,32].
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Figure 1: A) Chemical structure of the hemin-L-lysine (HL) complex. B) Various collagen type I 
templates. Macroscopic image of (i) a disc-shaped COL template, (ii) hybrid tubular COL-CHC 
template, and (iii) COL-CHC patches derived from tubular hybrid templates. Cross-sectional 
scanning electron microscopy (SEM) images of COL (iv) and COL-CHC (v) (scale bar SEM = 100 μm). 
C) Covalent conjugation of HL to COL via N-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (ED-
C)/N-hydroxysuccinimide (NHS) during crosslinking procedure. D) Various collagen type I tem-
plates covalently conjugated with HL. Macroscopic image of (i) a disc-shaped COL-HL template, 
(ii) tubular COL-HL-CHC, and (iii) COL-HL-CHC patches. SEM of COL-HL (iv) and COL-HL-CHC (v) 
(scale bar: 100 μm). E) In vitro T1-weighted magnetic resonance images (T1w-MRI) of disc-shaped 
COL and COL-HL templates. F) In vitro T1w-MRI of tubular COL-CHC and COL-HL-CHC. G) Pore pe-
rimeter of honeycomb template structure of COL and COL-HL. Data represent mean ± standard 
deviation with a sample size of n = 3 for each group. Two-tailed Student’s t-test was performed 
to determine statistical differences. H) p < 0.05 was considered statistically significant ultimate 
tensile strength (UTS) and failure strain of COL-CHC and COL-HL-CHC. Data represent mean ± 
standard deviation with a sample size of n = 5. I) Cell attachment (day 0) and cell proliferation 
(day 7) of seeded NIH 3T3 fibroblasts to COL and COL-HL templates. Data represent mean ± 
standard deviation with a sample size of n = 3 for each group. Two-tailed Student’s t-test was 
performed to determine statistical differences. p < 0.05 was considered statistically significant.
After stopping the crosslinking process, HL loss during subsequent washing 
procedures was limited and only observed when collagen templates were incubated 
in HL concentrations of 1 mM and higher, suggesting that available conjugation sites 
were saturated. Covalently conjugated templates appeared in dark brown color (COL 
alone (COL-HL; Figure 1D-i), hybrid templates with coupled helical coil (COL-HL-
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CHC; Figure 1D-ii and 1D-iii). Alternatively, COL templates were physically adsorbed 
through incubation in HL of various concentration after crosslinking. This procedure 
of physical adsorption has been described as a strategy to bind growth factors such 
as bone morphogenetic protein-2 [33,34]. Substantial HL-loss was observed during 
washing steps. These templates appeared light brown with increasing intensity in 
an HL concentration-dependent trend (see Appendix A2).
Crosslinking of collagen type I templates was successful as evidenced by the 
2,4,6-Trinitrobenzenesulfonic acid (TNBS) assay. Non-crosslinked collagen templates 
showed an average of 260 ± 114 nmol of free amine groups per mg collagen. Free 
amine groups of crosslinked collagen templates significantly decreased (p < 0.0001) 
to 99 ± 27 nmol per mg collagen (38.2 ± 10.2% reduction). COL-HL templates used 
for covalent conjugation had an amount of 496 ± 52 nmol of free amine groups per 
mg prior to crosslinking / conjugation. After crosslinking / conjugation, free amine 
groups were significantly (p < 0.0001) reduced to 267 ± 48 nmol per mg (53.9 ± 9.7% 
reduction). Overall, covalent conjugation of HL to collagen resulted in significantly 
(p < 0.0001) higher free amine groups after crosslinking when compared to collagen 
alone.
The iron content of covalently conjugated- and physically adsorbed templates 
after subsequent washings are presented in Appendix A7 and was found higher 
for covalently conjugated templates. The iron content of covalently conjugated 
templates used for in vitro and in vivo studies was 6.8 ± 2.7 μg Fe / mg collagen. 
Collectively, covalent conjugation of HL was successful and preferable over physical 
adsorption as loss of HL is expected to be directly related to collagen remodeling 
whereas with physical adsorption HL loss is not necessarily a reflection of collagen 
remodeling.
3 . 2  I n  V it ro  M RI
To assess the applicability of HL as a CA, the relaxivity of HL dissolved in PBS 
was measured on an 11.7T pre-clinical MR system. Using a rapid acquisition with 
relaxation enhancement (RARE) sequence with variations of repetition time (TR) or 
echo time (TE), the T1-relaxivity (r1) was assessed as 0.42 ± 0.02 mM
-1s-1 and the T2-
relaxivity (r2) was assessed as 4.3 ± 0.7 mM
-1s-1 (Appendix A1). These relaxivities are 
common for metalloporphyrins such as HL [24]. However, bright MRI signal indicates 
HL as a T1-weighted MR CA similar to other Fe
3+-chelated CAs which may be an 
alternative to gadolinium-based CAs for T1-weighted magnetic resonance imaging 
(T1w-MRI) [35]. It is clear that a full characterization of the relaxivity properties 
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of HL at different field strengths (e.g. at 3T) is required to better understand the 
contrast properties observed and to be able to optimize these properties for future 
applications.
Subsequently, T1w-MR images of labeled collagen type I templates were acquired. 
Both covalently conjugated- and physically adsorbed collagen templates, were better 
visualized by MRI compared to unlabeled collagen templates. The best visualization 
in T1w-MR images (Appendix A2) and largest T1w-MR relaxation rate (R1) difference 
between HL-labeled and control templates changes (Appendix A7) were achieved 
for the covalently conjugated collagen type I templates. R1 significantly correlated 
with iron concentration (r = 0.9582; p = 0.0026; R2 = 0.9182), whereas no significant 
correlation was found for physically adsorbed HL (r = 0.7493; p = 0.0864; R2 = 0.5614), 
most likely because HL washout was faster at the highest HL concentrations due to 
a steeper concentration gradient. Furthermore, the contrast-to-noise ratio (CNR) 
of both covalently conjugated and physically adsorbed HL reached a plateau at 1.0 
mM HL (Appendix A7), resulting in a clear visualization when compared to COL 
alone (Figure 1E).
The T1 effect on the water signal may be variable for physically adsorbed collagen 
templates due to diffusion of HL out of the complex and thus unrelated to collagen 
remodeling and / or degradation. Therefore, physical adsorption was deemed 
unreliable, as the intention was to develop an MR imageable template where MR 
signal and collagen content were strongly correlated. The covalent conjugation of 
HL to collagen resulted in higher labeling efficacies as well as higher relaxation rates 
and contrast-to noise ratios of the templates compared to physical adsorption. 
HL labeling efficiency was concentration-dependent, but contrast-to-noise ratios 
did not improve when templates were incubated in HL levels beyond 1 mM. Thus, 
subsequent experiments were performed with collagen templates which were 
covalently conjugated with 1 mM HL via EDC / NHS.
Following to the identification of the best labeling strategy and the most efficient 
HL / iron concentration, hybrid templates covalently conjugated with 1 mM HL 
(COL-HL-CHC) showed a strong contrast in T1-weighted MR images (Figure 1F). The 
collagen component of the hybrid templates was clearly distinguishable from the 
surrounding tissue phantom and allowed the visualization of the integrated CHC (the 
negative contrast of CHC shown in MR images). In the unlabeled hybrid templates 
(COL-CHC), only the CHC was visible, while the collagen component could not be 
distinguished from the surrounding tissue phantom (Figure 1F). R1 and CNR values 
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of the labeled hybrid templates were significantly higher compared to unlabeled 
templates (p < 0.0001; see Table 1, Day 0).
To the best of our knowledge, this is the first time that an MRI examination 
of a hybrid template, for Tissue Engineering and Regenerative Medicine (TERM) 
purposes, enabled to visualize both collagen type I (the cellular stratum) labeled 
with a naturally-derived CA giving positive contrast and the CHC (the supportive 
polymer) giving negative contrast with respect to surrounding tissue. Similar to 
our approach, Gd has been used to monitor tissue-engineered templates, albeit 
very limited [36,37]. However, Gd is associated with a risk of nephrogenic systemic 
fibrosis, and there have also been concerns about the deposition of Gd in the body 
after repetitive use [22,38]. The degradation of heavily Gd labeled collagen scaffolds 
might lead to systemic Gd exposure. On the contrary, hemin and L-lysine are both 
natural compounds, and thus the corresponding degradation products are not 
anticipated to have adverse effects.
3 . 3  Te m p late  Po ro s it y,  (B i o) m e c h a n i c a l  Pro p e r ti e s  a n d 
Cy to co m p atib il it y
HL-labeled templates showed the same porous honeycomb collagen architecture 
with no changes in pore perimeter (Figure 1G) when compared to COL-alone 
templates (compare Figures 1B-iv,v with Figures 1D-iv,v). A porous structure is 
essential and plays a key-role in cellular/tissue ingrowth into the template as well 
is crucial for vascularization, diffusion of nutrients, metabolites and waste products 
[39,40].
When (bio)mechanical properties were evaluated, a significant increase in 
compressive strength was observed for covalently conjugated collagen templates 
(Appendix A7, Pearson correlation coefficient r = 0.9591, p = 0.0025) when compared 
to physically adsorbed collagen templates (Pearson correlation coefficient r = 0.7164, 
p = 0.19092). This significant enhancement in the stiffness of covalently conjugated 
COL-HL might be related to the conjugation of an increased amount of material 
(HL) compared to COL alone and physically adsorbed COL-HL. Template stiffness is 
known to have an effect on cell behavior as mechanical cues play a role in cell fate 
[41]. However, whether the increase in collagen stiffness is of importance in hybrid 
templates is questionable, because overall strength and structural integrity are 
dictated by this supportive structure [17]. For labeled- (COL-HL-CHC) and unlabeled- 
(COL-CHC) hybrid templates, a ‘J’-shaped stress-strain behavior (Appendix A3A) was 
observed, which is typical for soft tissues. Initial moduli E1 were 26 ± 3 x 10-3 MPa 
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for the unlabeled and 44 ± 22 x 10-3 MPa for the labeled template, respectively. The 
upswing (Young` s) moduli E2 were 1.0 ± 0.2 MPa and 1.2 ± 0.3 MPa for the unlabeled 
collagen templates and the labeled templates, respectively (Appendix A3B). 
Consequently, no significant differences in overall strength were found between 
COL-HL-CHC and COL-CHC hybrids (E1: p = 0.0930; E2: p = 0.3015). Furthermore, 
ultimate tensile strength (COL-CHC: 0.5 ± 0.2 MPa; COL-HL-CHC: 0.7 ± 0.3 MPa) and 
failure strain (COL-CHC: 1.35 ± 0.12 mm/mm; COL-HL-CHC: 1.43 ± 0.11 mm/mm) were 
similar between labeled- and unlabeled templates (Figure 1H). Thus, active labeling 
of COL-CHC with HL did not change the basic characteristics of the hybrid templates.
In a final set of in vitro experiments, cytocompatibility and cellular outgrowth 
were evaluated. Supernatants from unlabeled and labeled templates incubated in 
culture media did not show any cytotoxic effects on NIH 3T3 fibroblasts (Appendix 
A4). Furthermore, these cells attached and proliferated when seeded on COL and 
COL-HL templates with no significant differences between both groups (Figure 1I). 
Initial values (Day 0) for nanogram double-stranded DNA (ds-DNA) per mg template 
were 16.8 ± 9.3 and 15.3 ± 8.1 for COL and COL-HL, respectively. At day 7 post 
seeding, the DNA content increased significantly when compared with day 0 (P < 
0.0001). The DNA contents were 94.0 ± 10.5 nanogram ds DNA per mg for COL and 
99.4. ± 38.5 nanogram ds DNA per mg for COL-HL (not significant). Thus, active HL-
labeling did not influence cell adhesion and proliferation in vitro.
3 .4  I n  vivo  M RI  o f  H y b ri d  Te m p late s
Table 1. Relaxation rate R1 (n = 6), contrast-to-noise-ratio CNR (n= 6) and volume measurement 
(n = 6) of implanted hybrid collagen type I templates covalently conjugated (COL-HL-CHC) or 
unlabeled (COL-CHC) with hemin-L-lysine over time. Data are expressed as mean ± standard 
deviation. Two-tailed Student’s t-test was performed to determine statistical differences. P < 
0.05 was considered statistically significant. * = p < 0.05 compared to COL-CHC; ** = p < 0.01 
compared to COL-CHC. *** = p < 0.0001 compared to COL-CHC.
Day 0 Week 2 Week 4 Week 12
R1 [s-1]
COL-CHC
COL-HL-CHC
0.36 ± 0.04
0.62 ± 0.07***
0.41 ± 0.03
0.57 ± 0.08**
0.41 ± 0.07
0.57 ± 0.05**
0.51 ± 0.07
0.64 ± 0.09*
CNR [-]
COL-CHC
COL-HL-CHC
5.1 ± 3.9
49.6 ± 6.5***
9.9 ± 5.3
37.0 ± 11.5**
3.4 ± 2.2
31.0 ± 9.1**
7.1 ± 3.7
25.9 ± 14.1*
Template Volume [mm³]
COL-HL-CHC 57.0 ± 7.5 32.6 ± 7.5 27.3 ± 8.5 30.2 ± 7.4
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To study whether covalently conjugated collagen templates could be visualized in 
vivo, COL-CHC and COL-HL-CHC patches were subcutaneously implanted in immune 
competent BALB/c mice. Immediately after transplantation MRI revealed a strong 
signal / contrast of the labeled hybrid (COL-HL-CHC) patch which could easily be 
delineated from the surrounding tissue. Within the hybrid structure, the labeled 
collagen component could be distinguished with its bright contrast from the 
polymeric coupled helical coil (CHC) structure with negative contrast. In contrast, 
the collagen component of the unlabeled hybrid (COL-CHC) patch could not be 
identified by MRI, and only the CHC polymer was visible as an anatomical guide 
(Figure 2). At all evaluation points, T1 relaxation rate (R1) values of COL-HL-CHC were 
significantly higher than those for COL-CHC (Table 1). Also, the CNR was significantly 
higher for COL-HL-CHC. Identical ROI were selected for the T1 and CNR values and 
the hyperintense area of the T1 weighted MRI was selected. The average volume of 
the implanted COL-HL-CHC templates was 57.0 ± 7.5 mm³ at day 0 as determined 
visually on the T1 weighted images. This volume decreased to approximately 55% 
of its initial value at 2 weeks post-implantation. No further decrease in template 
volume was observed until the end of the experiment. The MRI contrast in close 
vicinity to the embedded polymer was decreasing, suggesting remodeling and/or 
loss of COL-HL-CHC material. For COL-CHC, accurate volume measurements were not 
feasible due to lack of contrast, which demonstrates that the covalent conjugation 
of HL to collagen templates is essential for their longitudinal assessment by MRI.
Whereas the template volume decreased over time, MR signal and gross 
morphology of the implanted templates were stable over time. This correlated very 
well with the histological evaluation of the implants: the template was still intact 
with no macroscopic signs of resorption, suggesting that the molecular modification 
permitted adequate monitoring of the template. In similar studies, USPIOs were 
passively entrapped within collagen templates and subcutaneously implanted or 
implanted on the bladder wall to monitor template integrity and remodeling [12,13]. 
Passive entrapment of USPIOs correlated well with template remodeling in early 
time points (e.g. 22 days) [13]. However, ultimately MR images did not correlate with 
the template anymore because the entrapped USPIO were washed out. Also, USPIO 
washout is heavily dependent on the site of implantation [12]. This site dependency 
is less likely to play a dominant role here on the COL-HL templates, as the density-
generating contrast agent HL is covalently conjugated to the collagen template.
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Figure 2. Coronal T1-weighted MR images of subcutaneously implanted COL-CHC and COL-HL-
CHC templates obtained by a 11.7T preclinical MRI system (BioSpec, Bruker, Germany) with 1H 
volume coil (ID = 40mm) via T1 RARE sequence (TE = 10 ms, TR = 560 ms, RARE factor = 2, number 
of slices = 20, slice thickness = 0.5 mm, FOV = 50 × 50 mm, matrix size = 512 × 512 and 16 aver-
ages). Scale bar = 5 mm. Transparent arrows indicate the subcutaneously implanted template. 
Please note the similar MR image intensities of unmodified collagen template. Filled arrows 
indicate the CHC component within COL at day 0, Week 2, 4 and 12 respectively. K = Kidney. 
S = Spine.
3 . 5  Ph e n ot y p i c  A n a l y s i s  o f  E xci s e d  Te m p late s
Representative images and the scoring of inflammatory cells in excised implants are 
presented in Figures 3-5 and Table 2, respectively. At 2 weeks post-implantation 
(Figure 3), lymphocytes, polymorphonuclear lymphocytes (PMNs) and fibroblasts 
were observed within all templates, regardless of whether HL was incorporated or 
not. Additionally, giant cells appeared in COL-HL-CHC. At this time point, no major 
differences in template remodeling and deposition of new extracellular matrix 
(ECM) within the template architecture were observed in both groups. (Appendix 
A5, Figure 3A-i and Figure 3B-i). Furthermore, the amount of F4/80 positive 
macrophages for labeled- and unlabeled- templates were similar (Figure 3A-ii 
for COL-CHC and Figure 3B-ii for COL-HL-CHC). COL-CHC and COL-HL-CHC were 
surrounded by a fibrous, well-vascularized capsule (Figure 3A-iii and Figure 3B-iii). 
Mature blood vessels as judged by Cluster of Differentiation 31 (CD31) and alpha 
smooth muscle actin (α-SMA) were found mainly at the template periphery (see 
Appendix A6 and Figure 3A-iv, Figure 3B-iv).
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Figure 3. (Immuno-)histochemistry of excised subcutaneously implanted COL-CHC (A, i-iv) and 
COL-HL-CHC (B, i-iv) 2 weeks after implantation. A,B) Template overview, Hematoxyline / Eosine 
staining (scale bar = 2 mm). Boxes correspond to areas shown in A,B i-iv, stars indicate the CHC 
polymer within the collagen template architecture. A,B-i) HE staining of the template center 
(scale bar = 200 micron). A,B-ii) Macrophage staining (F4/80) in red, cell nuclei in blue (scale 
bar = 10 micron). A,B-iii) Masson Trichrome / Verhoeff staining in template periphery (scale 
bar = 200 micron). A,B-iv) Alpha-smooth muscle actin staining, to indicate blood vessels, in 
template periphery (scale bar = 200 micron).
At 4 weeks post-implantation (Figure 4), cell ingrowth (Appendix A5), template 
remodeling and deposition of extracellular matrix appeared to be more pronounced 
for the COL-HL-CHC template as evaluated by Masson Trichrome / Verhoeff staining 
(Figure 4A-i, 4B-i). Additionally, more α-SMA positive cells were observed within 
COL-HL-CHC templates (compare Figure 4A-ii with Figure 4B-ii). Despite this 
enhanced remodeling, the templates’ scaffold structures remained intact, and the 
thickness of the fibrous tissue capsule at the periphery of both templates decreased 
(Figure 4A-iii for COL-CHC and Figure 4B-iii for COL-HL-CHC). No difference in 
vascularization between COL-CHC and COL-HL-CHC was detected (Figure 4A-iv, 
4B-iv) and similar macrophage infiltration was observed in both templates as 
indicated by F4/80 positive cells (Figure 4A-v and 4B-v). Moreover, no signs of 
structural degradation of the CHC in both templates were noticed (Figure 4A-vi 
and 4B-vi).
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Figure 4. (Immuno-)histochemistry of excised subcutaneously implanted COL-CHC (A, A-i-vi) 
and COL-HL-CHC (B, B-i-vi) 4 weeks after implantation. A,B) Template overview, Hematoxyline 
/ Eosine staining (scale bar 2 mm). Boxes correspond to areas shown in A,B-i-vi, stars indicate 
the CHC polymer within the collagen template architecture. A,B-i) Masson Trichrome / Ver-
hoeff staining. Black arrow heads indicate template architecture. White arrow heads indicate 
newly formed collagen fibrils within the template architecture (scale bar = 200 micron). A,B-ii) 
Alpha-smooth muscle actin staining of the template center (scale bar = 200 micron). A,B-iii) 
Masson Trichrome / Verhoeff staining of the template periphery (scale bar = 200 micron). 
A,B-iv) Alpha-smooth muscle actin staining, to indicate blood vessels, of the template pe-
riphery (scale bar = 200 micron). A,B-v) Macrophage staining (F4/80) in red, cell nuclei in blue 
(scale bar = 10 micron). A,B-vi) Masson Trichrome / Verhoeff staining of the CHC imbedded in 
collagen (scale bar = 200 micron).
At 12 weeks post-implantation (Figure 5), Masson Trichrome / Verhoeff staining 
revealed the presence of more ECM in the COL-HL-CHC group (Figure 5A-i for 
COL-CHC; Figure 5B-i for COL-HL-CHC). More newly formed mature blood vessels 
(Appendix A6) appeared to be present in and around the COL-HL-CHC templates 
(COL-CHC: 4 ± 2 blood vessels /mm2; COL-HL-CHC: 7 ± 3 blood vessels /mm2, Figure 
5A-ii,iv, 5B-ii,iv), albeit this difference was not significant (P=0.11). In addition, 
the fibrous capsule surrounding the template was further diminished compared 
to earlier time points. Only a thin ECM-rich layer was observed between the 
musculature and the template (Figure 5: A-iii and B-iii). Also, no difference in 
4
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macrophage infiltration was observed between COL-CHC and COL-HL-CHC (Figure 
5A-v and 5B-v). Structural degradation of the CHC in both templates started to 
occur (Figure 5A-vi and 5B-vi).
Figure 5. (Immuno-)histochemistry of excised subcutaneously implanted COL-CHC (A, A-i-vi) 
and COL-HL-CHC (B, B-i-vi) 12 weeks after implantation. A,B) Template overview, Hematoxyline 
/ Eosine staining (scale bar 2 mm). Boxes correspond to areas shown in A,B-i-vi, stars indicate 
the CHC polymer within the collagen template architecture. A,B-i) Masson Trichrome / Ver-
hoeff staining. Black arrow heads indicate template architecture. White arrow heads indicate 
newly formed collagen fibrils within the template architecture (scale bar 200 miron). A,B-ii) 
Alpha-smooth muscle actin staining of the template center to indicate blood vessel formation 
(scale bar = 200 micron). A,B-iii) Masson Trichrome / Verhoeff staining of the template periphery 
(scale bar = 200 micron). A,B-iv) Alpha-smooth muscle actin staining, to indicate blood vessels, 
of the template periphery (scale bar = 200 micron). A,B-v) Macrophage staining (F4/80) in red, 
cell nuclei in blue (scale bar = 10 micron). A,B-vi) Masson Trichrome / Verhoeff staining of the 
CHC imbedded in collagen (scale bar = 200 micron).
Collectively, at the last time point of evaluation (12 weeks) cell density in COL-HL-
CHC templates was higher and cells produced more ECM, and vascularization 
appeared to be more pronounced compared to unlabeled hybrids. This may 
be because more inflammatory cells were present within the COL-HL-CHC as a 
consequence of more foreign (bio)material (e.g. iron) that was implanted [12,42]. 
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Subsequently, more myofibroblast formation was observed within COL-HL-CHC 
4 weeks after implantation as evidenced by the expression of smooth muscle 
actin. Myofibroblasts play a crucial role in ECM production as well as they guide 
and mediate neo-vascularization [43,44]. It is possible that myofibroblasts were 
activated by the inflammatory signals provided by the inflammatory cells [45]. Since 
oxygen affinity is driven by hemin [46], enhanced oxygenation may have occured 
within COL-HL-CHC templates. This may also have contributed to enhanced ECM 
production and vascularization. In general, the faster template remodeling may 
ultimately be beneficial since both ECM production and vascularization within 
templates are pivotal in TERM to guarantee functionality and ultimately prevent 
template failure [47–49].
Table 2. Cellular content and remodelling of harvested templates after subcutaneous 
implantation in a mouse model. Scoring was performed based on Hematoxyline / Eosine (HE) 
and Masson Trichrome / Verhoeff slides of implanted COL-HL-CHC and COL-CHC templates. 
– (not present), +/- (sporadically present), + (moderately present) or ++ (abundantly present).
COL-CHC COL-HL-CHC
Macrophages Week 2
Week 4
Week 12
+/-
+
+/-
+/-
+
+/-
Giant cells Week 2
Week 4
Week 12
-
+/-
+/-
+
+
+/-
PMN Week 2
Week 4
Week 12
+
-
-
+/-
+
-
Lymphocytes Week 2
Week 4
Week 12
+
+/-
+/-
+
+
+/-
Vascularity Week 2
Week 4
Week 12
-
+/-
+/-
+/-
+/-
+
(Myo)fibroblasts Week 2
Week 4
Week 12
+/-
+
-
+/-
++
+/-
ECM deposition Week 2
Week 4
Week 12
+/-
+
+
+/-
++
++
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4 CONCLUSION
In conclusion, we show that collagen type I hybrid templates can easily and 
covalently conjugated with the hemin-L-lysine complex (HL). This allows the non-
invasive monitoring of the localization and remodeling of the template in vivo. For 
future applications full characterisation of the relaxivity properties at different field 
strengths for both, HL and template conjugates, may required to optimise these 
properties and better understand the contrast properties observed.
We found a close correlation between the acquired MR images and the 
histological findings. The covalent conjugation of HL did not alter the main structural 
properties in the hybrid templates, and initial cell attachment in vitro and in vivo was 
unaffected. Furthermore, the observed improvements in the cell penetration and 
colonization of HL-labeled templates indicate that the HL content may also support 
the template remodeling in vivo. Hence, the presence of HL can assist the visibility 
and integration performance of tissue-engineered constructs.
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APPENDIX
A1. Hemin-L-lysine complex (HL) and its relaxation properties in 11.7T magnetic resonance im-
aging (MRI). A: Qualitative T1-weighted MRI and R1 relaxometry analysis of HL at different (iron) 
concentrations in phosphate buffered saline (PBS). Data represent mean ± standard deviation 
(sample size n = 3). The relaxivity r1 was derived from the slope and of the relaxation-iron con-
centration curve. B: Qualitative T2-weighted MRI and R2 relaxometry analysis of HL at different 
(iron) concentrations in PBS. Data represent mean ± standard deviation (sample size n = 3). 
The relaxivity r2 was derived from the slope and of the relaxation-iron concentration curve.
A2. Visual depiction and T1-weigthed MRI of standard collagen type I cylinders (COL) which 
were covalently conjugated or physically adsorbed with hemin-L-lysine complex (HL) (initial HL 
concentrations are given in brackets). For covalent conjugation: incubation of collagen sponges 
in HL -> crosslinking / covalent conjugation via EDC/NHS -> subsequent washings; for physical 
adsorption: crosslinked collagen sponges -> incubation in HL -> subsequent washings. Template 
diameter = 14 mm. Iron content data represent mean ± standard deviation with a sample size 
of n = 9 of each group.
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A3. Mechanical Properties of COL-HL-CHC and COL-CHC. A: Stress-strain curve of COL-CHC 
and COL-HL-CHC. B: Initial modulus (E1) and Upswing (Young’s) modulus (E2) of COL-CHC and 
COL-HL-CHC derived from stress-strain curve. E1 was derived from the initial slope and E2 
was derived from the 2nd slope of the stress-strain curve, respectively. Data represent mean 
± standard deviation with a sample size of n = 5 of each group. Two-tailed Student’s t-test was 
performed to determine statistical differences. P < 0.05 was considered statistically significant.
A4. Cytotoxicity / cell viability study of COL-HL-CHC and COL-CHC. Equal amounts of COL-CHC 
and COL-HL-CHC templates were incubated in standard culture medium for 72 h. Latex was 
used as positive control (Ctrl +). Subsequently, the conditioned culture media were added to 
NIH 3T3 cells and incubated for 24 h in these extractions. Data of cytotoxicity analysis were 
obtained from raw absorbance data and normalized to negative control (3T3 cells in standard 
culture medium). Data are expressed as mean ± standard deviation and the sample size was n 
= 3 for positive control (Latex), COL-CHC and COL-HL-CHC, respectively. One-way ANOVA with 
Bonferroni post-hoc test was performed for comparison of these 3 groups. P < 0.05 was con-
sidered statistically significant. *** = p<0.0001 compared to all other conditions.
4
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A5. Hematoxyline and Eosin (HE) staining of the template center of excised templates. Scale 
bar = 200 micron.
A6. (Immuno)Fluorescence histochemistry of vasculature of excised templates (200x magni-
fication). White dotted line marks border of template and native tissue. White star marks the 
template center.
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A7. Iron content (n = 9), free NH2  groups (n = 3), compressive strength (n = 9), relaxation rate R1 
(n = 4) and contrast-to-noise ratio CNR (n = 4) of simple disc-shaped collagen type I templates 
(COL) covalently conjugated or physically adsorbed with hemin-L-lysine complex (HL). Data are 
expressed as mean ± standard deviation. Regression R2, Pearson correlation coefficient r and 
p value (two-tailed) were determined to describe the correlation between iron concentration 
and free NH2 groups / compressive strength / relaxation rate R1 / contrast-to-noise ratio CNR 
of different templates. P < 0.05 was considered statistically significant.
0.5 % (w/v) 
COL 
Incubated 
in HL [mM]
Iron Content
[ug Fe / mg COL]
Free NH2
[nmol / mg COL]
(% free NH2)
Compressive
Strength
[N]
R1
[s-1]
CNR
[-]
0.0 (Ctrl) - 99 ± 27 (38.2±10.2%) 0.11 ± 0.04 0.34 ± 0.03 6.0 ± 3.9
Covalent 
Conjugation
0.1 1.2 ± 1.1 281 ± 39 (75.1±10.3%) 0.12 ± 0.06 0.49 ± 0.07 17.7 ± 7.1
0.25 1.8 ± 1.2 304 ± 74 (74.9±18.2%) 0.13 ± 0.08 0.53 ± 0.13 27.8 ± 10.6
0.5 3.4 ± 3.0 263 ± 51 (64.7±12.6%) 0.17 ± 0.13 0.65 ± 0.18 31.0 ± 15.2
1.0 6.8 ± 2.7 267 ± 48 (53.9±9.7%) 0.18 ± 0.05 0.73 ± 0.16 49.9 ± 6.1
1.25 8.5 ± 4.5 178 ± 77 (69.7±30.2%) 0.24 ± 0.09 0.81 ± 0.11 40.0 ± 12.3
P value - 0.9165 0.0025 0.0026 0.0182
R² - 0.003102 0.9200 0.9182 0.7880
Pearson (r) - 0.05569 0.9591 0.9582 0.8877
Physical 
Adsorption
0.1 0.9 ± 0.4 138 ± 47 (36.7±12.4%) 0.09 ± 0.02 0.39 ± 0.02 9.2 ± 7.9
0.25 1.3 ± 0.7 175 ± 37 (43.1±9.2%) 0.13 ± 0.04 0.43 ± 0.08 14.6 ± 15.1
0.5 1.9 ± 0.9 171 ± 42 (39.7±9.7%) 0.09 ± 0.03 0.73 ± 0.11 17.5 ± 10.4
1.0 5.0 ± 1.7 198 ± 61 (40.0±12.2%) 0.19 ± 0.11 0.63 ± 0.14 24.8± 18.0
1.25 3.9 ± 0.6 236 ± 46(92.8±18.0%) 0.15 ± 0.08 0.76 ± 0.16 23.7 ± 19.7
P value - 0.0323 0.19092 0.0864 0.0023
R² - 0.7215 0.5132 0.5614 0.9232
Pearson (r) - 0.8494 0.7164 0.7493 0.9608
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ABSTRACT
Injectable hydrogels have become valuable tools in various (bio)medical applications 
such as cell-, drug delivery or Tissue Engineering and Regenerative Medicine (TERM) 
purposes. In this context, novel synthetic thermosensitive hydrogels such as 
polyisocyanopeptide (PIC) have gained interest as they provide unique properties: 
They form a stable 3D network at room temperature closely resembling the native 
extracellular matrix including stiffening response at high strains. Furthermore, 
PIC hydrogels can be decorated with cell binding motifs and/or growth factors to 
increase overall biocompatibility and tissue remodeling. Monitoring of hydrogels 
upon their injection in vivo may give valuable information of their integrity and 
degradation. However, direct monitoring of hydrogels with non-invasive imaging 
modalities such as magnetic resonance imaging (MRI) remains challenging due 
to similar contrast characteristics when compared to surrounding tissue. In this 
study, we functionalized PICs hydrogels with a gadolinium-based contrast agent 
(PIC-GdDO3A) to enhance their MR visibility. Mixtures of functionalized PIC hydrogels 
containing cell binding motifs (PIC-GRGDS) were used to form hybrid gels allowing 
both imaging and increased biocompatibility (PIC hybrid). Upon injection in vivo, 
PIC-GdDO3A- and PIC hybrids could be monitored via MRI. Longitudinal follow up 
demonstrated changes in volume and consistency of the gel scaffold over time 
and conventional histology correlated well with the MRI results. Longitudinal, non-
invasive monitoring by MRI may help to further develop smart PIC hydrogels which 
can be used for a wide variety of purposes.
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1 INTRODUCTION
Injectable hydrogels have become valuable tools in various medical procedures. They 
can be applied in a minimally invasive manner and once injected, they can form 
stable 3D environments which can mimic the extracellular matrix of native tissues. 
Hence, hydrogels are ideal candidates not only for cell delivery and tissue repair, but 
also for bulking procedures. In addition, they are frequently used for drug delivery 
[1,2]. Hydrogels can be created from natural- or synthetic materials: naturally-derived 
hydrogels provide biomimetic features such as cell-adhesive integrin-binding domains 
and biomechanical cues, but these features are hard to control. Hydrogels created 
from synthetic polymers provide the possibility to tune overall mechanical properties, 
molecular structure, and other physical attributes of the material [3], but many have 
dense architecture that render them unsuitable in 3D cell culture applications.
Polyisocyanopeptides (PICs) are fully synthetic and water-soluble polymers 
that spontaneously form a hydrogel when warmed above a critical temperature, 
even at a super-low concentration (0.1% w/w). In contrast to most other synthetic 
hydrogels, PIC hydrogels closely mimic the architecture and mechanical properties 
of the cytoskeleton or extracellular matrix mimetic, including strain-stiffening at low 
stresses [4]. Furthermore, conjugation of integrin binding peptides (GRGDS, Gly-Arg-
Gly-Asp-Ser) to compensate for the absence of cell binding sites induces bioactivity 
[5,6]. Because the thermosensitivity, strain-stiffening and ligand coverage can be 
tuned, PIC hydrogels are a promising class of new injectables.
Despite the increased use of injectable hydrogels follow-up procedures and 
longitudinal in vivo monitoring of hydrogels has been limited [7] because the contrast 
characteristics are similar to adjacent tissue. Magnetic resonance imaging (MRI) is a 
noninvasive tool which allows good soft tissue contrast at high resolution [7]. Due to their 
high water content, however, hydrogels are difficult to distinguish from surrounding tissue 
by MRI. To achieve sufficient contrast, contrast agents (CAs) such as low molecular weight 
gadolinium (Gd) complexes have been physically entrapped or chemically conjugated 
to hydrogels to enhance their MR visualization [8–12]. Chemical conjugation of CAs may 
be the preferred strategy for hydrogel labeling as images are likely to directly reflect 
morphology and location of the hydrogel after injection. In addition, conjugation prevents 
leaking of the CA in the surrounding tissue, allowing for long-term imaging.
In this research report, we describe conjugation of a Gd-based CA to the PIC 
polymer and created injectable hydrogel mixtures allowing to assess both bioactivity 
and visualization via MR imaging. Upon injection in vivo, we obtained fundamental 
insights in hydrogel properties in real-time.
5
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2 MATERIALS AND METHODS
2 .1  Sy nth e s i s  o f  Po l y i s o c ya n o p e p ti d e  (PI C)  Po l y m e r s
PIC polymers were synthesized as previously described [4,13]. In brief, 200 mg of a 
mixture of isocyanide monomers M1 (non-functional) and M2 (azide-functionalized) 
was dissolved in freshly distilled toluene (4 mL) The molar ratio between M1 and 
M2 was varied between 30:1 and 400:1. A solution of initiator nickel perchlorate 
hexahydrate (in 1:10 absolute ethanol:toluene, concentration 0.096 mg/mL) was 
added in a monomer:catalyst ratio 4000:1. After 24 hrs stirring at room temperatures, 
the polymers were precipitated in diisopropyl ether. Two more precipitations from 
dichloromethane in diisopropyl ether provided pure polymers. The molecular weight 
of all polymers, as measured by viscometry was ~500 kg/mol [14].
2 . 2  Fu n c ti o n a liz ati o n  o f  PI C  Po l y m e r s
PIC polymers were conjugated with a gadolinium(III) complex. To this end, 
gadolinium(III) 1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid)-10-(4-
aminobutyl)acetamide (Gd-DO3A-butylamine) was reacted with dibenzocyclooctyne-
N-hydroxysuccinimidyl ester (DBCO-NHS ester) (Figure 1A). Then, the complex 
DBCO-GdDO3A was reacted to PIC-N3 polymers via the strain-promoted azide-
alkyne cycloaddition reaction (copper-free click chemistry, Figure 1B). Finally, 
polymers were purified by precipitation in diisopropyl ether and air-dried. Hydrogel 
solutions were prepared by dissolving PIC-GdDO3A polymers at a concentration of 2 
mg/mL in MilliQ water for in vitro MR studies. For other in vitro and for in vivo studies 
PIC samples were dissolved in medium as described below. Solutions were gently 
stirred at 4 °C over 12 h in order to ensure complete dissolution of the material. The 
gadolinium (Gd) concentration of prepared hydrogels was determined by inductively 
coupled plasma mass spectrometry (ICP-MS).
To enable cell attachment, cell spreading and to enhance biocompatibility of 
PIC hydrogels, GRGDS (Gly-Arg-Gly-Asp-Ser peptides)-functionalized PICs with a 
GRGDS concentration of 100 μM/mg polymer [5,6]. In this work, PIC-GRGDS (75%) 
hydrogels were mixed with PIC-GdDO3A (25%) to form hybrid gels with enhanced 
cell-PIC interactions that allows MRI visualization.
All PIC polymers used for cell culture and in vivo studies, were disinfected via UV 
light exposure (4 x 5 min) prior to dissolving. Afterwards, disinfected materials were 
dissolved in minimum essential medium (MEM, Gibco/Life Technologies, Carlsbad, CA, 
USA) supplemented with 100 IU/mL penicillin and 100 microgram/mL streptomycin 
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(both Gibco/Life Technologies, Carlsbad, CA, USA) and incubated at 4 °C overnight. 
The final concentration of all PIC polymers used in this study was 2 mg/mL.
Rheology measurements of prepared PIC hydrogels were performed with a 
stress-controlled rheometer (DHR-1 / DHR-2 TA-Instruments) as previously described 
[4,14] and used to determine the storage modulus G’ and gelation temperature Tgel 
of the polymer solutions.
2 . 3  Cy to co m p atib il it y  a n d  Ce ll  Cultu re  in  PI C  H yd ro ge l s
For cell-hydrogel studies, human adipose derived stem cells (hADSCs) were isolated 
from healthy donors undergoing reconstructive surgery (Radboudumc Nijmegen, 
The Netherlands) and cultured as previous described [15]. For cytotoxicity studies, 
equal amounts of PIC-GdDO3A, PIC-GRGDS, hybrid gels and latex material (negative 
control) were incubated in standard culture medium (MEM supplemented with 
100U/mL penicillin/100µg/mL streptomycin and 10% fetal calf serum (FCS)) for 72h. 
Subsequently, the conditioned culture media were added to hADSCs (passage 2-4; 
cell density: 4,000 cells / 96-well) and incubated for 24 h. Cell viability was measured 
using the WST-1 assay (Roche) according to the manufacturer’s protocol. NIH 3T3 
cells incubated in standard cell culture medium were used as positive control. The 
measured absorbance was normalized against the positive control to indicate cell 
viability.
For 3D studies hADSCs (100,000 cells) at passage 2-4 were resuspended in the 
cold PIC solution (0.3 mL) at approximately 8 °C and seeded into insert rings (0.4 
μm polyester membranes, Costar, NY, USA). Immediately after seeding, the PIC/
cell mixtures were warmed up to allow the formation of the 3D hydrogel and the 
samples were incubated at standard cell culture conditions (37 °C and 5% CO2). 
Culture media was refreshed every 2-3 days and monitored via light microscope 
(Leica DC200, Wetzlar, Germany).
2 .4  I n  vit ro  M RI
 PIC hydrogels conjugated with various GdDO3A densities, PIC-GRGDS and hybrid 
PIC hydrogels (all 0.1 mL) were stored in Eppendorf tubes (0.5 mL) and transferred 
to an 11.7 Tesla preclinical MR system (BioSpec, Bruker, Germany) equipped with 
a 1H volume coil with an inner diameter of 40 mm. Scanning was performed as 
previously described [16]. In detail, a rapid acquisition with relaxation enhancement 
(RARE) sequence was employed for acquiring T1-weighted MR imaging, with the 
following parameters: echo time (TE) = 6 ms, repetition time (TR) = 600 ms, excitation 
5
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angle = 90°, refocusing angle = 180°, number of slices = 20, slice thickness = 0.5 
mm, RARE factor = 4, field of view (FOV) = 50 × 50 mm matrix size = 256 × 256 and 
8 averages. The scan time was 3 minutes and 5 seconds. In addition, this RARE 
sequence was also used for T2-weighted MR image acquisition but with some 
parameter modifications, including TE = 60 ms, TR = 2000 ms, number of slices = 10, 
RARE factor = 1 and 1 average. The scan time was thus 4 minutes 16 seconds. The 
T1- and T2 relaxation properties of various PIC hydrogels were also respectively 
estimated with a multi-TR and multi-TE RARE sequence. For T1 estimation, the images 
at 8 TRs (i.e., 200, 500, 1000, 2000, 3000, 5000, 7000, 10000 ms) were applied and the 
T1 values were estimated by fitting signal intensities (Mz) to the following equation:
The scan time was 7 minutes 39 seconds. For T2 estimation, the image signal 
intensity at 30 TEs from 10 to 300 ms with an increment of 10 ms were recorded 
with a total scan time of 3 minutes and 12 seconds. The image signal intensities (M) 
at different TEs were fitted with a mono-exponential model to determine T2 values:
The reciprocals of T1- and T2 relaxation times, defined as R1- and R2 relaxation 
rates, were calculated, respectively. Subsequently, R1- and R2 relaxation rate were 
plotted as a function of the Gd concentration to determine the overall relaxivity 
(slope of the curve) of GdDO3A-functionalized PIC hydrogels.
Subsequently, T1-weighted MR images were processed with ImageJ (U.S. National 
Institutes of Health, Bethesda, Maryland, USA). Image contrast between the applied 
hydrogel and the background were assessed using a pseudo-color function.
2 . 5  PI C  a s  i n  vivo  In j e c t a b l e s
Hydrogels (unmodified PIC, PIC-GRGDS, PIC-GdDO3A, and PIC hybrids) were injected 
in immune-competent female, inbred, Balb/cByJ mice (Charles River, L’Arbresle, 
France; age: 7-8 weeks; weight: approx. 20 gram). Animal experiments were 
performed after approval by the Animal Welfare Body of the Radboudumc (DEC 
2016-0013), conducted in accordance with institutional and national guidelines. In 
detail, 18 mice were randomly divided into three groups of different time points 
(day 7; day 14; day 28). PIC aliquots were placed on ice. Prior to injection, the mice 
were pre-medicated by the intravenous injection of the analgesic Rimaldyl (Pfizer, 
USA; 5 mg carprofen/kg). Anesthesia was induced by inhalation of 5% Isoflurane 
FiO2/N2O 1:2 (maintenance dose of 2-3% Isoflurane FiO2/N2O 1:2) and the skin of 
the intervention area was shaved followed by disinfection with Jodium (Eurovet 
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animal health, the Netherlands). Subsequently, 100 µL of hydrogels were injected 
subcutaneously, on the left- (PIC alone or PIC-GRGDS) or right (PIC-GdDO3A or PIC-
GdDO3A/PIC-GRGDS hybrid mixture) side of the back, respectively. Injection was 
carried out via a pre-cooled 18G needle (BD, Oxford, United Kingdom). Injection 
areas were marked with a waterproof marker. Subsequently, mice were placed in 
a heating chamber at 37°C for a minimum of 10-15 min to ameliorate hydrogel 
solidification. Subsequently, n = 3 randomly chosen animals were used for MR 
imaging (day 0 evaluation) under prolonged anaesthesia. Body temperature and 
breathing were monitored. In vivo MRI experiments were also performed at 11.7T 
using the 1H volume coil as described before [16]: High resolution T1-weighted images 
were acquired with a RARE sequence to visualize the injected hydrogels in mice at 
day 7, 14 and 28 post injection. The corresponding scanning parameters were of 
TE = 10ms, TR = 560 ms, RARE factor = 2, number of slices = 20, slice thickness = 0.5 
mm, FOV = 50 × 50 mm, matrix = 512 × 512 and 16 averages. The scan time was 28 
mins 40 secs.
In addition, the same protocol as used for the in vitro study was applied to 
determine R1 relaxation rates of injected hydrogels at each time point. In addition, 
image contrast of the injected hydrogels in mice was estimated as described above.
At pre-determined endpoints (7, 14, and 28 days post injection), animals 
were sacrificed by carbon dioxide asphyxiation, scanned via MRI, and hydrogels 
and surrounding tissues were harvested from the animals and fixated in 4% 
formaldehyde prior to dehydration and embedding in paraffin. Subsequently, 
paraffin samples were cut at 5 µm and stained with hematoxylin and eosin (HE) 
and Masson trichrome / Verhoeff staining.
2 . 6  St ati s ti c s
Unless otherwise indicated, data sets are expressed as mean ± standard 
deviation. Regression, Pearson correlation coefficient r and p value (two-tailed) 
were determined to describe the correlation between Gd concentration and r1,2-
relaxivity of GdDO3A-functionalized PIC hydrogels. A one-way ANOVA test with 
post-hoc Bonferroni correction was performed for statistical analysis of differences 
between PIC-GdDO3A, PIC-GRGDS, PIC hybrids and control. For all analysis, p < 0.05 
was considered statistically significant. GraphPad Prism (version 5.03, GraphPad 
Software Inc, La Jolla, CA, USA) was used for all statistical analysis.
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3 RESULTS AND DISCUSSION
3 .1  Fu n c ti o n a liz ati o n  o f  PI C  Po l y m e r s
PIC polymers with different degrees of azide functionalization were prepared 
by copolymerization of the isocyanide monomers M1 and M2. The molar ratios 
between the two monomers ranged from 1:30 to 1:400, which gives a statistical 
spacing of functional groups along the PIC backbone of 3 nm to 40 nm. The DBCO-
GdDO3A complex (Figure 1A) was reacted to the PIC-N3 polymers via the strain-
promoted azide-alkyne cycloaddition reaction (copper-free click chemistry, Figure 
1B). Since this click reaction shows nearly quantitative conversion [17], the azide 
density in PIC-N3 directly determines the Gd loading in the polymers. Indeed, 
quantitative analysis of polymer-bound Gd via coupled plasma mass spectrometry 
(ICP-MS) confirms that hydrogels with increasing M2 contain increasing amounts 
of Gd (Figure 2A). This conjugation approach allows for precise control over the 
degree of functionalization of the hydrogel and ultimately fosters reproducibility 
[3]. All prepared PIC polymers remained a liquid at 4-8 °C and formed a hydrogel 
beyond 16 °C (Figure 2). Prepared hydrogels are relatively soft materials with similar 
storage moduli (G´) between 150-250 Pa at 37 °C.
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Figure 1: Gadolinium-decorated polyisocyanopeptide (PIC) gels. A: GdDO3A was equipped with 
a DBCO group suitable for copper-free click chemistry. Key: borate buffer, pH = 8.5, overnight, 
room temperature. B: Azide-functionalized PICs were obtained by copolymerization of mono-
mers M1 and M2 and subsequently reacted with DBCO-GdDO3A. Key: (i) Ni(ClO4)2 in ethanol/
toluene, overnight, room temperature; (ii) acetonitrile, overnight, room temperature.
Figure 2: Stiffness of PIC-GdDO3A in culture medium as a function of temperature T. A gel is 
formed at T > 16 °C and dissolved again on cooling.
5
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3 . 2  I n  vit ro  M RI  a n d  Cy to co m p atib il it y  o f  Fu n c ti o n a lize d  PI C 
H yd ro ge l s
Figure 3: MRI characteristics of PIC hydrogels conjugated with the MRI contrast agent Gd-DO3A. 
A: M2/M1 ratio, T1-weighted MRI images at 11.7T, corresponding pseudo-color images, and 
concentration of Gd of PIC hydrogels conjugated with various amounts of GdDO3A. B: r1- and 
r2 relaxivity assessment of PIC hydrogels conjugated with various amounts of GdDO3A.
MR imaging of the GdDO3A-conjugated PIC hydrogels at room temperature was 
performed to determine their MRI properties. The contrast of these hydrogels 
increased with increasing GdDO3A content in T1-weighted MR images (Figure 3A). 
The corresponding r1-relaxivity of PIC-GdDO3A hydrogels, as assessed by a RARE 
sequence with variable TR’s, was 4.8 ± 0.9 mM
-1s-1, which is in line with values obtained 
in similar studies at 11.7 T using Gd-based CAs to label injectables [8,18]. Using variable 
TE’s a r2-relaxivity of 9.2 ± 2.9 mM
-1s-1 was obtained, which is remarkably smaller than 
we previously obtained for other Gd labeled injectables at 11.7 T [8,18]. However, 
with an r2/r1 ratio of 1.9 the PIC-GdDO3A hydrogels can still be adequately imaged by 
T1-weighted MR imaging [19,20]. Furthermore, both the R1- and R2 relaxation rates 
strongly correlated with the Gd-content (Figure 3B; r = 0.9208 and p = 0.0092 for 
R1; r = 0.8473 and p = 0.0332 for R2). The highest R1 relaxation rate (1.0 ± 0.2 s
-1) and 
highest contrast in T1-weighted MR images was achieved with PIC-GdDO3A at a ratio 
of 1:30, and thus this material was used in mixing experiments.
Although PIC-GdDO3A hydrogels were clearly visible in vitro in MR imaging, 
further modification of the hydrogel is necessary for use in e.g. a 3D matrix for cell 
culture, injectable and functional organ regeneration. We used GRGDS (Gly-Arg-Gly-
Asp-Ser)-modified PICs (PIC-GRGDS) to enable cell attachment, cell spreading and 
to enhance bioactivity of PIC hydrogels [5,6] and prepared hybrids of PIC-GRGDS 
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(75%) with PIC-GdDO3A (25%) at 2 mg/mL total concentration. Despite the lower 
CA density, this hydrogel mixture was still clearly visible in MRI as indicated by 
enhancement of the relaxation rate and contrast when compared to non-labeled 
Gd hydrogels (Figure 4A and Figure 4B).
Figure 4: MRI imaging and cytocompatibility of PIC hydrogels conjugated with GRGDS peptides 
(PIC-GRGDS), PIC hydrogels conjugated with the MR contrast agent GdDO3A (PIC-GdDO3A) and 
a mixture (75 % PIC-GRGDS + 25% PIC-GdDO3A) of both hydrogels (PIC Hybrid). A: T1-weighted 
MRI- and corresponding pseudo-color images. B: R1 relaxation rate. C: cell viability assay with 
adipose derived stem cells (ADSCs) cultured for 48h with hydrogel extractions (control -: Latex). 
D: Brightfield images of ADSCs cultured within PIC hydrogels (scale bar = 50 micron). A one-
way ANOVA with Bonferroni post hoc test was performed for statistical analysis of differences 
between PIC-GdDO3A, PIC-GRGDS, and PIC Hybrid. ***: p < 0.0001, *: p < 0.05.
Cell viability assays with adipose derived stem cells (ADSCs) confirmed the 
absence of cytotoxicity of unmodified PIC hydrogels and PIC hydrogels functionalized 
with GdDO3A (Figure 4C). This suggests that Gd is stably chelated after covalent 
conjugation to the backbone of the PIC polymer and that mixing of different 
gels and solidifying at low concentrations does not influence the Gd content. 3D 
culture of ADSCs in modified PIC hydrogels showed extensive cell spreading and 
cell-cell contact (Figure 4D) suggesting cell attachment and interaction with this 
‘artificial extracellular matrix’. In contrast, when ADSC were cultured in unmodified 
PIC hydrogels or PIC-GdDO3A conjugates cell-matrix interactions were impaired: 
5
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ADSCs remained round-shaped suggesting no spreading or interaction with the PIC 
polymers. Consequently, this may be an unfavorable environment for cells and may 
hamper functional tissue formation for regeneration purposes when used in vivo.
The PIC-GdDO3A/PIC-GRGDS hybrid showed a gelation temperature at 
approximately 16 °C and a stiffness G′ = 188 Pa at 37 °C (Figure 2). Thus, this mixture 
has similar physical properties as the other (functionalized) PIC gels described in other 
studies [17,21]. Especially the stiffness of our prepared hybrid injectable mixture should 
be carefully considered when the intended use is a (cell-containing) substitute for 
tissue repair (injectable) since the stiffness of scaffolds is known to have an effect on 
cell behavior as mechanical cues play a role in (stem) cell fate [17,22]. Taken together, 
the prepared PIC hydrogels may offer a favorable microenvironment, which closely 
resembles the natural microenvironment as far as mechanical characteristics go.
3 . 3  I n  vivo  M RI  o f  Fu n c ti o n a lize d  PI C  H yd ro ge l s
In a final set of experiments, we tested various PIC hydrogels in vivo to follow their 
fate upon injection. Subcutaneous injection of PIC-GdDO3A and hybrid hydrogels 
resulted in a ‘bleb-like’ polymer deposit which could easily be identified via T1-
weighted MR imaging (Figure 5A). The signals in T1-weighted MR images were bright 
in contrast to surrounding tissue (Figure 5B), whilst PIC hydrogels containing no CA 
(unmodified PIC and PIC-GRGDS) could not be detected. Indeed, through coupling of 
a contrast agent to the PIC polymer, MR imaging may be an adequate tool to assess 
the hydrogel patency and degradation / remodeling upon injection. PIC-GdDO3A 
might be useful to also follow this hydrogel when used as dressing, particularly 
because loss of material can be caused by cleaning and rubbing. In a recent 
study, PIC hydrogels (PIC alone and PIC-GRGDS) were used as wound dressings 
[21]. Unfortunately, not unexpected, these hydrogels could not be localized after 
application and assessment of their patency and effects remained unclear.
The volume of injected hydrogels decreased from its initial value 7 days after 
injection as judged by MRI (Figure 5C; 35.7 ± 7.0% for PIC-GdDO3A and 43.0 ± 13.6% 
for PIC Hybrid). The loss of volume in this early phase of monitoring can be explained 
by fluid loss and / or polymer loss resulting from hysteresis when forming a gel in situ 
[11]. The contrast increased, hence the T1 value of the hydrogels decreased (Figure 5A, 
Figure 5B and Table 1) indicating densification of the injected material and the loss of 
volume is therefore most likely caused by fluid loss. Densification of the hydrogel may 
decrease molecular tumbling and this may ultimately enhance the relaxation rate, and 
subsequently improve MR contrast [12,20,23].
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Table 1: T1- relaxation times of PIC hydrogels upon injection in vivo over time. Data represent 
mean ± standard deviation (day 0: n = 3; other time points: n = 6).
T1 Hydrogel [ms] Day 0 Day 7 Day 14 Day 28
PIC-GdDO3A 1011.3 ± 235.7 527.8 ± 181.2 691.2 ± 180.8 578.2 ± 139.8
PIC Hybrid 1919.5 ± 196.4 939.4 ± 118.9 995.2 ± 291.9 911.8 ± 155.6
Figure 5: In vivo MRI imaging and analysis of PIC hydrogels with GRGDS peptides (PIC-GRGDS), 
PIC hydrogels conjugated with the MR contrast agent GdDO3A (PIC-GdDO3A) and a mixture (75 
% PIC-GRGDS + 25% PIC-GdDO3A) of both hydrogels (PIC Hybrid). A: Representative T1-weight-
ed MR images of different PIC hydrogels subcutaneously injected in a mouse model. The red 
circle indicates the injected hydrogel. B: Representative pseudo-color T1-weighted MR images 
of different PIC hydrogels. Scale bar = 5mm. C: Residual volume upon injection over time. Data 
represent mean ± standard deviation (day 0: n = 3; other time points: n = 6).
The loss of volume in the early phase upon injection is particularly relevant when the 
hydrogel is used as an injectable, for instance as drug delivery vehicle. Simple physical 
entrapment of e.g. growth factors or therapeutic drugs will lead to an immediate 
burst release into the surrounding tissue caused by the fluid loss. Straightforward 
chemical conjugation as performed in this study may prolong the exposure of cells 
to therapeutics or growth factors within the gels and release would occur due to 
degradation of the hydrogel. When used for cell delivery, cells may be released 
immediately into the surrounding and, more importantly, the physical characteristics 
5
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of the gel will be altered as densification leads to higher polymer concentrations and 
higher strain-stiffening values. Hence, when aiming for particular strain-stiffening 
values in vivo either the polymer concentration needs to be adjusted or the initial 
strain-stiffening values as measured in vitro may need to be lowered to ultimately reach 
the desired strain-stiffening values in vivo. Polymer volume, contrast, and relaxation 
time of Gd-loaded PIC hydrogels remained stable from day 7 onwards until the end 
of the experiment, whereas bulk- or surface degradation was anticipated during the 
time of monitoring. Thus, the polymer is remarkably stable and resistant to in vivo 
degradation. This can partly be explained by the polymer composition which does not 
contain biologically degradable chemical bonds. The MRI image observations correlated 
well to the histological analysis (Figure 6): hydrogels remained structurally intact over 
time. PIC hydrogels deposits harvested 7 days post injection were encapsulated by 
host tissue and no or very limited cell influx was observed regardless of the hydrogel 
composition. A collagenous fibrous network, host immune cells (lymphocytes), and 
capillaries surrounded the injected hydrogels without any influx of cells into the gel in 
the early observation period. At day 28 post injection, invasion of host cells into the 
gels was observed and these cells deposited extracellular matrix components within 
the PIC hydrogel, albeit that the gross morphology of the gels stayed intact (Figure 6). 
Overall, the immune reaction of PIC hydrogels was assessed to be mild to moderate very 
similar when compared to well-established standard hydrogels such as Matrigel® [21].
Interestingly, cell invasion and remodeling within PIC alone, PIC-GRGDS, PIC-
GdDO3A and the hybrid mixture deposits were similar. The in vivo influx of cells in 
PIC alone and PIC-GdDO3A hydrogels was somewhat unanticipated as in in vitro 
studies cell spreading and migration was much more apparent in 3D PIC-GRGDS 
constructs. Apparently, the dynamic tissue microenvironment permitted cell in-
growth, a situation which is dissimilar from the passive cell encapsulation in the 
in vitro studies. This suggests that although GRGDS conjugation to PIC polymers is 
necessary in vitro, its benefit in vivo may be limited.
The high visibility in MR imaging that we achieved through conjugation of 
GdDO3A to the backbone of the PIC polymer may be of clinical relevance for the use 
of these hydrogels. Safety concerns in using Gd-based CAs upon injection have been 
considered [24], but the molar amount of Gd in the polymer deposits is very limited 
and orders of magnitude lower than Gd-based agents used for MRI examinations 
such as heart and vessels imaging. It is therefore unlikely that this may pose a safety 
concern. Alternatives such as naturally-derived CAs are available, albeit that their 
overall T1-relaxivity is lower when compared to gadolinium [16,25]. However, such CA 
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alternatives may be potentially considered for PIC labelling as their relaxivity may be 
further increased due to densification upon injection. Overall, the data obtained in 
this study provides important clues for further development of PIC-based hydrogels 
which can be used for a wide variety of purposes.
Figure 6:  Representative histological images of injected hydrogels at day 7 and day 28 post injec-
tion. Left images (Hematoxyline/Eosine HE) give an overview on the injected hydrogels (scale bar = 
500 micron). Right images (Masson Trichrome / Verhoeff staining) display the center of the injected 
hydrogels at higher magnification (scale bar = 100 micron; Pic polymer = purple/transparent (p); 
de novo extracellular matrix deposit by invaded cells = green (arrow); cell nuclei = red/brown).
5
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4 CONCLUSION
Through chemical conjugation of contrast agents and cell-binding sides to PIC 
polymers, functional and highly reproducible smart hydrogel mixtures can be 
created that can be monitored by MR imaging. Conjugation of contrast agents did 
not impair basic PIC hydrogel characteristics. The MRI and histological analysis of 
these hydrogels after injection gave fundamental insights into their fate in vivo and 
provide a proper basis for further development of PIC-based hydrogels which can 
be used for a wide variety of purposes.
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ABSTRACT
Clinical implementation of novel products for tissue engineering and regenerative 
medicine requires a validated sterilization method. In this study, we investigated 
the effect of γ-irradiation and EtO degassing, on material characteristics in vitro 
and the effect on template remodeling of hybrid tubular constructs in a large 
animal model. Hybrid tubular templates were prepared from type I collagen and 
Vicryl® polymers and sterilized by 25 kGray of γ-irradiation or EtO degassing. The 
in vitro characteristics were extensively studied, including tensile strength analysis 
and degradation studies. For in vivo evaluation, constructs were subcutaneously 
implanted in goats for 1 month to form vascularized neo-tissue. Macroscopic and 
microscopic appearances of the γ- and EtO-sterilized constructs slightly differed due 
to additional processing required for the COL-Vicryl®-EtO constructs. Regardless 
of the sterilization method, incubation in urine resulted in fast degradation of the 
Vicryl® polymer and decreased strength (<7 days). Incubation in SBF was less invasive 
and strength was maintained for at least 14 days. The difference between the two 
sterilization methods was otherwise limited. In contrast, subcutaneous implantation 
showed that the effect of sterilization was considerable. A well-vascularized tube 
was formed in both cases, but the γ-irradiated construct showed an organized 
architecture of vasculature and was mechanically more comparable to the native 
ureter. Moreover, the γ-irradiated construct showed advanced tissue remodeling as 
shown by enhanced ECM production. This study shows that the effect of sterilization 
on tissue remodeling cannot be predicted by in vitro analyses alone. Thus, validated 
sterilization methods should be incorporated early in the development of tissue 
engineered products and this requires both in vitro and in vivo analyses.
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1 INTRODUCTION
Recent advances in the field of tissue engineering and regenerative medicine have 
led to the application of advanced tissue engineered products (skin grafts, tracheas, 
cartilage, bladder augmentations) in different patient groups, albeit that patient 
numbers were limited [1–4]. The majority of research within this field is still at the 
pre-clinical stage and novel biomaterials are still being developed for a variety of 
indications. Evaluation of novel biomaterials varies from mechanical characterization 
and degradation studies to cyto- and biocompatibility assays [5,6]. In general, the 
first step in in vivo evaluation is limited to subcutaneous implantation in small 
animals [7,8]. For evaluation in larger animals, and in particular for successful clinical 
translation and implementation, standardized production with medical grade 
materials is required. One of the essential steps in this process is sterilization of 
constructs using a validated sterilization procedure [9]. The choice of sterilization 
method may affect the mechanical and biological features, for instance due to 
the aggressiveness of the sterilization procedure [10]. It is therefore important to 
evaluate the final sterilized medical grade products in vitro and in vivo [11,12].
For pre-clinical application of biomaterials, gamma(γ)-irradiation and ethylene 
oxide degassing (EtO) are the most frequently used sterilization methods [13]. With 
γ-irradiation wet materials can be sterilized, which eliminates additional processing. 
Materials can therefore be packaged in ethanol, which is necessary for long-term 
sterility and storage at -80°C. However, during γ-irradiation of wet materials free 
radicals are formed, leading to altered material properties [9]. Ethylene oxide (EtO) 
is a highly diffusive alkylating agent and adequate degassing is needed to permit 
diffusion of remaining toxic derivatives, like chlorohydrin and ethylene glycol [14]. 
Compared to γ-irradiation, EtO degassing is a less invasive sterilization technique 
and this may result in a material with prolonged strength and support. It may 
therefore be a preferred technique for polymeric materials [15,16].
Collagen-based templates have been used for various reconstructive purposes, 
including in preclinical studies for urological tissue engineering to reconstruct parts 
of the urological tract [17–19]. In a previous study, a γ-irradiated hybrid tubular 
construct from type I collagen and a biodegradable Vicryl® polymer mesh was used to 
create an artificial urinary conduit in a porcine model [20]. Interestingly, a functional 
conduit with urinary flow could be created after subcutaneous pre-implantation, 
although severe shrinkage of the graft and skin contraction was observed. The 
implanted material was completely remodeled and did not provide sufficient 
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structural integrity to prevent contraction. This could have been the consequence 
of several important aspects. It is possible that urine can contribute to the tissue 
remodeling as it creates an aberrant (micro)environment which may ultimately 
lead to deposition of more fibroblasts leading to graft shrinkage. Secondly, young 
(porcine) animals were used, known for their fast growth, specific skin properties 
and regeneration [21]. This may also cause excessive wound contraction. Thirdly, the 
choice of sterilization technique may have extensively influenced the final outcome 
since γ-sterilization enhances Vicryl® biodegradability from 2 months to less than 
1 month [22].
We hypothesized that using a less invasive sterilization technique, i.e. EtO-
degassing would result in prolonged template stability and improved remodeling. 
In this study we therefore compared two validated sterilization techniques, i.e. 
y-irradiation and EtO degassing, in terms of mechanical properties, degradation and 
template remodeling in an adult animal model (goat) mimicking tissue regeneration 
in the adult patient population.
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2 MATERIALS AND METHODS
2 .1  Tu b ula r  H y b ri d  Te m p late  Pre p a rati o n
Tubular hybrid templates (l = 10 cm, Ø = ± 15 mm) were prepared in a cleanroom 
facility (EMCM B.V., Nijmegen, The Netherlands), using a previously described protocol 
[23]. In brief, a 0.7% (w/v) collagen type I suspension prepared from bovine achilles 
tendon (Collagen Solutions, Eden Praire, USA) was combined with a tailor-made 
tubularized Vicryl® polymer mesh (VM74, Ethicon, Somerville, NJ, USA) in a silicon 
mold. A stainless steel mandrel (Ø = 15 mm) was inserted to create a lumen in the 
tubular construct. After freezing and freeze-drying, scaffolds were strengthened by 
chemical cross-linking using EDC/NHS [24]. Subsequently, constructs were either 
packaged in blisters with 70% ethanol for sterilization by a standard dose of 25 kGray 
of gamma (γ)-irradiation (Synergy Health, Etten-Leur, The Netherlands), or further 
processed for sterilization by ethylene oxide degassing (EtO, Synergy Health, Venlo, 
The Netherlands). This required additional freezing and freeze-drying and subsequent 
packaging in blisters. Cross-linking efficiency was determined by trinitrobenzene 
sulfonic acid assay [24] and construct morphology was assessed by scanning electron 
microscopy (SEM, JEOL 6310) and histology by hematoxylin (Klinipath, Duiven, The 
Netherlands) and eosin (Boom, Meppel, The Netherlands) (HE).
2 . 2  Te n s il e  Stre n g th  A n a l y s i s
The mechanical characteristics of the wetted tubular constructs were evaluated 
using a tensile tester with a 2.5 kN load cell (Z2.5 TN, Zwick/Roell, Ulm, Germany). 
A circular ring test was performed on ring pieces of the constructs (width (w): 6.4 
± 0.7 mm, thickness (t): 3.1 ± 0.4 mm, n = 14 from 2 COL-Vicryl®-EtO constructs and 
l: 6.1 ± 0.6 mm, t: 2.9 ± 0.4 mm, n = 11 from 2 COL-Vicryl®-γ constructs). The hooks 
of the apparatus were placed in contact with the upper and lower areas opposite 
each other (hook-to-hook distance), spaced 18.45 mm apart for the COL-Vicryl®-
EtO and 22.53 mm for the COL-Vicryl®-γ avoiding any ‘pre-stretch’. The upper hook 
was then moved upwards with a crosshead speed of 50 mm/min until rupture. 
Samples were compared to native goat ureters, the primary anastomosis site for 
the artificial urostomy, which acts as an extended ureter. Ureters from two different 
goats were similarly analyzed, spaced 1.27 mm apart (n=12). Data generation were 
performed as previously described [25,26]. In brief, recorded force-displacement 
data were normalized to the test specimen dimensions to compute a stress-strain 
curve. The stress was expressed as the recorded force F [N] which reacted on the 
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cross-sectional area A [mm2] of the test specimen (thickness (t) x width (w) x 2), while 
the strain was expressed as the change in length delta L [mm] divided by its original 
length (hook-to-hook distance) L0 [mm]. As an indicator for construct stiffness, the 
Young s´ modulus was calculated from the slope (upswing region) of the computed 
stress-strain curve. Ultimate tensile strength (UTS) and failure strain were defined 
as the maximum stress and maximum strain, respectively in the stress-strain curve 
before failure of the construct.
2 . 3  D e g ra dati o n  A s s ay
A degradation assay was performed in goat urine as well as in simulated body fluid 
(SBF) during 28 days. The goat urine was centrifuged at 2000 g for 10 min at 4°C and 
filter sterilized to avoid cellular contaminants and ensure sterility. Urine was kept at 
4°C until use. SBF was created as described [27]. In brief, SBF was made in a plastic 
beaker with 700 mL demi-water and the consecutive addition of the following: 9.23 
mM NaCl (Merck, Darmstadt, Germany), 0.56 nM NaHCO3 (Sigma-Aldrich, St. Louis, 
MO, USA), 0.41 mM Na2CO3 (Boom, Meppel, The Netherlands), 0.30 mM KCl (Sigma-
Aldrich, St. Louis, MO, USA), 0.10 mM K2HPO4•3H20 (Merck, Darmstadt, Germany), 
0.15 mM MgCl2•6H20 (Merck, Darmstadt, Germany), 200 mL 0.2 M NaOH (Merck, 
Darmstadt, Germany), 7.51 mM HEPES (Invitrogen, Thermo Scientific, Waltham, MA, 
USA), 0.26 mM CaCl2 (Sigma-Aldrich, St. Louis, MO, USA), 0.05 mM Na2SO4 (Sigma-
Aldrich, St. Louis, MO, USA). The mixture was then warmed until 36.5°C and adjusted 
to pH 7.4 with 1.0 M NaOH (Merck, Darmstadt, Germany). The precipitation potential 
of the SBF was checked on broken glass at 37°C. In contrast, the mixture should not 
precipitate at 4°C on plastic. Ring pieces of COL-Vicryl®-EtO (w: 6.2 ± 0.8 mm, t: 2.8 ± 
0.5 mm, n = 36 from 3 constructs) and COL-Vicryl®-γ (w: 5.2 ± 0.6 mm, t: 3.2 ± 0.4 mm, 
n= 36 from 3 constructs) and incubated in 6-well plates (Corning, Corning, New York, 
USA) at 37°C. N = 3 was used for each time point (day 0, 3, 7, 14 and 28) for 3 different 
conditions (goat urine and SBF). The constructs were evaluated by histology and 
tensile strength analysis using circular ring tests as described above. COL-Vicryl®-EtO 
and COL-Vicryl®-γ rings in urine were spaced ‘hook-to-hook’ 21.05 ± 1.75 mm and 21.81 
± 0.40 mm apart, respectively. COL-Vicryl®-EtO and COL-Vicryl®-γ rings in SBF were 
spaced 24.84 ± 1.50 mm and 21.63 ± 1.27 mm apart, respectively.
2 .4  S u b c ut a n e o u s  Im p la nt ati o n
 The animal experiment was approved by the Ethical Committee on Animal Research 
of the Radboud University Medical Center, Nijmegen, The Netherlands (RU-DEC 2014 
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233). We included nine adult Saane goats (2-3 years, ± 60 kg), receiving restricted 
diet and water ad libitum. Animals were transported with a ‘buddy’ goat, but 
were individually housed with nose contact after surgery and placed in groups 
when possible at the animal farm. Randomization and blinding was not possible 
due to clear differences in physical appearances. Subcutaneous implantation was 
performed to form vascularized neo-tissue as previously described.20 Under 
general anesthesia subcutaneous pockets were created on the right flank below 
the muscle layer of the skin, through a 5 cm incision above the shoulder of the right 
hind leg. In 3 animals one COL-Vicryl®-EtO construct was implanted and in 3 other 
animals both the COL-Vicryl®-EtO and COL-Vicryl®-γ were implanted in different 
pockets on the same flank. The pockets were spatially apart to avoid interference 
of regeneration and/or inflammation. Constructs were extensively washed in PBS, 
slid over a silicon mandrel and attached to the mandrel using CT-1 Vicryl® sutures 
(Ethicon, Somerville, NJ, USA). The construct was then inserted into the pocket and 
attached to the fascia with CT-1 Vicryl® sutures (Ethicon). The skin incision was 
subsequently closed with 2-0 Vicryl® (Ethicon) for the subcutaneous fat and the skin. 
Goats received Albipen LA (ampicillin) 15 mg/kg I.M. during surgery and Albipen LA 
15 mg/kg S.C. every 48h after surgery.
2.4.1 Evaluation of Implants
One month later, the remodeled tubes were harvested and evaluated. Ring pieces 
(w: 7.0 ± 2.1 mm, t: 3.1 ± 0.1 mm, n = 7 for COL-Vicryl®-EtO from 2 goats and w: 7.0 
± 1.5 mm, t: 3.4 ± 1.0 mm; n = 11 for COL-Vicryl®-γ from 3 goats) were transferred 
to PBS and immediately measured by tensile strength analysis by circular ring 
tests as described above. The hook spacing was 12.7 ± 1.9 mm for COL-Vicryl®-EtO 
and 15.5 ± 0.6 mm for COL-Vicryl®-γ, respectively. Ring pieces were transferred to 
4% (v/v) formaldehyde (Sigma-Aldrich, St. Louis, MO, USA) in PBS for fixation and 
subsequent embedding in paraffin for microscopic analysis. HE slides were scored 
by three independent observers (MS, PG, PdJ) for collagen and Vicryl® degradation, 
inflammation, tissue integration and vascularity. Averages of the independent 
scorings were calculated and combined into a scoring profile. Representative slides 
were used for confirmation by Masson’s Trichrome and immunohistochemistry.
2.4.2 Immunohistochemistry
Expression of type IV Collagen (COLIV) and HIF1α was analyzed on paraffin-
embedded material (5 µm thickness), mounted on Silane-coated slides (New Silane 
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III, Muto Pure Chemicals Co., Ltd., Tokyo, Japan). After deparaffinization and PBS 
washings, endogenous peroxidase activity was blocked by incubation in 1% (v/v) 
H2O2 in PBS for 20 min.
For COLIV, antigen retrieval was performed using 0.05% (v/v) proteinase in PBS 
(20 min, 37°C, Merck, Darmstadt, Germany). Slides were then washed with PBS/
Tween and incubated with 10% (v/v) swine serum (30 min) followed by incubation 
with the primary antibody (1h, rabbit-α-human COLIV, 1:250, Abcam, Cambridge, 
UK). After washings, the sections were incubated with peroxidase-labelled swine-
α-rabbit secondary antibody (30 min, SWARPO, 1:100, DakoCytomation, Glostrup, 
Denmark) followed by washings.
For HIF1α, heat-induced antigen retrieval was performed using sodium citrate 
(pH 6) followed by TBS/0.1%Tween20 washings. Blocking of endogenous biotin (and 
receptors) and avidin receptors (10 min, Vector Laboratories, Burlingame, California, 
USA) was performed with washing in between. After additional washing, endogenous 
proteins were blocked with 2% BSA (5 min), directly followed by incubation with the 
primary antibody (45 min, mouse-α-human HIF1α, 1:500, BD Biosciences, San Jose, 
CA, USA). After washings, sections were incubated with a biotin-labeled secondary 
antibody (15 min, donkey-α-mouse, 1:500, Jackson ImmunoResearch, West Grove, 
PA, USA). Slides were then washed and 15 min incubated with peroxidase-labeled 
streptavidin/biotin complex (1:100 Avidin solution and 1:100 Biotin solution, 30 min 
pre-incubation, Vector Laboratories, Burlingame, California, USA). An amplification 
step was performed after washings using biotinyl tyramide (15 min, DAKO, Heverle, 
Belgium). After washings, slides were incubated with peroxidase-labelled streptavidin 
(15 min, 1:250, Thermoscientific, Rockford, IL, USA) followed by washings.
For both COLIV and HIF1α, sections were developed with Bright-DAB 
(ImmunoLogic, Duiven, The Netherlands) and counterstained with hematoxylin 
(Klinipath, Duiven, The Netherlands). For negative controls the primary antibody 
was omitted, and no staining was observed in these samples. Native tissue was used 
for a positive control, showing staining in expected tissue components.
2 . 5  St ati s ti c s
Data is presented as mean with standard deviation and analyzed with Prism 
software (Version 5.03, Graphpad Software Inc, La Jolla, CA, USA). A one-way ANOVA 
with Bonferroni post-hoc test was performed for statistical analysis of differences 
between COL-Vicryl®-EtO, COL-Vicyl®-γ and native goat ureter.
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3 RESULTS
3 .1  Co n s tr u c t  A n a l y s i s
The macroscopic appearance of the COL-Vicryl®-EtO and COL-Vicryl®-γ constructs can 
be seen in Figure 1A-B. The luminal diameter (13.1 ± 1.1 mm for COL-Vicryl®-EtO and 
14.6 ± 1.4 mm COL-Vicryl®-γ, respectively) slightly differed due to additional processing 
(freezing and freeze-drying) required for COL-Vicryl®-EtO constructs. Microscopic analysis 
by scanning electron microscopy and histology showed integration of the Vicryl® polymer 
as indicated by visible collagen-Vicryl® connections and a typical honeycomb structure 
(Figure 1C-D). For the COL-Vicryl®-EtO constructs, that required additional processing 
(freezing and freeze-drying), a thinner and compressed wall with smaller pores was 
observed (Figure 1E-F). Cross-linking was successful as indicated by the decrease in free 
amine groups and was comparable for both groups: 35% for the COL-Vicryl-γ (reduced 
to 109 ± 15 nmol/mg) and 37% for the COL-Vicryl®-EtO (reduced to 202 ± 5 nmol/mg). 
The mechanical characteristics of the construct were compared to native goat ureter, 
the primary anastomosis site for the construct in an artificial urostomy and conform 
the animal model (Figure 1G-H). The COL-Vicryl®-γ Young’s modulus (2.31 ± 0.67 MPa) 
was approximately twice as high as the ureter (0.95 ± 0.39 MPa) whilst the COL-Vicryl®-
EtO showed a Young’s modulus only 1.5x as high (1.57 ± 0.75 MPa). The ultimate tensile 
strength (UTS) and failure strain of the ureter and both constructs was similar (ureter: 
0.83 ± 0.26 MPa at 2.6 ± 1.1 mm/mm strain, COL-Vicryl®-EtO: 0.66 ± 0.39 MPa at 1.22 ± 0.31 
mm/mm strain, COL-Vicryl®-γ: 0.74 ± 0.28 MPa at 0.85 ± 0.10 mm/mm strain).
Figure 1. Construct analysis. A-B) show the macroscopic overview of the COL-Vicryl®-EtO and 
COL-Vicryl®-γ, scale bar = 0.5 cm. C-D) show the SEM images, scale bar = 250 μm, pore size for 
COL-Vicryl®-EtO is approximately 150-250 μm and for COL-Vicryl®-γ 200-300 μm, and E-F) show the 
histological overview of the construct, scale bar = 250 μm. G-H) represents the mechanical char-
acteristics of the constructs. V = Vicryl® polymer, * p < 0.05, *** p < 0.0001, ns = non-significant.
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3 . 2  D e g ra dati o n  A s s ay
Incubation in goat urine resulted in fast degradation (<7 days) of the Vicryl® polymer 
in both constructs (Figure 2A). Microscopic analysis revealed negative imprints of the 
multi-filamented Vicryl® in the scaffold after 3 days. The collagen structure was barely 
affected in the COL-Vicryl®-γ constructs. In contrast, swelling of collagen lamellae was 
seen in the urine-incubated COL-Vicryl®-EtO constructs at day 28 (Figure 2A). Tensile 
strength analysis of the ring pieces showed a strongly diminished UTS and Young’s 
modulus, already after 3 days (Figure 2B), regardless of the sterilization method.
Figure 2. Degradation assay. A) shows the microscopic overview by HE of the degradation 
assay in urine and SBF, scale bar = 100 μm, V = Vicryl® polymer, * = collagen degradation. 
Images presented at for urine day 28 are representable for day 14 and 7. Images presented for 
SBF day 3 are representable for day 7 and 14. B) Mechanical characteristics of the degraded 
constructs. Urine exposure resulted in immediate diminished mechanical properties of both 
construct types at day 3, although the Vicryl® was still morphologically visible. In SBF prolonged 
mechanical stability was observed until day 14 for both constructs. At day 28 the mechanical 
properties were lost and the polymer showed signs of severe degradation.
The effect of SBF was less extensive, and Vicryl® remnants were still present at 28 days 
in both constructs, although their original multi-filamented structure was lost. Only 
in the COL-Vicryl®-EtO construct the collagen was substantially affected by SBF and 
showed swelling of collagen lamellae at 14 and 28 days. The UTS and Young’s modulus 
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of the constructs in SBF were maintained for at least 14 days. At this evaluation point, 
COL-Vicryl®-EtO showed a higher UTS and Young’s modulus then COL-Vicryl®-γ, but after 
28 days UTS and Young’s modulus of both constructs were similar.
3 . 3  S u b c ut a n e o u s  Im p la nt ati o n
Figure 3. Subcutaneous implantation. A) shows the overview of the washed constructs with the 
inserted mandrel, all scale bars – 1 cm. COL-Vicryl®-γ is the upper construct, COL-Vicryl®-EtO is 
the lower construct, B) shows the subcutaneous pocket, C) shows the autologous tissue tubes 
one month after implantation (same formation as in A) and D) shows the open lumen after 
removal of the mandrel. E-F) shows the mechanical characteristics of the implanted constructs 
compared to native goat ureter. ns = non-significant.
Subcutaneous implantation was successful in all goats and for all constructs. After 
one month, a remodeled neo-tissue tube was formed regardless of the sterilization 
method. The neo-tissue tube was encapsulated but easy to harvest from the 
subcutaneous pocket (Figure 3A-D). The rims of the neo-tissue, where scaffold 
material was absent, were fragile and ruptured easily and were therefore eliminated 
from analysis. After removal of the mandrel, the firm tissue was able to maintain an 
open lumen and was suitable for translocation to serve as an artificial urostomy. No 
clear macroscopic differences between the construct types were observed.
Ring pieces of both implants were analyzed by tensile strength analysis and 
compared to the native goat ureter (Figure 3E-F). After subcutaneous implantation, 
the UTS of the COL-Vicryl®-EtO was 0.28 ± 0.03 MPa at 1.04 ± 0.14 mm/mm strain 
and 0.40 ± 0.25 MPa at 1.26 ± 0.33 mm/mm strain for the COL-Vicryl®-γ. This was 
significantly lower than the UTS for the native goat ureter (0.83 ± 0.26 MPa at 2.6 ± 
1.1 mm/mm strain). The Young’s modulus was similar for all groups (ureter: 0.95 ± 
0.39 MPa, COL-Vicryl®-EtO: 0.56 ± 0.19 MPa and COL-Vicryl®-γ 0.87 ± 0.72 MPa). The 
UTS and Young’s modulus of the COL-Vicryl®-γ implant approximated the native 
ureter (the tissue to be mimicked in the urostomy) more closely than the COL-Vicryl®-
EtO.
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3 .4  (Im m u n o) h i s to l o g i c a l  A n a l y s i s  of  Im p la nt s
Table 1. Scoring profile. Hematoxyline and eosin (HE) slides of implanted COL-Vicryl®-EtO and 
COL-Vicryl®-γ constructs were independently scored for relative comparison to one another 
to create a representative profile for each implanted construct. No reference material was 
used. Items were scored – (not present), +/- (sporadically present), + (moderately present), ++ 
(abundantly present) or +++ (excessively present).
COL-Vicryl®-EtO COL-Vicryl®- γ
Collagen degradation + ++
Vicryl® degradation +/- +
Inflammation + +
Tissue integration + ++
Vascularity + +
Detailed microscopic evaluation showed a clear difference between the COL-
Vicryl®-EtO and the COL-Vicryl®-γ implants (Figure 4 and Table 1). The implanted 
COL-Vicryl®-γ constructs were well integrated in the surrounding tissue and both 
collagen and the Vicryl® polymer were partially degraded. Ingrowing fibroblast-like 
cells from the surrounding tissue were present within the honeycomb structures 
of the collagen and between the Vicryl® filaments. In contrast, the COL-Vicryl®-EtO 
constructs did not successfully integrate in the surrounding tissue, resulting in a 
clear boundary between the construct and surrounding tissue in some areas (Figure 
4D). Degradation of collagen and Vicryl® was substantially less in the COL-Vicryl®-
EtO constructs. In these less degraded areas of the COL-Vicryl®-EtO constructs and 
increased expression of HIF1α+ was observed, indicating hypoxia. 
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Figure 4: Histological and immunohistochemical analysis of the implants. A-B) Macroscopic 
overview of ring pieces of COL-Vicryl®-EtO and COL-Vicryl®-γ by HE, scale bar = 1 mm. C-G, I) 
Masson’s Trichrome staining from indicated boxes in A and B, blue/green = collagen, collagen 
from constructs is indicated by arrows, light blue (V) = Vicryl® polymer, red/brown = cell nuclei, 
yellow line = construct/tissue boundary, scale bar = 100 μm. G-H) contruct material showing 
limited regeneration, without vascular structures, but high expression of HIFaα. I-J) construct 
material showing progressive regeneration with presence of vascular structures (*) and limited 
HIF1α expression. Scale bar = 200 μm.
Although the amount of vascularity was comparable between groups, a different 
vascular architecture was observed in the luminal area (Table 1 and Figure 5). In 
the COL-Vicryl®-γ an organized layer of COLIV+ vasculature was formed, whilst in the 
COL-Vicryl®-EtO group an aberrant architecture of vasculature was observed when 
compared to the vascular bed in normal tissue. Since COL IV staining completely 
coincided with capillaries, COL IV staining was judged to be an appropriate surrogate 
marker for the capillary network.
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Figure 5. Evaluation of vascularization in COL-Vicryl®-EtO and COL-Vicryl®-γ implant. Luminal, 
middle and outer area of implants were stained with COLIV to visualize the vasculature. Outer 
and central areas are comparable between construct types. However, the luminal area showed 
a thin organized architecture of vasculature in the COL-Vicryl®-γ, which is comparable to native 
urinary tissue. The COL-Vicryl®-EtO shows an aberrant vasculature in the luminal area. V = 
Vicryl®, scale bar = 200 μm.
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4 DISCUSSION
Clinical implementation of biomaterials requires sterilization with EMA- (European 
Medicines Agency) and FDA- (United States Food and Drug Administration) approved 
techniques, like γ-irradiation or EtO-degassing. In the pre-clinical phase materials 
are generally tested in vitro and in vivo with non-validated, in-house disinfection or 
sterilization methods, to evaluate strength, cyto- and biocompatibility. This study 
shows that sterilization procedures are a crucial aspect in template design as it 
significantly influences tissue remodeling upon implantation. Therefore, evaluation 
of the effects of the sterilization procedures should become standard in early 
biomaterial development. Moreover, we demonstrate that in vitro data cannot be 
solely used as predictive factors for material behavior in vivo: whereas remodeling 
of EtO-sterilized constructs –the initial method of choice- was limited, enhanced 
tissue remodeling was observed after γ-sterilization. I.e., the in vivo behavior of 
templates is heavily dependent on the sterilization methods used. Biomaterial 
evaluation, preferably in a large animal, is required to facilitate clinical translation 
and registration as a medical device.
In the in vitro part of this study, we evaluated the mechanical and morphological 
characteristics of the hybrid tubular constructs. For urological tissue engineering 
and specifically the artificial urinary conduit, the addition of a reinforcing 
polymer to the collagen, e.g. Vicryl®, is desired to provide additional strength for 
template functionality and surgical handling [25,28]. Terminal sterilization of this 
hybrid tubular construct by EtO-degassing or γ-irradiation did not lead to major 
differences between constructs with respect to the morphological and mechanical 
characteristics, similar to earlier studies for collagen alone [29]. Other studies 
already showed that γ-sterilization of collagen results in enhanced enzymatic 
degradation and reduced integrity and stability due to chain disintegration in 
collagen molecules in comparison to non-sterilized construct. In contrast, the 
structure and stability of EtO-sterilized collagen is reported to remain unaltered 
and comparable to unsterilized scaffolds [29,30]. The enhanced tissue remodeling 
of the γ-irradiated constructs, when placed in a subcutaneous pocket in our study, 
may well be explained by the γ-irradiation induced alterations of the collagen.
Furthermore, we assessed the influence of a wet environment using either urine, 
mimicking direct implantation e.g. when used as an artificial urinary conduit, or 
Simulated Body Fluid (SBF), mimicking subcutaneous implantation. Interestingly, 
exposure of both constructs to urine resulted in immediate loss of Vicryl® polymer 
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integrity (3 days). This suggests that direct implantation of the construct in the 
urinary tract will lead to material collapse before sufficient tissue regeneration can 
occur and may therefore not be advisable. Pre-implantation to form neo-tissue may 
solve this by creating a (semi-)autologous construct. 
The biomechanical properties of absorbable multifilament sutures, like Vicryl®, 
have been previously evaluated in equine urine and similarly showed total loss of 
Vicryl® integrity albeit after 21 days [31]. The absence of any buffering capacity of 
both goat and equine urine may have influenced Vicryl® degradation by enhancing 
pH-dependent hydrolysis. The higher degradation rate of the Vicryl® mesh observed 
in our study was probably the consequence of additional γ-sterilization of the 
commercially available and already sterilized Vicryl® polymer mesh [32].
Exposing the construct to SBF instead of urine prolonged Vicryl® polymer stability 
up to two weeks. At this time, the strength and Young’s Modulus of the COL-Vicryl®-
EtO was significantly higher than the COL-Vicryl®-γ. After 28 days, signs of collagen 
degradation (swelling) were observed in the EtO-sterilized construct and not in the 
γ-sterilized constructs. The swelling may have been the consequence of the thinner 
and compressed wall in the COL-Vicryl®-EtO. The γ-sterilization results in additional 
crosslinking and strengthening of collagen which may explain this difference [33]. 
In contrast, it is well established that sterilization of Vicryl® by γ-irradiation results 
in enhanced degradability due to chain fragmentation [34]. Although this explains 
the lower Young’s modulus of the COL-Vicryl®-γ over time, this in vitro assay only 
evaluated material degradation, whilst the creation of an autologous tissue tube 
is a balance between material degradation and tissue regeneration. Adequate 
assessment of this balance requires in vivo analysis. 
Besides the slightly prolonged stability of the COL-Vicryl®-EtO in a wet 
environment, neither of the constructs was superior in the in vitro analyses. 
Both constructs were therefore tested in a subcutaneous implantation model. 
Interestingly, when the implanted constructs were harvested, tissue ingrowth 
of pre-implanted COL-Vicryl®-γ was much further developed compared to EtO-
degassed constructs. In accordance with the in vitro data, the Vicryl® polymer in the 
EtO-sterilized constructs was less susceptible to degradation in vivo and contributed 
to prolonged strength over time. This is in agreement with a previous study showing 
that γ-irradiation enhanced Vicryl® degradation when implanted in the lumbar 
muscle of rats [22,33]. It is likely that the enhanced degradation rate of Vicryl® 
facilitates the ingrowth of surrounding tissue and the formation of an organized 
subluminal vasculature in the pre-implanted COL-Vicryl®-γ. The aberrant vascular 
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architecture in the COL-Vicryl®-EtO pre-implant may have been the consequence of 
prolonged and increased levels of hypoxia. Full comprehension of the sterilization 
effect required functional analysis in vivo. Our earlier studies suggested that perhaps 
prolongation of template stability to achieve sustained mechanical stability might be 
important in the formation of the artificial conduit [17]. Indeed, our in vitro analyses 
showed that prolonged stability in a fluid could be accomplished by applying EtO-
sterilization to the hybrid tubular construct. However, the COL-Vicryl®-EtO was not 
superior in vivo. Clearly, other aspects like cellular ingrowth and vascularization 
are equally or even more important. Furthermore, mechanical analysis after 
implantation did not indicate a difference in strength or elasticity, suggesting that 
the loss of construct integrity is compensated by tissue ingrowth, with no net loss 
of strength as a result. 
Absorption of urine by collagen scaffolds may cause aberrant remodeling. 
Previously, cell seeded constructs have been tested as urostomy constructs, but this 
was not very successful, although urine exposure of the collagen graft was limited 
[20]. In an ongoing pilot experiment, we noticed that creation of an artificial conduit 
with pre-implanted COL-Vicryl®-EtO tubes was not successful due to disconnection 
from the ureter and poor integration to the surrounding tissue. In contrast, when 
the completely remodeled COL-Vicryl®-γ construct was used, this ultimately resulted 
in a functional conduit (results not shown, manuscript in preparation), showing that 
urine did not influence the outcome of constructs aligned with cells, but that the 
outcome is more dependent on the sterilization method used.
EtO and γ-irradiation are two of the most commonly used and FDA-approved 
sterilization techniques and were therefore chosen as comparators. Recently, 
novel sterilization techniques, like supercritical carbon dioxide (scCO2), have come 
available and this may provide a valuable alternative [35]. In combination with an 
altered collagen component and/or bioreactor conditioning in combination with 
cells this may ultimately lead to superior constructs for in vivo use. Our study 
shows that for full comprehension of the effect of a novel sterilization method on 
in vivo biomaterial behavior a complete panel of analyses ranging from mechanical 
characterization to implantation in a functional setting in a large animal model is 
essential.
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5 CONCLUSION
Thorough analysis of the in vitro and in vivo behavior of sterilized collagen-Vicryl® 
tubular templates shows that the effect of final sterilization is considerable. 
Subcutaneous implantation of a γ-sterilized hybrid template resulted in better 
tissue remodeling compared to EtO-sterilized constructs. This study shows that 
sterilization affects tissue remodeling upon implantation. Clinical translation of 
tissue engineered biomaterials can only be achieved when EMA-FDA-approved 
sterilization methods are included in a full panel of in vitro and in vivo analyses.
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Chapter 7
1 SUMMARY AND DISCUSSION
1 .1  Clin i c a l  Ch a ll e n ge  a n d  A im  of  th i s  T h e s i s
Long-segment ureter reconstruction (e.g. after trauma) or forming an urinary 
diversion (e.g. after radical cystectomy) can be a challenge for most urologists. 
The standard treatment is the creation of neotissue by using autologous bowel 
segments. However, this source of tissue is associated with multiple side effects 
[1–5]. Alternative graft (bio)materials are highly desirable and may circumvent 
standard-treatment related complications and graft shortage. The field of Tissue 
Engineering (TE) aims to replace or repair damaged organs and tissues [6]. The 
backbone of tissue-engineered grafts is the so-called scaffold which can be 
composed of natural biomaterials, synthetic biomaterials or combining both to 
create smart hybrid scaffolds. The scaffold acts as a starter matrix to fill the defect 
and carries various (bio)mechanical loads until it is remodeled by host tissue [7]. 
Since the ultimate goal of ureter reconstruction and urinary diversion is the safe 
transport of urine, implanted graft (bio)materials should actively contribute to this 
safe transport and protect surrounding tissue. Furthermore, the patient’s own cells 
may be seeded on the scaffold to generate functional tissue substitutes [8]. Upon 
implantation, noninvasive imaging techniques are of utmost importance to access 
graft patency and tissue remodeling in real-time [9].
The aim of this thesis was to develop innovative imageable tissue-engineered 
tools which can be used for ureteral reconstruction and/or creation of an artificial 
urostomy. 
1 . 2  St ate - o f-th e -A r t  U rete r  Re co n s tr u c ti o n  a n d  U rin a r y 
D i ve r s i o n  u s in g  T i s s u e  En g in e e rin g  A p p ro a c h e s
In chapter 2, the state-of-the-art TE approaches for ureter reconstruction and 
urinary diversion with emphasis on biomaterials and scaffold design was reviewed. 
Studies were further categorized based on whether scaffolds were directly 
implanted, seeded with cells prior to implantation, or preimplanted (with or without 
cells) before functional implantation. 
The collective evidence showed that regeneration of ureteral tissue and the 
formation of a urinary diversion using TE approaches is possible, albeit that it is 
complex to achieve well-developed and functional neotissue. Preclinical studies 
showed that cell-free functional implantation of scaffolds is problematic: it leads 
to fibrosis, graft-shrinkage, stricture formation and hydronephrosis despite the 
534676-L-bw-Janke
Processed on: 27-8-2019 PDF page: 165
165
Summary, Discussion and Future Perspectives
generation of a urothelial lining. The addition of autologous smooth muscle cells 
(SMCs) and urothelial cells (UCs) to achieve contractile yet functional neotissue prior 
to implantation does not significantly improve the functional outcome. In contrary, 
results with stem cells sources are promising. 
Preimplantation to improve vascularization of scaffolds alone or in combination 
with cell seeding has shown encouraging results, but these procedures are 
extraordinary time consuming and they can only be used for individual patients. 
Faster regeneration approaches with defined scaffolds are desirable.
1 . 3  H y b ri d  S c af f o l d s
Thus far the proper biomaterial and scaffold design have not been identified for 
genitourinary reconstruction. Scaffolds designed from different (bio)materials may 
be advantageous, because strength, tunability, and controllability of synthetic 
polymers can be combined with overall biocompatibility derived from natural 
biomaterials such as collagen.
Besides being the main structural protein of most hard and soft tissues 
in mammals, collagen is a promising naturally-derived biomaterial due to its 
biocompatibility, biodegradability, bioactivity and low antigenicity [10,11]. However, 
highly porous scaffolds produced from collagen are too weak to withstand the (bio)
mechanical demands of native tissue, hence collagen scaffolds have been reinforced 
with synthetic polymers to create stronger hybrid tubular scaffolds [12,13]. Indeed, 
reinforcement with a tubularized biodegradable synthetic polymer mesh increased 
the overall strength and greatly improved the surgical handling which was much 
better compared to collagen-alone scaffolds [14]. 
When hybrid scaffolds such as COL-Vicryl® were used for ureter reconstruction 
or urinary diversion in preclinical models, tissue regeneration with urothelial 
lining was possible. However, graft shrinkage, stricture formation, and ultimately 
hydronephrosis occurred [15–17]. This suggests that new hybrid scaffold designs are 
needed. In a first approach the (bio)mechanical performance, hence the synthetic 
component of the hybrid scaffold may be further optimized. In chapter 3, coupled 
helical coils (CHCs) were manufactured to mimic collagen fiber orientation as found in 
nature. Monofilaments of different commercially available biodegradable polymers 
were wound and subsequently fused, resulting in right-handed and left-handed 
polymer helices fused together in joints where the filaments cross. Subsequently, 
seamless and stable hybrid constructs were embedded in porous collagen type 
scaffolds which showed similar (bio)mechanical properties as native (ureteral) 
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tissue. Importantly, these stent-like hybrid templates can resist compressive loads 
which may be beneficial to prevent strictures or graft occlusion [18]. Furthermore, 
these CHCs are very versatile as the overall (bio)mechanical performance of CHCs 
can be modified by simply changing the diameter of fiber filaments, the filament 
arrangement and the filament intersection points. The overall degradation profile 
can be adjusted by changing the polymer.
1 .4  N o n inva s i ve  M a g n eti c  Re s o n a n ce  Im a g in g  o f  T i s s u e -
En g in e e re d  G raf t s
Since the failure rate of implanted scaffolds for ureter reconstruction and urinary 
diversion are relatively high, real-time monitoring of tissue-engineered constructs 
is of tremendous importance to assess their integrity, remodeling, and degradation 
upon implantation in vivo. Magnetic resonance imaging (MRI) is an attractive 
multifunctional and noninvasive imaging modality that does not use ionizing 
radiation and MRI has been used to image tissue engineered collagen based 
scaffolds [19,20]. However, monitoring of these grafts is challenging because their 
contrast with neighboring tissues is low, necessitating labeling with contrast agents 
(CAs). But current CAs have limitations such as toxicity, negative contrast, label 
instability. 
Therefore, a naturally derived hemin-L-lysine (HL) complex was used as a 
potential CA to label collagen-based scaffolds for MRI (chapter 4). Labeling through 
chemical conjugation of HL to collagen did not change the basic characteristics 
of the collagen scaffolds. When hybrid scaffolds composed of collagen type I 
reinforced with degradable polymers were subcutaneously implanted in a mouse 
model, longitudinal visualization by MRI was possible with good contrast and 
contrast change correlated with scaffold remodeling. On the contrary, unlabeled 
collagen templates were hardly visible, and the fate of these templates could not 
be monitored by MRI. Interestingly, tissue remodeling and vascularization were 
enhanced within HL-labeled templates. Taken together, HL labeling was introduced 
as a promising universal imaging marker to label tissue-engineered implants for 
MRI, which additionally seems to accelerate tissue regeneration.
Alternatively, hydrogels are versatile tools for TE applications. For example, 
injectable hydrogels offer the advantage to be applied in a minimal invasive 
manner. Once injected, they can form a stable 3D environment which can mimic 
the extracellular matrix of native tissues, hence hydrogels are ideal candidates for 
cell- and drug delivery [21,22]. In chapter 5, fully synthetic imageable hydrogels 
534676-L-bw-Janke
Processed on: 27-8-2019 PDF page: 167
167
composed of polyisocyanopeptide (PIC) were produced. this material has unique 
properties: PIC gels remain liquid below 15°C and form a stable 3D network at 37°C, 
and, more importantly, closely resemble the native extracellular matrix including 
stiffening response at high strains [23]. Through chemical conjugation by “copper-
free” click chemistry, soft (G’  ~ 200 Pa) PIC hydrogels were further functionalized 
with cell binding motifs (PIC-GRGDS) and a gadolinium-based contrast agent (PIC-
GdDO3A). Subsequently, mixtures of both gels were prepared to create hybrid 
gels allowing both cellular outgrowth and visualization via MRI (PIC hybrid). Upon 
injection in a mouse model, PIC-GdDO3A- and PIC hybrids were monitored by 
MR imaging. Longitudinal follow up provided a fundamental insight on hydrogel 
patency over time: soft PIC hydrogels lost approximately 50 % of its volume within 
7 days after injection. R1 relaxometry and the contrast-to-noise ratio confirmed 
densification of the injected material due to fluid loss rather than bulk degradation. 
Furthermore, MRI signal remained stable till the end of the experiment (28 days). 
Conventional histology correlated well with MR images. The findings of this study 
may help to further develop smart PIC hydrogels which can be used for a wide 
variety of purposes such as drug- and cell delivery for ureter regeneration or urinary 
diversion.
1 . 5  Ste ril iz ati o n  o f  Co lla ge n - ba s e d  H y b ri d  S c af f o l d s
Clinical implementation of tissue-engineered hybrid constructs, which is governed 
by Advance Therapies Medical Products (ATMP) regulation of EMA and FDA, requires 
a validated FDA- and EMA approved sterilization method. Since the choice of the 
sterilization method may affect the scaffold performance of both synthetic [24]- and 
natural polymers [25,26], the effect of γ-irradiation (25 kGray) and EtO degassing on 
hybrid scaffolds in vitro and the effect on scaffold remodeling in a large animal model 
was studied (chapter 6). In this chapter, collagen scaffolds were reinforced with a 
biodegradable surgical mesh (Vicryl®) to form a hybrid scaffold (COL-Vicryl®). The 
in vitro characteristics were extensively studied, including tensile strength analysis 
and degradation studies. For in vivo evaluation, constructs were subcutaneously 
implanted in goats for 1 month to form vascularized neo-tissue. Macroscopic and 
microscopic appearances of the γ- and EtO-sterilized constructs slightly differed due 
to additional processing required for the COL-Vicryl®-EtO constructs. Regardless 
of the sterilization method, incubation in urine resulted in fast degradation of 
the Vicryl® polymer and decreased strength. The difference between the two 
sterilization methods was otherwise limited. In contrast, subcutaneous implantation 
Summary, Discussion and Future Perspectives
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showed that the effect of sterilization was considerable. A well-vascularized tube 
was formed in both cases, but the γ-irradiated construct showed an organized 
architecture of vasculature and was mechanically more comparable to the native 
ureter. Moreover, the γ-irradiated construct showed advanced tissue remodeling 
as shown by enhanced ECM production of invading cells. 
This study showed that the effect of sterilization on tissue remodeling cannot 
be predicted by in vitro analyses alone. Thus, validated sterilization methods should 
be carefully considered when designing hybrid scaffolds. As shown in this chapter, 
y-sterilization enhanced tissue remodeling by changing its degradation profile, but 
y-sterilization also enhanced the degradation rate of the supportive polymer. This 
suggests that polymers with a low degradation profile such as polycaprolactone 
(PCL) should be used to ensure long-term support of the hybrid [27]. In view of 
ureter regeneration and urinary diversion, the supportive structure should be 
at least longer than 1 month when considered to be used after preimplantation. 
Subsequently, when EtO is chosen as the sterilization method of choice, the 
degradation rate of the supportive structure and collagen remains unaffected 
[24–26,28,29]. 
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2 FUTURE PERSPECTIVES 
2 .1  A n im a l  M o d e l s  a n d  Clin i c a l  Tra n s lati o n
This thesis describes multiple components of scaffold design which may aid 
in development of personalized functional grafts for ureter reconstruction and 
urinary diversion. To foster clinical translation, these tools need to be evaluated in 
preclinical studies to reconstruct a ureter or forming an artificial urinary conduit. 
Choosing a proper animal model is a critical step. Large animal models are preferred 
as they allow a better translation to the human situation, within respect to surgical 
techniques, scaffold dimensions and anatomy [30]. Nevertheless, remodeling 
kinetics of tissue-engineered constructs may vary: for example, Göttingen minipigs 
and juvenile German Landrace pigs differ in (cell) growth, and show different 
regeneration kinetics [31]. In view of clinical translation, the overall scaffold design 
should be adjusted to specific patient dimensions since the diameter of the ureter, 
its wall thickness, and its (bio)mechanical properties differ between the defect 
area and these are also unique for a particular species [32,33]. Therefore, it may 
worthwhile to derive specific ureter dimensions from CT- and/or MRI scans to be 
able to develop custom made grafts. 
To fully assess the benefit of a (personalized) tissue-engineered construct, future 
animal studies should include the standard clinical treatment such as reconstruction 
with autologous bowel tissue to permit adequate comparison with the chosen 
scaffold biomaterial and reconstruction strategy. This may ultimately aid the 
translation of TE approaches to the clinic as alternative reconstruction procedures. 
Furthermore, the time-frame to generate functional graft material is of utmost 
importance in clinical settings when complex reconstruction procedures, including 
cell-seeding and preimplantation, are considered. For urinary diversion (e.g. after 
radical cystectomy) there is a time-window of up to 3 months between diagnosis and 
surgical intervention [4]. In contrary, ureter reconstruction (e.g. due to trauma) is 
usually acute and requires urgent surgical interaction. A percutaneous nephrostomy 
catheter could be used to drain urine in a first step before a long segment ureter 
reconstruction can follow [34]. Taken together, there may be a time-window which 
would allow for a complex reconstruction procedure albeit formation of functional 
neotissue by means of SMCs and UCs formation should be as fast as possible.
Summary, Discussion and Future Perspectives
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2 . 2  G e n e rati o n  o f  Fu n c ti o n a l  N e oti s s u e
In general, collagen scaffolds are chemically crosslinked e.g. by N-ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDC) / N-hydroxysuccinimide (NHS) to enhance 
strength and resistance against enzymatic degradation. However, this crosslinking 
strategy may diminish the availability of essential cell binding motifs, hence has a 
strong impact on cell spreading, apoptosis and proliferation within scaffolds [35]. 
Since the CHC component dictates strength and faster regeneration strategies are 
desired for ureter reconstruction and urinary diversion, it may worthwhile to neglect 
crosslinking and use collagen in its native fashion. Indeed, when hybrid scaffolds 
were not crosslinked more cells attached to collagen and cellular outgrowth was 
enhanced in ongoing experiments (manuscript in preparation). Furthermore, 
when primary human bladder smooth muscle cells (hbSMCs) were seeded on non-
crosslinked hybrid scaffolds and conditioned in a bioreactor functional neotissue 
could be generated most likely because the dynamic stimulation in combination 
with native collagen triggered hbSMCs to a more mature contractile phenotype. 
In healthy conditions, the urine flow is actively guided by smooth muscle cells 
(SMCs) within the ureter wall. Thus, addition of SMCs to (hybrid) scaffolds to achieve 
functional neotissue may reduce the complication rate for ureter reconstruction 
and urinary diversion. As described in chapter2, stem cells such as adipose derived 
stem cells (ADSCs) are of interest for genitourinary TE applications. In future studies, 
the so-called adipose stromal vascular fraction (SVF) may be an appropriate cell 
source: it can be isolated from easily from accessible fat tissue and seeded to 
(hybrid) scaffolds. The SVF contains a heterogeneous cell population comprised 
of endothelial cells, macrophages, pericytes, and various stem cell populations 
[36] and when these cells are stimulated in a bioreactor system, smooth muscle 
tissue can be generated [37]. Indeed when cells are added to scaffolds, bioreactor 
stimulation should be implemented in the study design, as they provide mechanical 
cues which can differentiate cells to a more matured contractile phenotype and align 
cells similar to native tissue [37,38]. Furthermore, generated functional muscular 
tubes showed a high patency when used for urethra reconstruction in a preclinical 
setting [39].
2 . 3  N o n inva s i ve  M o n ito rin g  o f  Fu n c ti o n a l  G raf t s  a n d  Ce ll s
In view of imaging hybrid scaffolds as described in this thesis, there is need to 
adequately image both the supportive component and the cellular stratum. Since 
supportive structures such as the CHC gives a negative contrast in 1H-MR imaging, 
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the collagen component needs to give a positive contrast. When cells are seeded 
to these imageable hybrids, cells may also be labeled with a contrast agent for 
visualization. 19F-MRI have been established as a proper tool to track and quantify 
therapeutic cells upon injection in vivo [40]. For TE applications, cells can be simply 
labeled with an 19F-MRI contrast agent such as PERFECTA [41] for localization of their 
fate upon seeding to (hybrid) scaffolds. This strategy can give valuable qualitative 
and quantitative information of cell distribution within the scaffold. 19F-MR images 
can be simply overlaid with 1H-MR images; it would permit efficient visualization of 
all 3 distinct structures: cells, collagen labeled with HL and CHC by 1H-MR imaging. 
However, labelling of cells allows only short-term monitoring as the contrast 
decreases e.g. due to dilution of the label during cell division and this should be 
carefully considered. 
Other non-invasive monitoring strategies such as ultrasound imaging (US) can 
be implemented during maturation of tissue-engineered scaffold in a bioreactor. 
It has been shown that the grey values of US images correlated well with the newly 
synthetized collagen content within fibrin-based constructs [42]. Furthermore, US 
can be used to assess the mechanical behavior of tissue-engineered constructs 
when stimulated in bioreactor [43]. How this translates to in vivo remains to be 
established.
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1 SAMENVATTING EN DISCUSSIE
1 .1  K lin i s c h e  Uitda g in g  e n  D o e l  va n  dit  Pro e f s c h rif t
Reconstructie van lange ureter-segmenten (bijv. na een trauma) of het vormen 
van een urineafleiding door een urostoma (bijv. na radicale cystectomie) kan voor 
urologen een uitdaging zijn. De standaardbehandeling bestaat uit het creëren van 
nieuw weefsel van autologe darmsegmenten. Dit is geassocieerd met meerdere 
bijwerkingen [1-5]. Alternatieve (bio)materialen zijn daarom zeer wenselijk en 
kunnen standaard behandelingsgerelateerde complicaties en weefseltekorten 
mogelijk oplossen indien goed toepasbaar. Het doel van Tissue Engineering (TE) 
is het vervangen of herstellen van beschadigde organen en weefsels [6]. De basis 
van TE is een zogenaamde scaffold die kan worden samengesteld uit natuurlijke 
biomaterialen, synthetische biomaterialen of een combinatie van beide om 
hybride scaffolds te creëren. De scaffold fungeert als startmatrix om het defect 
op te vullen en de verschillende (bio)mechanische belastingen te dragen tot het 
door eigen weefsel wordt vervangen [7]. Aangezien het uiteindelijke doel van 
ureterreconstructie en urineafleiding het veilig transporteren van urine is, moet 
een geïmplanteerd (bio)materiaal hier actief aan bijdragen en het omringende 
weefsel beschermen. Verder is het mogelijk om cellen van de patiënt op de scaffold 
te laten groeien om de vorming van functioneel weefsel te stimuleren [8]. Bij de 
implantatie zijn niet-invasieve beeldvormingstechnieken belangrijk om real-time de 
doorgankelijkheid en weefselhermodellering te kunnen volgen [9].
Het doel van dit proefschrift was de ontwikkeling van innovatieve hybride TE 
constructen die gebruikt kunnen worden bij ureter reconstructie en/of het creëren 
van een kunst-urostoma voor urineafleiding. 
1.2 State-of-the-art van Reconstructie van de Ureter 
Reconstructie en Urineafleiding met Behulp van Tissue Engineering
Een overzicht van state-of-the-art TE-benaderingen voor ureter reconstructie en 
urineafleiding door een urostoma met de nadruk op biomaterialen en scaffolds is 
beschreven In hoofdstuk 2. De studies werden verder gecategoriseerd op basis van 
de vraag of de scaffolds direct werden geïmplanteerd, werden ingezaaid met cellen 
voorafgaand aan de implantatie, of vooraf werden geïmplanteerd (met of zonder 
cellen) voorafgaand aan de functionele implantatie. 
Deze studies toonden samen aan dat regeneratie van ureteraal weefsel en de 
vorming van een urineafleiding met behulp van TE-benaderingen mogelijk is, hoewel het 
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complex is om goed ontwikkeld en functioneel weefsel te creëren. Preklinische studies 
hebben aangetoond dat de celvrije functionele implantatie van scaffolds problematisch 
is: het leidt tot fibrose, krimpen van het construct, vernauwing en hydronefrose 
ondanks de vorming van urotheel cellen. Het toevoegen van autologe gladde spiercellen 
(engels: smooth muscle cells, SMCs) en urotheliale cellen (UCs) om vóór de implantatie 
contractiel, functioneel weefsel te verkrijgen, verbetert het functionele resultaat niet 
significant. Daarentegen zijn de resultaten met stamcellen veelbelovend. 
Preimplantatie ter verbetering van de vascularisatie van scaffolds, alleen of in 
combinatie met het zaaien van cellen, heeft veelbelovende resultaten opgeleverd, 
maar deze procedures zijn zeer tijdrovend en kunnen alleen voor individuele patiënten 
worden gebruikt. Snellere benaderingen met gedefinieerde scaffolds zijn wenselijk.
1 . 3  H y b ri d e  S c af f o l d s
Tot nu toe zijn het juiste biomateriaal en scaffold design nog niet geïdentificeerd voor 
genitourinaire reconstructie. Scaffolds samengesteld uit meerdere verschillende 
(bio)materialen kunnen van voordeel zijn, omdat de sterkte en controleerbaarheid 
van synthetische polymeren gecombineerd kunnen worden met natuurlijke 
biomaterialen zoals collageen.
Naast het feit dat collageen het belangrijkste structurele eiwit is van de meeste 
harde en zachte weefsels in zoogdieren, is collageen een veelbelovend natuurlijk 
biomateriaal vanwege zijn biocompatibiliteit, biologische afbreekbaarheid, bio-
activiteit en lage antigeengehalte [10,11]. Hoogporeuze scaffolds geproduceerd uit 
collageen zijn echter te zwak om de (bio)mechanische eisen van normaal weefsel 
te weerstaan, vandaar dat collageen-scaffolds zijn versterkt met synthetische 
polymeren om sterkere hybride buisvormige scaffolds te creëren [12,13]. Versterking 
met een buisvormig, biologisch afbreekbaar synthetisch polymeernetwerk 
verhoogde de totale sterkte en verbeterde de chirurgische hanteerbaarheid 
aanzienlijk ten opzichte van scaffolds die alleen uit collageen bestonden [14]. 
Wanneer hybride scaffolds zoals COL-Vicryl® werden gebruikt voor ureter 
reconstructie of een urostoma in preklinische modellen, was weefselregeneratie 
met urotheliale bekleding mogelijk. Er was echter sprake van krimpen van het 
construct, vernauwing en uiteindelijk hydronefrose [15-17]. Dit suggereert dat er 
nieuwe hybride scaffold ontwikkelt moeten worden. In een eerste stap moeten 
de (bio)mechanische eigenschapen van het synthetische component van de 
hybride scaffold verder geoptimaliseerd worden. In hoofdstuk 3 werden coupled 
helical coils (CHCs) gemaakt die de natuurlijke collageenvezel oriëntatie nabootst. 
534676-L-bw-Janke
Processed on: 27-8-2019 PDF page: 177
177
Samenvatting, Discussie en Toekomstvisie
Monofilamenten van verschillende commercieel verkrijgbare biologisch afbreekbare 
polymeren werden gewikkeld en vervolgens samengesmolten. Dit resulteerde in 
rechtshandige en linkshandige polymeer helices die samensmelten in kruisende 
verbindingen. Vervolgens werden deze naadloze en stabiele hybride constructies 
ingebed in poreuze collageen scaffolds die dezelfde (bio)mechanische eigenschappen 
vertoonden als natuurlijk ureteraal weefsel. Belangrijk is dat deze stent-achtige 
hybride scaffolds drukbelastingen kunnen weerstaan die nodig kunnen zijn om 
vernauwingen of occlusie van het construct te voorkomen [18]. Bovendien zijn deze 
CHCs zeer veelzijdig doordat de algemene (bio)mechanische eigenschappen van 
CHC’s kan worden gewijzigd door bijvoorbeeld het veranderen van de diameter van 
de vezeldraden, de filament indeling en de filament snijpunten. Het afbraakprofiel 
kan worden aangepast door het veranderen van de polymeer compositie.
1 .4  N i et-inva s i eve  M a g n eti c  Re s o n a n ce  Im a g in g  va n  T i s s u e -
e n g in e e re d  We e f s e l
Aangezien de kans op problemen met geïmplanteerde scaffolds voor ureter 
reconstructie en urineafleiding door een urostoma relatief hoog is, is real-time 
monitoring van tissue-engineered constructies van groot belang om hun integriteit, 
weefselingroei en degradatie na implantatie in vivo te beoordelen. Magnetic 
Resonance Imaging (MRI) is een aantrekkelijke multifunctionele en niet-invasieve 
beeldvormingsmodaliteit die geen gebruik maakt van ioniserende straling en gebruikt 
kan worden voor beeldvorming van collageen scaffolds [19,20]. Echter, beeldvorming 
van deze scaffolds is uitdagend omdat hun contrast met naburige weefsels laag is, 
waardoor labeling met contrastmiddelen (CAs) nodig is. Huidige CA’s hebben echter 
beperkingen zoals toxiciteit, negatief contrast en instabiliteit van het labeling. 
Daarom werd een natuurlijk hemin-L-lysine (HL) complex gebruikt als een 
potentieel CA om scaffolds op basis van collageen voor MRI te labelen (hoofdstuk 
4). Labeling door middel van chemische conjugatie van HL met collageen veranderde 
de basiskenmerken van de collageen scaffolds niet. Wanneer hybride scaffolds 
bestaande uit collageen type I versterkt met afbreekbare polymeren subcutaan 
werden geïmplanteerd in een muismodel, was longitudinale visualisatie door MRI 
mogelijk met een goed contrast.Verder gecorreleerde contrastveranderingen aan 
hermodellering van de scaffolds. Daarentegen waren ongelabelde collageen scaffolds 
nauwelijks zichtbaar en konden deze scaffolds niet worden vervolgd met MRI. 
Interessant is de betere weefselhermodellering en vascularisatie van HL-gelabelde 
scaffolds. Samenvattend werd HL-labeling geïntroduceerd als een veelbelovende 
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universele beeldvormingsmarker voor het labelen van van tissue-engineered 
constructen voor MRI, waarbij bovendien de weefselregeneratie lijkt te versnellen.
In aanvulling op scaffolds zijn hydrogelen veelzijdige hulpmiddelen voor TE-
toepassingen. Injecteerbare hydrogelen bieden bijvoorbeeld het voordeel dat ze 
op een minimale invasieve manier kunnen worden toegepast. Eenmaal geïnjecteerd, 
kunnen ze een stabiele 3D-omgeving vormen die de extracellulaire matrix van 
natuurlijke weefsels kan nabootsen, vandaar dat hydrogelen ideale kandidaten zijn 
voor cel- en medicijnafgifte [21,22]. In hoofdstuk 5 werden volledig synthetische 
afbeeldbare hydrogelen geproduceerd die bestaan uit polyisocyanopeptide (PIC). 
Dit materiaal heeft unieke eigenschappen: PIC-gels blijven vloeibaar onder de 
15°C en vormen een stabiel 3D-netwerk bij 37°C en de structuur lijkt sterk op de 
natuurlijke extracellulaire matrix met een vergelijkbare verstijvingsreactie bij hoge 
spanningen [23]. Door chemische conjugatie door “kopervrije” klikchemie, werden 
zachte (G’ ̴ 200 Pa) PIC hydrogels verder gefunctionaliseerd met celbindende petiden 
(PIC-GRGDS) en met een MRI contrast contrastmiddel (PIC-GdDO3A). Vervolgens 
werden mengsels van beide gelen (PIC hybride) bereid om gels te creëren waardoor 
zowel cellulaire uitgroei en visualisatie via MRI mogelijk was. Na injectie in een 
muismodel werden PIC-GdDO3A- en PIC hybriden geevalueerd met behulp van MR 
beeldvorming. Longitudinale follow-up zorgde voor een fundamenteel inzicht in 
het gedrag van de hydrogel in de tijd: zachte PIC hydrogels verloren ongeveer 50% 
van het volume binnen 7 dagen na injectie. R1 relaxometrie en evaluatie van de 
contrast-to-noise-ratio bevestigde de verdichting van het geïnjecteerde materiaal 
als gevolg van vochtverlies in plaats van bulkdegradatie. Bovendien bleef het MRI-
signaal stabiel tot het einde van het experiment (28 dagen). Conventionele histologie 
correleerde goed met de MR beelden. De bevindingen van deze studie kunnen 
helpen bij de verdere ontwikkeling van PIC hydrogels die kunnen worden gebruikt 
voor een breed scala van doeleinden, zoals medicijn-en celtoevoer voor ureter 
regeneratie of urine afleiding door een kunststoma.
1 . 5  Ste ril i s ati e  va n  Co lla ge e n - ge ba s e e rd e  H y b ri d e  S c af f o l d s
Voor de klinische implementatie van tissue-engineered hybride constructen, die wordt 
gereguleerd door de Advance Therapies Medical Products (ATMP)-regeling van het 
EMA, en de FDA, is een gevalideerde FDA- en EMA-goedgekeurde sterilisatiemethode 
vereist. Aangezien de keuze van de sterilisatiemethode de prestaties van zowel 
synthetische [24]- als natuurlijke polymeren [25,26] kan beïnvloeden, werd het 
effect van γ-straling (25 kGray) en EtO-ontgassing op hybride scaffolds in vitro en 
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het effect op het remodelleren van de scaffolds in een groot diermodel bestudeerd 
(hoofdstuk 6). In dit hoofdstuk werden de collageen scaffolds versterkt met 
een biologisch afbreekbaar chirurgisch gaas (Vicryl®) om hybride scaffolds te 
vormen (COL-Vicryl®). De in vitro eigenschappen werden uitgebreid bestudeerd, 
met behulp van treksterkteanalyses en degradatiestudies. Voor in vivo evaluatie 
werden de constructen gedurende 1 maand subcutaan geïmplanteerd in geiten om 
gevasculariseerd weefsel te vormen. Macroscopisch en microscopisch verschilden 
de γ- en EtO-gesteriliseerde constructen licht van elkaar door de extra bewerking 
die nodig is voor de COL-Vicryl®-EtO-constructen. Ongeacht de sterilisatiemethode 
leidde incubatie in urine tot een snelle afbraak van het Vicryl® -polymeer en een 
verminderde sterkte. Het verschil tussen de twee sterilisatiemethoden was verder 
beperkt. Subcutane implantatie daarentegen toonde aan dat het effect van de 
sterilisatie aanzienlijk was. In beide gevallen werd een goed gevasculariseerde buis 
gevormd, maar de γ-bestraalde constructen toonde een georganiseerde bloedvat 
architectuur en deze was mechanisch beter vergelijkbaar met een natuurlijke ureter. 
Bovendien vertoonde het γ-bestraalde construct een betere weefselhermodellering, 
blijkend uit verhoogde ECM-productie van ingroeiende cellen. 
Deze studie toonde aan dat het effect van sterilisatie op weefselhermodellering 
niet alleen kan worden voorspeld door in vitro analyses. Daarom moeten 
gevalideerde sterilisatiemethoden zorgvuldig worden overwogen bij het ontwerpen 
van hybride scaffolds. Zoals in dit hoofdstuk wordt aangetoond, verbeterd 
y-sterilisatie de weefselhermodellering door het degradatieprofiel te veranderen, 
maar leidt y-sterilisatie ook tot een versnelde degradatie van het ondersteunende 
polymeer. Dit suggereert dat polymeren met een langzaam afbraakprofiel zoals 
polycaprolacton (PCL) moeten worden gebruikt om de constructen ook op lange 
termijn te kunnen ondersteunen [27]. Met het oog op ureterregeneratie en 
urineafleiding moet de ondersteunende structuur ten minste 1 maand intact blijven 
als deze na de preimplantatie gebruikt moet kunnen worden. Wanneer vervolgens 
EtO wordt gekozen als de gewenste sterilisatiemethode, blijft de afbraaksnelheid 
van de ondersteunende structuur en het collageen onaangetast [24-26,28,29].
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2 TOEKOMSTVISIE 
2 .1  D i e r m o d e ll e n  e n  K lin i s c h e  Tra n s lati e
Dit proefschrift beschrijft meerdere onderdelen van het ontwerpen van scaffolds 
voor het ontwikkelen van gepersonaliseerde functionele weefsels voor ureter 
reconstructie en urineafleiding. Om klinische translatie te bevorderen moeten deze 
hulpmiddelen worden geëvalueerd in preklinische studies. Het kiezen van een goed 
diermodel is hierbij een kritische stap. Grote diermodellen hebben de voorkeur 
omdat ze een betere vertaling naar de menselijke situatie mogelijk maken met 
betrekking tot de chirurgische technieken, dimensies van de scaffold en anatomie 
[30]. Toch kan de kinetiek van tissue-engineered constructen variëren: zo verschillen 
bijvoorbeeld Göttingen minivarkens van landrasvarkens in(cel)ingroei en vertonen 
ze verschillende regeneratiekinetiek [31]. Met het oog op de klinische translatie 
moet het totale scaffold design worden aangepast aan de specifieke afmetingen 
van de patiënt: De diameter, wanddikte en de (bio)mechanische eigenschappen 
van de ureter kunnen verschillen [32,33]. Daarom kan het de moeite waard zijn om 
specifieke ureterafmetingen af te leiden uit CT- en/of MRI-scans om vervolgens op 
maat gemaakte constructen te kunnen produceren. 
Om het nut van een (gepersonaliseerd) tissue-engineered construct volledig 
te kunnen beoordelen, moeten toekomstige dierstudies rekening houden met de 
standaard klinische behandeling, zoals reconstructie met autoloog darmweefsel. 
Alleen met een dergelijke controle kan een adequate vergelijking met het gekozen 
biomateriaal en de reconstructiestrategie gemaakt worden. Dit kan uiteindelijk 
helpen bij de vertaling van TE-benaderingen naar de kliniek als alternatieve 
behandeloptie. 
Bovendien is het tijdsbestek voor het genereren van functioneel kunstmateriaal 
belangrijk in de klinische setting wanneer complexe reconstructieprocedures, 
inclusief cel-zaaien en preimplantatie, worden overwogen. Voor urineafleiding 
(bijvoorbeeld na radicale cystectomie) is er maximaal 3 maanden tussen diagnose 
en chirurgische ingreep beschikbaar [4]. Aan de andere kant is ureterreconstructie 
(bijv. door een trauma) meestal acuut en is de beschikbare tijd veel korter. Een 
percutane nefrostomiekatheter kan worden gebruikt om de urine in een eerste 
stap af te voeren voordat een lange segmentaire ureterreconstructie volgt 
[34]. Door deze combinatie kan tijdwinst geboekt worden zodat een complexe 
reconstructieprocedure mogelijk wordt, hoewel de vorming van functioneel weefsel 
door middel van SMCs en UCs zo snel mogelijk dient te gebeuren.
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2 . 2  Fu n c ti o n e e l  We e f s e l
In het algemeen worden collageen in scaffolds chemisch aan elkaar gekoppeld door 
bijvoorbeeld N-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC)-carbodiimide 
(N-hydroxysuccinimide (NHS) om de sterkte en weerstand tegen enzymatische 
afbraak te verhogen. Deze crosslinking strategie kan echter de beschikbaarheid van 
essentiële celbindende eigenschappen verminderen, en heeft dus een sterke invloed 
op celmigratie, apoptose en proliferatie binnen de scaffolds [35]. Bij het gebruik van 
CHC zullen deze de sterkte bepalen en aangezien snellere regeneratiestrategieën 
gewenst zijn voor ureterreconstructie en urinereproductie, kan het de moeite waard 
zijn om collageen crosslinking achterwege te laten. Wanneer hybride scaffolds 
niet werden gecrosslinked konden er meer cellen aan collageen hechten en was 
de cellulaire uitgroei verbeterd (manuscript in voorbereiding). Conditionering 
van niet-gecrosslinkte hybride scaffolds bezaaid met primaire menselijke blaas 
gladde spiercellen (hbSMCs) in een bioreactor, genereerde functioneel weefsel 
waarschijnlijk omdat de dynamische stimulatie in combinatie met collageen de 
hbSMCs induceerde tot een meer volwassen, contractiel fenotype. 
Onder normale omstandigheden wordt de urinestroom actief geregeld door 
gladde spiercellen (SMCs) in de ureterwand. Zo kan toevoeging van SMCs aan 
(hybride) scaffolds helpen om functioneel weefsel te verkrijgen en complicaties 
te verminderen. Zoals beschreven in hoofdstuk 2, zijn stamcellen zoals ADSCs 
(vet afgeleide stamcellen) van belang voor genitourinaire TE-toepassingen. In 
toekomstige studies kan de zogenaamde adipose stromal vascular fraction (SVF) 
een geschikte celbron zijn. Deze kan worden geïsoleerd uit gemakkelijk toegankelijk 
vetweefsel en gezaaid worden op (hybride) scaffolds. De SVF bevat een heterogene 
celpopulatie bestaande uit endotheelcellen, macrofagen, pericyten en verschillende 
stamcelpopulaties [36] en wanneer deze cellen worden gestimuleerd in een 
bioreactorsysteem, kan glad spierweefsel worden gegenereerd [37]. Waneer 
cellen worden toegevoegd aan een scaffold is bioreactorstimulatie aan te raden. 
De mechanische stimulatie kan cellen stimularen te differentiëren naar een meer 
contractiel fenotype en cellen kunnen zich orientieren analoog aan natuurlijk 
weefsel [37,38]. In een preklinsche studie is aangetoond dat gecreerd functioneel 
spierbuisweefsel goed toepasbaar is bij urethra-reconstructies [39].
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2 . 3  N i et-inva s i ve  M o n ito rin g  va n  Fu n c ti o n e e l  We e f s e l  e n 
Ce ll e n
Met het oog op de beeldvorming van hybride scaffolds zoals beschreven in dit 
proefschrift, is er behoefte aan het in beeld brengen van zowel de ondersteunende 
component als de cellulaire laag. Aangezien ondersteunende structuren zoals de 
hier beschreven CHC een negatief contrast geeft in 1H-MR beeldvorming, moet de 
collageencomponent een positief contrast geven. Wanneer cellen worden gezaaid 
op deze constructen, kunnen cellen ook worden gelabeld met een contrastmiddel 
voor visualisatie. 19F-MRI kan worden gebruikt als instrument om cellen na injectie 
in vivo te volgen en te kwantificeren [40]. Voor TE toepassingen kunnen cellen 
eenvoudig worden gelabeld met een 19F-MRI contrastmiddel zoals PERFECTA [41] 
om ze te volgen. Deze strategie kan waardevolle kwalitatieve en kwantitatieve 
informatie geven over de celverdeling binnen de scaffolds. 19F-MR beelden kunnen 
eenvoudig over 1H-MR beelden worden gelegd en zo een efficiënte visualisatie van 
de 3 verschillende structuren mogelijk maken: cellen, collageen gelabeld met HL en 
CHC door 1H-MR imaging. Echter, het labelen van de cellen is tijdelijk en het contrast 
neemt af in de tijd, bijvoorbeeld door verdunning van het label tijdens de celdeling. 
Andere niet-invasieve monitoring strategieën zoals echografie kunnen ook 
worden gebruikt tijdens de kweek in een bioreactor. Het is aangetoond dat de 
grijswaarden van de beelden goed correleren met nieuw gevormd collageen in 
fibrine gebaseerde constructen [42]. Bovendien kan deze techniek worden gebruikt 
om het mechanische gedrag van TE constructen te beoordelen tijdens stimulatie in 
een bioreactor [43]. Hoe dit zich vertaalt naar de in vivo omgeving moet nog worden 
vastgesteld.
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on how many coils I made, and on how many times I failed during the secondment. 
However, you encouraged me to stay on the topic and provided me with smart ideas. 
“Danielito”, thanks for the good time in Uppsala and for your friendship. 
Another example for a fruitful collaboration within iTERM was the work with 
MRI contrast agents. Dear Joan, thank you so much for your help on synthesizing 
various PIC hydrogels and for the good times we had spent together inside- and 
outside the lab. I wish you all the best for the future. Furthermore, my deepest 
gratitude goes to Dr. Paul Kouwer for enlightening discussions, proofreading 
sessions and his encouragement. 
Furthermore, I will never forget the good memories associated with the awesome 
MRI contrast agent called Hemin-Lysinate. Many thanks to Nihan Güvener and Dr. 
Sjef Cremers for providing me this contrast agent. Dear Nihan and Sjef, furthermore 
I would like to thank both of you for your help in the lab and on finalizing the 
manuscript, and the many good talks we had after work in the “cultuur café” or the 
“Tangente”! Nihan, I wish you all the best for finalizing your PhD thesis. Don’t worry, 
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you will rock it! Furthermore, I appreciate the comments and suggestions of Prof. 
Dr. Paul Borm and Prof. Dr. Fabian Kiessling to improve the “hemin story”. 
After having prepared (hybrid) scaffolds it was time for MR imaging. Without 
the help of the following people I would still sit at PRIME and cry. My deepest 
gratitude goes to Prof. Dr Arend Heerschap. Dear Arend, many thanks for giving me 
the opportunity to work with the 11.7T preclinical MR scanner and to perform my 
experiments with animal models. You were always highly interested in my work and 
very curious in testing TE-constructs in the MRI. Your help and MRI knowledge were 
of utmost importance especially during finalizing the manuscripts. Regarding the MRI 
scanner itself, I would like to thank Andor Veltien and Sjaak van Asten for technical 
support. Dear Andor and Sjaak, you were also there to help especially when there 
were technical problems. Just one call, you came within 15 minutes, and solved the 
problem! I owe you many drinks! Last but not least, special thanks to Dr. Weiqiang 
(Chris) Dou. Dear Weiqiang, I am still very happy that I met you. Without your huge 
help and knowledge especially on optimizing the MR scanning protocols, several 
projects weren’t that successful. We spend uncountable hours at PRIME. However, 
and more important, besides all the experiments you became a good friend! 
Now it’s time to acknowledge Dr. Simone Mastrogiacomo! Dear Simone, we started 
together in Nijmegen as iTERM fellows and PhD students, albeit in different labs. However, 
we always had a strong connection. You were a good friend since the beginning. When 
I was frustrated or just in doubt about PhD-related issues, you were the best person to 
talk with. After long discussions with you -preferably at the bar- and Pizza at your place, 
everything was fine again! Together we managed the ups and downs in the tough life 
of a PhD student. You also introduced me to all the smart- and amazing people of the 
Biomaterials Department. Together we had a lot of fun at the PhD retreat or just at the 
“Casa Mastrogiacomo”. Thank you very much for everything my brother! It was an honour 
to be your paranymph at your defence. I wish you and Giuliana all the best in the US!
All the animal studies that performed during my PhD would have been very challenging 
without the support from the staff of the central animal laboratory (CDL) and Preclinical 
Imaging Center (PRIME). Thanks to Michael, Kitty, Karin, Iris, Wilma and Bianca. With 
your help, the animal experiments were performed much easier. Furthermore, I 
would like to thank Dr. Rob de Vries et al. from SYRCLE (SYstematic Review Centre for 
Laboratory animal Experimentation) for the hands-on training in synthesis of evidence 
in animal experimentation which inspired and still inspires a lot of (young) researcher.
534676-L-bw-Janke
Processed on: 27-8-2019 PDF page: 191
191
When I recall all the experiments to characterize the (bio)mechanical of my 
constructs, I am deeply thankful that I had the support of two persons: Roger 
Lomme and Edwin Rozen, or better called the “Nijmegen super-centre for testing 
(bio)mechanical properties of soft tissue”. Dear Roger and Edwin, I will never forget 
your help with the “Zwick” and its equipment. We had many fruitful discussions 
about the different (bio)mechanical testing methods and there were uncountable 
nice testing sessions we have spent in your lab. Thanks a lot!
There was always a strong collaboration between the matrix biochemistry group and 
the Tissue Engineering group within the Lab of Experimental Urology. I would like 
to express my deepest gratitude to Dr. Toin van Kuppevelt for his broad expertise 
in using collagen as a smart biomaterial for Tissue Engineering applications. 
Subsequently, I would to thank Dr. Willeke Daamen for being my mentor within the 
RIMLS PhD programme and for the discussions we had during our regular meetings. 
Dear Willeke, many thanks for your advice and encouragement. Additionally, 
many thanks to Elly Versteeg. Dear Elly, I appreciate your help at the microscope, 
the homogenizer, and the freeze-dryer. Furthermore, thank you very much for 
performing some trial/feasibility stainings for me and my student. 
In general, great memories are associated with the matrixbiochemistry 
group. Many thanks to Danique, Lars, Henk, René, Corien, Luuk and Michiel for 
integrating in your group and many thanks for the unforgettable moments in- and 
outside the lab! We did a lot of activities together (e.g. NBTE meetings, after work 
meetings at the SQL, pizza at Romana, whiskey tasting, 4 daagse and the legendary 
“Frinkandelleneetwedstrijd 2014”). I will never forget my first Party in Nijmegen: 
“Apres-Ski Party” @ SQL + “Aftershow Party” @ Rene’ .
Now let’s write about the famous “Collagen Mansion” at the “Via Gladiola”! Dear 
Luuk and Michiel, I am so thankful and proud that you asked me to join the mansion 
when Paul left. I really enjoyed the time there and it became a second home for me. 
Many thanks for the good times in- and outside the mansion. For me, the mansion 
was always the “place-to-be” not only during 4 daagse! Dear Michiel, thanks for 
being a good friend at any time. I wish you, Lies and Mieke all the best for the future! 
Dear Luuk, thanks for all the legendary discussions we had, especially those about 
football and our villages! I still have the “Lierop-Song” in my ears! 
I would also like to thank the other housemates Ruud, Daniek and Dianne for 
being a part and enrichment of the mansion. 
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Truly, this thesis was not possible without the people from the Lab of Experimental 
Urology: MY FAMILY! My time in the Netherlands would never been so pleasant and 
enjoyable without my wonderful colleagues which made me feel home since the first 
day! I am so thankful that I ever met Gerald, Onno, Cindy, Mirjam, Egbert, Tilly, Dorien, 
Kees, Jeannette, Elze, Marion and Renate. All smart people, open-minded, true saviors 
and friends! I learned a lot from each of you and all truly contributed to this thesis! 
Thanks for the pleasant time and unforgettable moments (there are far too many to list) 
in the lab. Furthermore, I would like to thank all the other PhD students and residents 
for their friendship and good vibrations. Levi, Vicky, Ola, Sabrina, Anglita, Caroline, Allert, 
Siebren, Boy, Dick, Hans, Rianne, Ruben, Max, Tom, Elle, Maarten, Sebastian, Cindy and 
Jasmijn. Really the URL was like a family! We respected each other, laughed together 
and had much fun… but we also stayed together and took care of each other in (very) 
dark times. 
Many thanks to Boy Rozenberg for being my personal medical doctor during the time 
in Nijmegen. Dear Boy, you diagnosed me often with “Aanstelleritis” especially when I was 
too pessimistic and even scared of future experiments. The best treatment for this kind 
of illness were drinks @ SQL, eating “Kapsalon” and watching STAR WARS with you. May 
the force be with you, Marcella and James! Dear Allert, thanks for the many “wordgrapjes” 
which made my day in the lab. Will never forget our weekly Pubquiz activities together with 
Gabriel. Dear Kees, many thanks for organizing the famous Lab Pubquiz, for arranging all 
the lab equipment I needed, and your friendship. Dear Caroline, you became my U-mate 
2.0 and a good colleague to talk with. Our analyses over the recent Game of Thrones 
episodes together with Paul and Sebastian were just EPIC! Dear Anglita, many thanks for 
your support regarding scoring of the histological stainings. Furthermore, many thanks 
for the great Indonesian dishes you prepared for lunchbreak. Herr Professor(!), Dear Jack, 
you can be proud of this people. It was an honour to have performed this thesis in your 
lab. Jack, thanks for all the nice scientific- and non-scientific discussions, interest in my 
work and your encouragement. I wish you and Anja all the best for the future.
And Egbert you can be proud of the Tissue Engineering group in our lab. For me it 
was an honour to work with Alejandra, Silvia, Kaizheng (Max), Rayna, Bronte, Wouter, 
Peter L., Tamar, Linde, Bronte, Paul, Marije and Dorien. Furthermore, I would like to 
thank my students Sanne, Dounia and Leonie for their contribution to several projects.
Dear Alejandra, I still remember your direct and warm-hearted personality. 
Thanks for all the nice moments in the lab or after work at Sint Anneke. I wish you 
and Alan all the best for the future.
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Dear Silvia, what would I do without you? I guess still sitting in the corner and thinking 
about the best experimental set-ups. Thank you very much for all the discussions and 
brilliant ideas you had. I still have your voice in my ears when you started the discussion 
with “PETERRRRR JANKE”. You were truly an enrichment for the whole TE group. I am 
still impressed about your broad knowledge about TE. You are a real tissue-engineer! 
I wish you, Dennis, Amy, Noah and Jason all the best for the future. 
Dear Kaizheng, thanks for helping me with handling the PIC hydrogels and for 
your good explanations. Dear Rayna, I really enjoyed your company especially during 
cell culturing. 
Dear Bronte, many thanks for your help especially in the beginning of my 
adventure in Nijmegen. I will never forget all the amazing conversations we had. 
I would also like to thank Dr. Martin Koens and Dr. Paul Geutjes, the pioneers 
of designing tubular collagen-based scaffolds! Dear Martin and Paul, thank you 
very much for all the priceless discussions and advices you gave especially at the 
beginning of my PhD. 
To be a successful PhD candidate you need to learn, to be patient, to focus… and 
you need to have Dorien Tiemessen! Dear Dorien, some experiments would have 
been very challenging without your fundamental help. When you were around, 
everything was fine! Thank you very much for your support in the cell culture room, 
at the SEM and for helping me with all the histochemistry. There was always a 
positive atmosphere when we worked together. Truly, I really learned a lot from 
you, and I am so thankful for this. Besides that, you became a good mentor and a 
friend in- and outside the lab. 
This section is dedicated to my paranymphs. It’s an honour to have Dr. Marije Sloff 
on my side. Dear Marije, you were my U-mate and colleague, but more important 
you became a true friend! You were always there when help was needed. Since the 
beginning, you are good partner to talk with. You were listening to all my issues and 
gave the right feedback. If needed, in a sensitive, yet direct way. In the beginning, I 
was a bit afraid of that directness ;-). Seriously, I really enjoyed your company in the 
lab and when we went to symposia or congresses. Also, outside the scientific world, 
we had legendary moments. I will never forget our trips together with your husband 
Derk und the “Milsbeek / Jaarclub” crew to the Oktoberfest in Munich. I am very 
glad that you will be on my side during the defence. Thanks for everything Malije! 
Actually, I am so thankful that you were sitting right between Paul and me in lab, so 
you could act as a referee or as a “slapmaster” when I was in trouble with that guy.
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This brings us to the next paranymph: Dr. Paul, Kees, Jan, Dick de Jonge. I am so 
sorry for you that you cannot be one of the opponents during my defence. I wanted 
you to be at my side! “Junge”, you are like a brother for me. During the past 6 years 
we had lot of hilarious/legendary/awesome moments together. You were a good 
partner in crime in the lab, @ SQL, or elsewhere in the world. Additionally, many 
thanks for being my personal coach in the gym, during next-level-outdoor exercises 
and during boxing sessions. I will never forget that I showed you a kick you will never 
forget. Bro! Thanks for being a very good friend!
Ein guter Gegenpol zu dem anstrengenden Leben als Doktorand bilden Freunde und 
Familie. Ein herzlicher Dank gilt meinen „Jungs“ in der Heimat, die mich teilweise 
seit dem Kindergarten begleiten. Benni, Peterchen, Thomas, Christoph, Nils, Martin 
B., Lucas, Gregor, Andreas, Hermann-Josef, Dominik, Martin S., Jörn, Christian 
und Volker. In besonderer Erinnerung bleibt mein Junggesellenabschied während 
4 daagse in Nijmegen! Aber auch an den „normalen“ Wochenenden wart ihr in 
besonderer Weise für mich da. Ihr wart Therapeuten, gute Zuhörer, und ziemlich 
beste Freunde! Danke für alles!
Zum guten Schluss möchte ich meiner Familie danken. Ihr wart wahrhaftig immer 
für mich da! 
Zunächst gilt ein besonderer Dank meiner (Schwieger)-Familie in Niederkrüchten 
Karin, Klaus, Janina und Theo. Danke für Eure Unterstützung und das Interesse an 
meiner Doktorarbeit während all den langen Jahren. 
Ich danke meinem Zwillingsbruder Heinz Bert. Berti, mein kleiner Bruder, 
du hast dich schon seit frühester Kindheit um mich gekümmert. So hat es mich 
nicht gewundert, dass Du deine Passion im Pflegebereich gefunden hast. Ich habe 
großen Respekt vor deiner Tätigkeit in der Intensivpflege. Du bist jeden Tag für deine 
Patienten und Mitmenschen da! Der Patient steht bei dir im Vordergrund; ein hohes 
Ideal welches leider nicht mehr selbstverständlich ist. Lass dich nicht entmutigen. 
Auch bin ich froh, dass du deinen Weg gefunden hast. Ich wünsche dir und Sebastian 
alles Gute für die Zukunft.
Ein weiterer Dank gilt meiner großen Schwester Beate. Liebes Schwesterherz, nie 
werde ich deine Unterstützung vergessen! Seit ich denken kann, warst du immer für 
mich und die ganze Familie da. Oft warst du Taxifahrer, Zuhörer, Ratgeber, Betreuer 
und Führsprecher in einer Person. Wer dich an seiner Seite hat, kann sich Wahrhaft 
glücklich schätzen. Danke für alles liebste Schwester!
534676-L-bw-Janke
Processed on: 27-8-2019 PDF page: 195
195
Ein großer Dank gilt meiner lieben Mutter. Liebe Mama, du hast mich, Beate 
und Berti allein großgezogen und dabei noch eine Metzgerei (+ Partyservice + 
Wirtschaft) geführt. Du warst und bist ein großes Vorbild für mich. Du hast mir 
vieles beigebracht und oft gezeigt was richtig und was falsch ist. Weiter hast du 
mir vieles ermöglicht. Natürlich habe ich dir so manche Bauchschmerzen bereitet 
und oft warst du skeptisch über manchen eingeschlagenen Weg. Aber du bist den 
Weg mitgegangen und warst mit gutem Rat an meiner Seite. Den Weg Doktorarbeit 
konnte ich meistern. Mama, ich hoffe du bist stolz auf mich. 
Zum Schluss möchte ich mich bei meiner geliebten Frau bedanken. Mein Leben 
einschließlich dieser Doktorarbeit wäre sicherlich nicht so wie jetzt verlaufen, 
hätte ich dich, liebe Alena, nicht kennengelernt. Du hast mich ermutigt Biomedical 
Engineering zu studieren und mich weiterzuentwickeln. Als ich das Angebot bekam 
nach Nijmegen zu gehen, hast du nicht lange überlegt und dein volles Einverständnis 
gegeben. Während dieser Zeit warst du die tragende Säule in meinem Leben. Du 
warst immer an meiner Seite und dein Support kannte keine Grenzen. Du hast mir 
den Rücken freigehalten, so dass ich mich voll auf diese Arbeit konzentrieren konnte. 
Oft war ich sehr angespannt und unsicher. Doch du hast alles ertragen und konntest 
mich immer wieder aufs Neue motivieren. 
Während dieser Zeit gab es viele Höhen und Tiefen, die wir durchlebten. Doch 
wir sind immer wieder aufgestanden und speziell du hast dafür gesorgt, dass es 
weiter geht! Dafür bin ich dir unendlich dankbar. Daher ist diese Doktorarbeit Dir 
gewidmet. Wahrhaftig hast Du sehr großen Anteil an dieser Arbeit! 
Du bist eine großartige Ehefrau und eine herzensgute Mutter. Ich bin unsagbar 
stolz auf dich und auf unseren Sohn Mares! Lieber Mares, du hast das Leben von 
Mama und mir grundlegend verändert. Du hast uns gezeigt, was im Leben wirklich 
wichtig ist. Danke für jedes Lächeln und die nötige Ablenkung während der Endphase 
dieser Doktorarbeit. Ich verspreche dir ein guter Vater zu sein!
Danke für alles ihr 2! Ich liebe Euch!... Immer!
Garzweiler im August 2019
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Re s e a rc h  Dat a  M a n a ge m e nt  u s in g  FAI R  Prin cip l e s
The research data management of this thesis was performed according to the FAIR 
principles to ensure findability, accessibility, interoperability, and reusability [1]:
For findability purposes, raw- and processed data produced in this thesis were 
recorded on paper in traditional laboratory notebooks as well as digitally on a 
local server (H drive) within the Laboratory of Experimental Urology, Department 
of Urology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboudumc 
Nijmegen (NL). In the end-period of this thesis, data were also recorded and stored 
on a digital laboratory notebook (Labguru) within the department. Back-up of the 
local server and Labguru were performed by the Information and Communications 
Technology (ICT) Radboudumc. Furthermore, published data and references used 
in this thesis were assigned to a unique digital object identifier (DOI) which allows 
for exact findability.
For accessibility, data files on the local server and Labguru are accessible by 
assigned laboratory members of the Laboratory of Experimental Urology. After the 
end of the experiment, data were locked and can only be viewed but not edited. 
Furthermore, the standard communication protocol for already published data 
and references were in general http(s)-based which are open, free and universally 
implementable. For example, data and references are accessible via the homepage 
of the journal on which the data and references have been published. Subsequently, 
published data and references are accessible e.g. via PubMed and ResearchGate as 
well as all data files can be requested by the author of this thesis.
The data used for this thesis were saved in widely used file formats (e.g. doc(x), 
xls(x), pzf(x), pdf, tif, jpg) ensuring interoperability. The language used in this 
thesis is English to reach a broad audience and data are presented in a detailed, 
formal and objective way. Furthermore, the vocabulary, keywords and chapter 
titles mainly include MeSH (medical subject headings) terms and sub headings for 
standardization.
In this thesis, the Materials and Methods section in every chapter are described 
as detailed as possible to ensure reusability of generated data.
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